activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	789707	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	N[C@@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL432168	=	IC50	nM	50.0	CHEMBL4101	Homo sapiens	IC50	uM	0.05
	789707	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	N[C@@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL432168	=	IC50	nM	50.0	CHEMBL4101	Homo sapiens	IC50	uM	0.05
	793584	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	NC[C@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL307708	=	IC50	nM	170.0	CHEMBL4101	Homo sapiens	IC50	uM	0.17
	794654	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CN2CCC(CC2)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL78129	=	IC50	nM	1700.0	CHEMBL4101	Homo sapiens	IC50	uM	1.7
	794663	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CC(C(=O)C(F)(F)F)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL262980	=	IC50	nM	2600.0	CHEMBL4101	Homo sapiens	IC50	uM	2.6
	795789	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	CC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL441802	=	IC50	nM	3600.0	CHEMBL4101	Homo sapiens	IC50	uM	3.6
	798003	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1COCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306373	=	IC50	nM	450.0	CHEMBL4101	Homo sapiens	IC50	uM	0.45
	798012	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CNCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67442	=	IC50	nM	350.0	CHEMBL4101	Homo sapiens	IC50	uM	0.35
	798021	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1C[C@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL75661	=	IC50	nM	230.0	CHEMBL4101	Homo sapiens	IC50	uM	0.23
	800443	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1C[C@@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL75004	=	IC50	nM	220.0	CHEMBL4101	Homo sapiens	IC50	uM	0.22
	804156	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CC(O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306580	=	IC50	nM	130.0	CHEMBL4101	Homo sapiens	IC50	uM	0.13
	809512	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	70.0	CHEMBL4101	Homo sapiens	IC50	uM	0.07
	809521	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	CC1(C)C2CCC1(C)[C@@H](OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)[C@@H]2NC(=O)c1ccc(O)cc1		CHEMBL309078	=	IC50	nM	26000.0	CHEMBL4101	Homo sapiens	IC50	uM	26.0
	810673	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	CN1C2CCC1C(NC(=O)c1ccc(O)cc1)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2		CHEMBL306883	>	IC50	nM	50000.0	CHEMBL4101	Homo sapiens	IC50	uM	50.0
	811842	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CSCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL76537	=	IC50	nM	7500.0	CHEMBL4101	Homo sapiens	IC50	uM	7.5
	811851	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CS(=O)(=O)CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL305718	=	IC50	nM	38000.0	CHEMBL4101	Homo sapiens	IC50	uM	38.0
	813179	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@H]1CNCCC[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL77970	=	IC50	nM	5200.0	CHEMBL4101	Homo sapiens	IC50	uM	5.2
	813188	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CCCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL304549	=	IC50	nM	1400.0	CHEMBL4101	Homo sapiens	IC50	uM	1.4
	813197	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	COC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL77399	=	IC50	nM	13000.0	CHEMBL4101	Homo sapiens	IC50	uM	13.0
	818011	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	CC(C)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL76920	<	IC50	nM	330.0	CHEMBL4101	Homo sapiens	IC50	uM	0.33
	818020	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	CNC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL312067	=	IC50	nM	3000.0	CHEMBL4101	Homo sapiens	IC50	uM	3.0
	820332	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	30.0	CHEMBL4101	Homo sapiens	IC50	uM	0.03
	820341	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	CS(=O)(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL306623	=	IC50	nM	4500.0	CHEMBL4101	Homo sapiens	IC50	uM	4.5
	821385	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1C2CCC(C2)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL80525	=	IC50	nM	1900.0	CHEMBL4101	Homo sapiens	IC50	uM	1.9
	821394	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1C2CC(C3CCCC32)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL263910	=	IC50	nM	32000.0	CHEMBL4101	Homo sapiens	IC50	uM	32.0
	822485	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	50.0	CHEMBL4101	Homo sapiens	IC50	uM	0.05
	823725	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	O=C(N[C@@H]1C[C@@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL309034	=	IC50	nM	250.0	CHEMBL4101	Homo sapiens	IC50	uM	0.25
	826282	CHEMBL770106	Inhibitory concentration against recombinant human cAMP-dependent Protein kinase A	B	NC[C@@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL308263	=	IC50	nM	90.0	CHEMBL4101	Homo sapiens	IC50	uM	0.09
0.0053 +/- 0.0007	1790347	CHEMBL912715	Inhibitory potency towards human cAPK C alpha in the presence of 100 uM ATP and 30 uM TAMRA-kemptide	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	IC50	nM	5.3	CHEMBL4101	Homo sapiens	IC50	uM	0.0053
0.067 +/- 0.019	1790348	CHEMBL912715	Inhibitory potency towards human cAPK C alpha in the presence of 100 uM ATP and 30 uM TAMRA-kemptide	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	IC50	nM	67.0	CHEMBL4101	Homo sapiens	IC50	uM	0.067
0.0083 +/- 0.0015	1790401	CHEMBL912715	Inhibitory potency towards human cAPK C alpha in the presence of 100 uM ATP and 30 uM TAMRA-kemptide	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	IC50	nM	8.3	CHEMBL4101	Homo sapiens	IC50	uM	0.0083
0.109 +/- 0.021	1790402	CHEMBL912715	Inhibitory potency towards human cAPK C alpha in the presence of 100 uM ATP and 30 uM TAMRA-kemptide	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	IC50	nM	109.0	CHEMBL4101	Homo sapiens	IC50	uM	0.109
	1981703	CHEMBL899231	Inhibition of cAPK Calpha in presence of 0.1 mM ATP	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1C[C@H](O)[C@@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL438491	=	IC50	nM	97.3	CHEMBL4101	Homo sapiens	IC50	nM	97.3
	1981705	CHEMBL899230	Inhibition of cAPK Calpha in presence of 1 mM ATP	B	COC(=O)[C@H]1C[C@H](O)[C@@H](n2cnc3c(N)ncnc32)C1	Outside typical range	CHEMBL235072	>	IC50	nM	1000000.0	CHEMBL4101	Homo sapiens	IC50	uM	1000.0
	1981706	CHEMBL899230	Inhibition of cAPK Calpha in presence of 1 mM ATP	B	COC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1	Outside typical range	CHEMBL235074	=	IC50	nM	168000.0	CHEMBL4101	Homo sapiens	IC50	uM	168.0
	1981707	CHEMBL899230	Inhibition of cAPK Calpha in presence of 1 mM ATP	B	COC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1	Outside typical range	CHEMBL235074	=	IC50	nM	169824.37	CHEMBL4101	Homo sapiens	Log IC50		-3.77
	1981708	CHEMBL899231	Inhibition of cAPK Calpha in presence of 0.1 mM ATP	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1C[C@H](O)[C@@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL438491	=	IC50	nM	97.72	CHEMBL4101	Homo sapiens	Log IC50		-7.01
	1981709	CHEMBL899231	Inhibition of cAPK Calpha in presence of 0.1 mM ATP	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	IC50	nM	12.9	CHEMBL4101	Homo sapiens	IC50	nM	12.9
	1981710	CHEMBL899231	Inhibition of cAPK Calpha in presence of 0.1 mM ATP	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	IC50	nM	12.88	CHEMBL4101	Homo sapiens	Log IC50		-7.89
	2250946	CHEMBL1011040	Inhibition of PKAalpha	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL4101	Homo sapiens	IC50	uM	4.0
	2250975	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL450179	=	Kd	nM	319.0	CHEMBL4101	Homo sapiens	Kd	uM	0.319
	2250976	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	C[C@@H](NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(=O)NCCCCCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O		CHEMBL498924	=	Kd	nM	1.8	CHEMBL4101	Homo sapiens	Kd	nM	1.8
	2250977	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	C[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O		CHEMBL505949	=	Kd	nM	5.8	CHEMBL4101	Homo sapiens	Kd	nM	5.8
	2250978	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL447678	=	Kd	nM	594.0	CHEMBL4101	Homo sapiens	Kd	nM	594.0
	2250979	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL506331	=	Kd	nM	8.7	CHEMBL4101	Homo sapiens	Kd	nM	8.7
	2250980	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	<	Kd	nM	0.5	CHEMBL4101	Homo sapiens	Kd	nM	0.5
	2250981	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL524516	=	Kd	nM	0.5	CHEMBL4101	Homo sapiens	Kd	nM	0.5
	2250982	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL509411	=	Kd	nM	95.4	CHEMBL4101	Homo sapiens	Kd	nM	95.4
	2250983	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL465518	=	Kd	nM	247.0	CHEMBL4101	Homo sapiens	Kd	nM	247.0
	2250984	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL449834	=	Kd	nM	83.0	CHEMBL4101	Homo sapiens	Kd	nM	83.0
	2250985	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL495088	=	Kd	nM	9.5	CHEMBL4101	Homo sapiens	Kd	nM	9.5
	2250986	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL500989	=	Kd	nM	12.6	CHEMBL4101	Homo sapiens	Kd	nM	12.6
	2250987	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL297394	=	Kd	nM	7.6	CHEMBL4101	Homo sapiens	Kd	nM	7.6
	2250988	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NC(=O)[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL454225	=	Kd	nM	1960.0	CHEMBL4101	Homo sapiens	Kd	uM	1.96
	2250989	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL450260	>	Kd	nM	100000.0	CHEMBL4101	Homo sapiens	Kd	uM	100.0
	2250990	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NCCCCCC(=O)NCc2ccccc2)[C@@H](O)[C@H]1O		CHEMBL522899	=	Kd	nM	13500.0	CHEMBL4101	Homo sapiens	Kd	uM	13.5
	2250991	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NCCCCCC(=O)NCCO)[C@@H](O)[C@H]1O		CHEMBL510221	=	Kd	nM	18700.0	CHEMBL4101	Homo sapiens	Kd	uM	18.7
	2250992	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NCCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL496141	=	Kd	nM	1640.0	CHEMBL4101	Homo sapiens	Kd	uM	1.64
	2250993	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL497800	=	Kd	nM	6050.0	CHEMBL4101	Homo sapiens	Kd	uM	6.05
	2250994	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL523401	=	Kd	nM	8230.0	CHEMBL4101	Homo sapiens	Kd	uM	8.23
	2250995	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL523738	=	Kd	nM	443.0	CHEMBL4101	Homo sapiens	Kd	uM	0.443
	2250996	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL501706	=	Kd	nM	249.0	CHEMBL4101	Homo sapiens	Kd	uM	0.249
	2250997	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NC(=O)CCCCCNC(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL521551	=	Kd	nM	52100.0	CHEMBL4101	Homo sapiens	Kd	uM	52.1
	2250998	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NC(=O)CCCNC(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL495767	=	Kd	nM	98700.0	CHEMBL4101	Homo sapiens	Kd	uM	98.7
	2250999	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL495766	=	Kd	nM	2180.0	CHEMBL4101	Homo sapiens	Kd	uM	2.18
	2251000	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NCCCCCC(=O)O)[C@@H](O)[C@H]1O		CHEMBL496365	=	Kd	nM	55800.0	CHEMBL4101	Homo sapiens	Kd	uM	55.8
	2251003	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	Cl.Cl.O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1315166	=	IC50	nM	100.0	CHEMBL4101	Homo sapiens	IC50	nM	100.0
	2251004	CHEMBL1011050	Inhibition of PKA catalytic subunit alpha using 1 mM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	Cl.Cl.O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1315166	=	IC50	nM	850.0	CHEMBL4101	Homo sapiens	IC50	nM	850.0
	2251013	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	C[C@@H](NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(=O)NCCCCCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O		CHEMBL498924	=	IC50	nM	21.1	CHEMBL4101	Homo sapiens	IC50	nM	21.1
	2251014	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	C[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O		CHEMBL505949	=	IC50	nM	97.0	CHEMBL4101	Homo sapiens	IC50	nM	97.0
	2251015	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	IC50	nM	5.32	CHEMBL4101	Homo sapiens	IC50	nM	5.32
	2251016	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL524516	=	IC50	nM	13.4	CHEMBL4101	Homo sapiens	IC50	nM	13.4
	2251017	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL297394	=	IC50	nM	54.0	CHEMBL4101	Homo sapiens	IC50	nM	54.0
	2251018	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL501706	=	IC50	nM	2100.0	CHEMBL4101	Homo sapiens	IC50	nM	2100.0
	2251019	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL495766	=	IC50	nM	26000.0	CHEMBL4101	Homo sapiens	IC50	nM	26000.0
	2251020	CHEMBL1011048	Inhibition of PKA catalytic subunit alpha using 100 uM ATP and 30 uM TAMRA-kemptide substrate by fluorometric TLC assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL450179	=	IC50	nM	2600.0	CHEMBL4101	Homo sapiens	IC50	nM	2600.0
	2251028	CHEMBL1011049	Binding affinity to PKA catalytic subunit alpha by fluorescence polarization assay	B	Cl.Cl.O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1315166	=	Kd	nM	23000.0	CHEMBL4101	Homo sapiens	Kd	uM	23.0
	2251053	CHEMBL1011928	Inhibition of PKA catalytic subunit alpha at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	104.0	CHEMBL4101	Homo sapiens	INH	%	104.0
	2296612	CHEMBL1034200	Inhibition of PKAalpha	B	O=C1N=C(NCc2ccccc2)S/C1=C\c1c[nH]c2ncccc12		CHEMBL484990	<	IC50	nM	50.0	CHEMBL4101	Homo sapiens	IC50	nM	50.0
	2361185	CHEMBL970661	Inhibition of PKAalpha	B	COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL505896	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	nM	100000.0
	2361207	CHEMBL970661	Inhibition of PKAalpha	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL453737	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	nM	100000.0
	2361230	CHEMBL970661	Inhibition of PKAalpha	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1		CHEMBL447602	>	IC50	nM	25000.0	CHEMBL4101	Homo sapiens	IC50	nM	25000.0
	2419146	CHEMBL1019634	Inhibition of PRKACA at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	0.0	CHEMBL4101	Homo sapiens	INH	%	0.0
	2470362	CHEMBL981744	Inhibition of PKAC-alpha at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4101	Homo sapiens	INH	%	10.0
	2511974	CHEMBL973495	Inhibition of PRKACA at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	7.0	CHEMBL4101	Homo sapiens	INH	%	7.0
	2596888	CHEMBL1017906	Inhibition of PKAC-alpha assessed as enzyme activity relative to control	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Activity	%	30.0	CHEMBL4101	Homo sapiens	Activity	%	30.0
	2596895	CHEMBL1017906	Inhibition of PKAC-alpha assessed as enzyme activity relative to control	B	C[C@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL457871	=	Activity	%	18.0	CHEMBL4101	Homo sapiens	Activity	%	18.0
	2661423	CHEMBL1058629	Inhibition of PKAalpha	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	2893866	CHEMBL1061087	Percentage PKA activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	102.0	CHEMBL4101	Homo sapiens	Activity	%	102.0
Antagonist	2893867	CHEMBL1061087	Percentage PKA activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	26.0	CHEMBL4101	Homo sapiens	Activity	%	26.0
	2893868	CHEMBL1061087	Percentage PKA activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	63.0	CHEMBL4101	Homo sapiens	Activity	%	63.0
	2893869	CHEMBL1063724	Percentage PKA activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	89.0	CHEMBL4101	Homo sapiens	Activity	%	89.0
	2893870	CHEMBL1063724	Percentage PKA activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	72.0	CHEMBL4101	Homo sapiens	Activity	%	72.0
Antagonist	2893871	CHEMBL1063724	Percentage PKA activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	3.0	CHEMBL4101	Homo sapiens	Activity	%	3.0
	2893872	CHEMBL1063724	Percentage PKA activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	79.0	CHEMBL4101	Homo sapiens	Activity	%	79.0
	2893873	CHEMBL1063724	Percentage PKA activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	51.0	CHEMBL4101	Homo sapiens	Activity	%	51.0
Antagonist	2893874	CHEMBL1063724	Percentage PKA activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	50.0	CHEMBL4101	Homo sapiens	Activity	%	50.0
	2893875	CHEMBL1063724	Percentage PKA activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	59.0	CHEMBL4101	Homo sapiens	Activity	%	59.0
	2893876	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	87.0	CHEMBL4101	Homo sapiens	Activity	%	87.0
	2893877	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	108.0	CHEMBL4101	Homo sapiens	Activity	%	108.0
	2893878	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	68.0	CHEMBL4101	Homo sapiens	Activity	%	68.0
	2893879	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	59.0	CHEMBL4101	Homo sapiens	Activity	%	59.0
	2893880	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	85.0	CHEMBL4101	Homo sapiens	Activity	%	85.0
	2893881	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	79.0	CHEMBL4101	Homo sapiens	Activity	%	79.0
	2893882	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	97.0	CHEMBL4101	Homo sapiens	Activity	%	97.0
	2893883	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	77.0	CHEMBL4101	Homo sapiens	Activity	%	77.0
	2893884	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	69.0	CHEMBL4101	Homo sapiens	Activity	%	69.0
Antagonist	2893885	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	46.0	CHEMBL4101	Homo sapiens	Activity	%	46.0
	2893886	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	80.0	CHEMBL4101	Homo sapiens	Activity	%	80.0
Antagonist	2893887	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	15.0	CHEMBL4101	Homo sapiens	Activity	%	15.0
Antagonist	2893888	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	8.0	CHEMBL4101	Homo sapiens	Activity	%	8.0
	2893889	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	73.0	CHEMBL4101	Homo sapiens	Activity	%	73.0
	2893890	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	85.0	CHEMBL4101	Homo sapiens	Activity	%	85.0
	2893891	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	56.0	CHEMBL4101	Homo sapiens	Activity	%	56.0
Antagonist	2893892	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	7.0	CHEMBL4101	Homo sapiens	Activity	%	7.0
	2893893	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	93.0	CHEMBL4101	Homo sapiens	Activity	%	93.0
	2893894	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	72.0	CHEMBL4101	Homo sapiens	Activity	%	72.0
	2893895	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	92.0	CHEMBL4101	Homo sapiens	Activity	%	92.0
	2893896	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	86.0	CHEMBL4101	Homo sapiens	Activity	%	86.0
	2893897	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	70.0	CHEMBL4101	Homo sapiens	Activity	%	70.0
	2893898	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	93.0	CHEMBL4101	Homo sapiens	Activity	%	93.0
	2893899	CHEMBL1062780	Percentage PKA activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	77.0	CHEMBL4101	Homo sapiens	Activity	%	77.0
	2893900	CHEMBL1061169	Percentage PKA activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	82.0	CHEMBL4101	Homo sapiens	Activity	%	82.0
	2893901	CHEMBL1061169	Percentage PKA activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	65.0	CHEMBL4101	Homo sapiens	Activity	%	65.0
	2893902	CHEMBL1063725	Percentage PKA activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	88.0	CHEMBL4101	Homo sapiens	Activity	%	88.0
	2893903	CHEMBL1061170	Percentage PKA activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	85.0	CHEMBL4101	Homo sapiens	Activity	%	85.0
	2893904	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	69.0	CHEMBL4101	Homo sapiens	Activity	%	69.0
	2893905	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	89.0	CHEMBL4101	Homo sapiens	Activity	%	89.0
	2893906	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	74.0	CHEMBL4101	Homo sapiens	Activity	%	74.0
	2893907	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	99.0	CHEMBL4101	Homo sapiens	Activity	%	99.0
	2893908	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	60.0	CHEMBL4101	Homo sapiens	Activity	%	60.0
	2893909	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	102.0	CHEMBL4101	Homo sapiens	Activity	%	102.0
	2893910	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	71.0	CHEMBL4101	Homo sapiens	Activity	%	71.0
	2893911	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	89.0	CHEMBL4101	Homo sapiens	Activity	%	89.0
	2893912	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	73.0	CHEMBL4101	Homo sapiens	Activity	%	73.0
	2893913	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	86.0	CHEMBL4101	Homo sapiens	Activity	%	86.0
	2893914	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	73.0	CHEMBL4101	Homo sapiens	Activity	%	73.0
	2893915	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	79.0	CHEMBL4101	Homo sapiens	Activity	%	79.0
	2893916	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	63.0	CHEMBL4101	Homo sapiens	Activity	%	63.0
	2893917	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	93.0	CHEMBL4101	Homo sapiens	Activity	%	93.0
	2893918	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	80.0	CHEMBL4101	Homo sapiens	Activity	%	80.0
	2893919	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	112.0	CHEMBL4101	Homo sapiens	Activity	%	112.0
	2893920	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	80.0	CHEMBL4101	Homo sapiens	Activity	%	80.0
	2893921	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	90.0	CHEMBL4101	Homo sapiens	Activity	%	90.0
	2893922	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	2893923	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	89.0	CHEMBL4101	Homo sapiens	Activity	%	89.0
	2893924	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	109.0	CHEMBL4101	Homo sapiens	Activity	%	109.0
Antagonist	2893925	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	15.0	CHEMBL4101	Homo sapiens	Activity	%	15.0
Antagonist	2893926	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	31.0	CHEMBL4101	Homo sapiens	Activity	%	31.0
	2893927	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	85.0	CHEMBL4101	Homo sapiens	Activity	%	85.0
	2893928	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	86.0	CHEMBL4101	Homo sapiens	Activity	%	86.0
Antagonist	2893929	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	50.0	CHEMBL4101	Homo sapiens	Activity	%	50.0
Antagonist	2893930	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	32.0	CHEMBL4101	Homo sapiens	Activity	%	32.0
	2893931	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	77.0	CHEMBL4101	Homo sapiens	Activity	%	77.0
	2893932	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	98.0	CHEMBL4101	Homo sapiens	Activity	%	98.0
	2893933	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	66.0	CHEMBL4101	Homo sapiens	Activity	%	66.0
	2893934	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	2893935	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	91.0	CHEMBL4101	Homo sapiens	Activity	%	91.0
	2893936	CHEMBL1062854	Percentage PKA activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	52.0	CHEMBL4101	Homo sapiens	Activity	%	52.0
Antagonist	2897337	CHEMBL1061943	Inhibition of PKA in the presence of 20uM ATP	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	500.0	CHEMBL4101	Homo sapiens	IC50	uM	0.5
	2899329	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	6900.0	CHEMBL4101	Homo sapiens	Kd	nM	6900.0
	2899330	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899331	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3700.0	CHEMBL4101	Homo sapiens	Kd	nM	3700.0
	2899332	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899333	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899334	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899335	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899336	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899337	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899338	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899339	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899340	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899341	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899342	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899343	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899344	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899345	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899346	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899347	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899348	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899349	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899350	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	5400.0	CHEMBL4101	Homo sapiens	Kd	nM	5400.0
	2899351	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899352	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899353	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899354	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	720.0	CHEMBL4101	Homo sapiens	Kd	nM	720.0
	2899355	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899356	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899357	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	1700.0	CHEMBL4101	Homo sapiens	Kd	nM	1700.0
	2899358	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899359	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899360	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899361	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	19.0	CHEMBL4101	Homo sapiens	Kd	nM	19.0
	2899362	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899363	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899364	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899365	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2899366	CHEMBL1051309	Binding constant for PKAC-alpha kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	uM	10.0
	2992236	CHEMBL1044539	Inhibition of human PRKACA at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	3127415	CHEMBL1064447	Inhibition of PKAalpha by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	3127449	CHEMBL1064447	Inhibition of PKAalpha by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	3219611	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL297394	=	IC50	nM	54.0	CHEMBL4101	Homo sapiens	IC50	nM	54.0
Not Active	3219612	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	CC(=O)NCCCCCC(=O)N[C@H](CCCCN)C(=O)NCCCCCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O		CHEMBL1077597		IC50			CHEMBL4101	Homo sapiens	IC50		
	3219613	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccccc1)C(N)=O	Outside typical range	CHEMBL1077598	=	IC50	nM	183000.0	CHEMBL4101	Homo sapiens	IC50	nM	183000.0
	3219614	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(C(N)=O)cc1)C(N)=O		CHEMBL1077599	=	IC50	nM	23000.0	CHEMBL4101	Homo sapiens	IC50	nM	23000.0
	3219615	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)Nc1ccc(C(N)=O)cc1)C(N)=O	Outside typical range	CHEMBL1077600	=	IC50	nM	240000.0	CHEMBL4101	Homo sapiens	IC50	nM	240000.0
	3219616	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077369	=	IC50	nM	14.0	CHEMBL4101	Homo sapiens	IC50	nM	14.0
	3219617	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1cccc(-c2ccncc2)c1)C(N)=O		CHEMBL1077370	=	IC50	nM	390.0	CHEMBL4101	Homo sapiens	IC50	nM	390.0
	3219618	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1cccc(-c2ccnc(N)n2)c1)C(N)=O		CHEMBL1077371	=	IC50	nM	61.0	CHEMBL4101	Homo sapiens	IC50	nM	61.0
	3219619	CHEMBL1110408	Inhibition of PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1cn(-c2ncnc3[nH]cnc23)nn1)C(N)=O		CHEMBL1077372	=	IC50	nM	3250.0	CHEMBL4101	Homo sapiens	IC50	nM	3250.0
	3219620	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL297394	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219621	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	CC(=O)NCCCCCC(=O)N[C@H](CCCCN)C(=O)NCCCCCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O		CHEMBL1077597	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219622	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccccc1)C(N)=O		CHEMBL1077598	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219623	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(C(N)=O)cc1)C(N)=O		CHEMBL1077599	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219624	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)Nc1ccc(C(N)=O)cc1)C(N)=O		CHEMBL1077600	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219625	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077369	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219626	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1cccc(-c2ccncc2)c1)C(N)=O		CHEMBL1077370	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219627	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1cccc(-c2ccnc(N)n2)c1)C(N)=O		CHEMBL1077371	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219628	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1cn(-c2ncnc3[nH]cnc23)nn1)C(N)=O		CHEMBL1077372	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219629	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219630	CHEMBL1110409	Activity at PKACalpha in presence of 100 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1077376	=	Km	nM	20000.0	CHEMBL4101	Homo sapiens	Km	uM	20.0
	3219631	CHEMBL1110410	Inhibition of PKACalpha in presence of 1000 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077369	=	IC50	nM	82.0	CHEMBL4101	Homo sapiens	IC50	nM	82.0
	3219632	CHEMBL1110410	Inhibition of PKACalpha in presence of 1000 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	IC50	nM	5.5	CHEMBL4101	Homo sapiens	IC50	nM	5.5
	3219633	CHEMBL1110410	Inhibition of PKACalpha in presence of 1000 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1077376	=	IC50	nM	4.9	CHEMBL4101	Homo sapiens	IC50	nM	4.9
	3219685	CHEMBL1110436	Inhibition of PKA Calpha at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	104.0	CHEMBL4101	Homo sapiens	INH	%	104.0
	3221885	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Cn1c(-c2nonc2N)nc2ccccc21		CHEMBL1078717	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	3221889	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Ki	nM	960.0	CHEMBL4101	Homo sapiens	Ki	uM	0.96
	3221893	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)n1c(-c2nonc2N)nc2ccccc21		CHEMBL1079208	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	uM	3.3
	3221897	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CC1		CHEMBL1079293	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	uM	3.3
	3221901	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CCC1		CHEMBL1079294	=	Ki	nM	540.0	CHEMBL4101	Homo sapiens	Ki	uM	0.54
	3221905	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CCCC1		CHEMBL1079295	=	Ki	nM	720.0	CHEMBL4101	Homo sapiens	Ki	uM	0.72
	3221909	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CCCCC1		CHEMBL1078929	=	Ki	nM	600.0	CHEMBL4101	Homo sapiens	Ki	uM	0.6
	3221913	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1CC1CC1		CHEMBL1078930	=	Ki	nM	380.0	CHEMBL4101	Homo sapiens	Ki	uM	0.38
	3221917	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1CC1CCC1		CHEMBL1078820	=	Ki	nM	1400.0	CHEMBL4101	Homo sapiens	Ki	uM	1.4
	3221921	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)Cn1c(-c2nonc2N)nc2ccccc21		CHEMBL1079040	=	Ki	nM	1100.0	CHEMBL4101	Homo sapiens	Ki	uM	1.1
	3222999	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1-c1ccccc1		CHEMBL1078426	=	Ki	nM	1300.0	CHEMBL4101	Homo sapiens	Ki	uM	1.3
	3223003	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	N#Cc1ccccc1-n1c(-c2nonc2N)nc2ccccc21		CHEMBL1078427	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	uM	5.0
	3223007	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	N#Cc1cccc(-n2c(-c3nonc3N)nc3ccccc32)c1		CHEMBL1078537	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	uM	5.0
	3223011	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	N#Cc1ccc(-n2c(-c3nonc3N)nc3ccccc32)cc1		CHEMBL1078538	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	uM	5.0
	3223015	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1ccccc1-n1c(-c2nonc2N)nc2ccccc21		CHEMBL1078539	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	uM	5.0
Not Determined	3223019	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1cccc(-n2c(-c3nonc3N)nc3ccccc32)c1		CHEMBL1078155		Ki			CHEMBL4101	Homo sapiens	Ki		
	3223023	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1ccc(-n2c(-c3nonc3N)nc3ccccc32)cc1		CHEMBL1078245	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	3223027	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2cc(O)ccc2n1C1CCC1		CHEMBL1079032	=	Ki	nM	2800.0	CHEMBL4101	Homo sapiens	Ki	uM	2.8
	3223031	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080071	=	Ki	nM	34.0	CHEMBL4101	Homo sapiens	Ki	uM	0.034
	3223035	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080072	=	Ki	nM	2500.0	CHEMBL4101	Homo sapiens	Ki	uM	2.5
	3223039	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COC(=O)c1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080073	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	uM	3.3
	3223043	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(=O)Nc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080245	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	uM	3.3
	3223047	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Cc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1079135	=	Ki	nM	2600.0	CHEMBL4101	Homo sapiens	Ki	uM	2.6
	3223051	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2cc(CO)ccc2n1C1CCC1		CHEMBL1080970	=	Ki	nM	1500.0	CHEMBL4101	Homo sapiens	Ki	uM	1.5
	3223055	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)Cn1cc(-c2ccccc2)nc1-c1nonc1N		CHEMBL1079243	=	Ki	nM	1200.0	CHEMBL4101	Homo sapiens	Ki	uM	1.2
	3223059	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Cc1cn(CC(C)C)c(-c2nonc2N)n1		CHEMBL1077670	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	uM	3.3
	3223063	CHEMBL1104157	Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)Cn1cc(C#N)nc1-c1nonc1N		CHEMBL1082061	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	uM	3.3
	3291466	CHEMBL1111965	Inhibition of PKA-alpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	3420247	CHEMBL1226943	Inhibition of PKAalpha	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	nM	10000.0
	3443489	CHEMBL1244255	Inhibition of PRKACA at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	13.0	CHEMBL4101	Homo sapiens	INH	%	13.0
	3443706	CHEMBL1244255	Inhibition of PRKACA at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	3444861	CHEMBL1244255	Inhibition of PRKACA at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	33.0	CHEMBL4101	Homo sapiens	INH	%	33.0
	3445485	CHEMBL1244255	Inhibition of PRKACA at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	1.0	CHEMBL4101	Homo sapiens	INH	%	1.0
	3445702	CHEMBL1244255	Inhibition of PRKACA at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	18.0	CHEMBL4101	Homo sapiens	INH	%	18.0
	3445897	CHEMBL1244255	Inhibition of PRKACA at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	26.0	CHEMBL4101	Homo sapiens	INH	%	26.0
	3446087	CHEMBL1244255	Inhibition of PRKACA at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	31.0	CHEMBL4101	Homo sapiens	INH	%	31.0
	3463322	CHEMBL1252624	Inhibition of PRKACA (PKA) at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	99.0	CHEMBL4101	Homo sapiens	INH	%	99.0
	3463866	CHEMBL1252624	Inhibition of PRKACA (PKA) at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	48.0	CHEMBL4101	Homo sapiens	INH	%	48.0
	3464085	CHEMBL1252624	Inhibition of PRKACA (PKA) at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	28.0	CHEMBL4101	Homo sapiens	INH	%	28.0
	3504217	CHEMBL1260168	Inhibition of PKAalpha	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	332.0	CHEMBL4101	Homo sapiens	IC50	uM	0.332
	3526965	CHEMBL1274179	Inhibition of PKAalpha	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	3556533	CHEMBL1285611	Inhibition of PRKCA at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	9.0	CHEMBL4101	Homo sapiens	INH	%	9.0
	3603121	CHEMBL1291218	Inhibition of PRKACA at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	14.0	CHEMBL4101	Homo sapiens	Inihibition	%	14.0
	5120072	CHEMBL1648815	Inhibition of PRKACA at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	5120088	CHEMBL1648815	Inhibition of PRKACA at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	3.0	CHEMBL4101	Homo sapiens	INH	%	3.0
	5120125	CHEMBL1648815	Inhibition of PRKACA at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	5120126	CHEMBL1648815	Inhibition of PRKACA at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	5120177	CHEMBL1648815	Inhibition of PRKACA at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	13.0	CHEMBL4101	Homo sapiens	INH	%	13.0
	5120230	CHEMBL1648815	Inhibition of PRKACA at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	47.0	CHEMBL4101	Homo sapiens	INH	%	47.0
	5120855	CHEMBL1646941	Inhibition of PRKACA at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL4101	Homo sapiens	INH	%	10.0
	5140491	CHEMBL1646796	Inhibition of PRKACA at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL4101	Homo sapiens	INH	%	10.0
	5152490	CHEMBL1656535	Inhibition of PKAalpha by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	5152515	CHEMBL1656535	Inhibition of PKAalpha by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	5249445	CHEMBL1686796	Inhibition of PRKACA at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	3.0	CHEMBL4101	Homo sapiens	INH	%	3.0
Active	5505462	CHEMBL1738330	PUBCHEM_BIOASSAY: Protein Kinase A Activity Assay Measured in Biochemical System Using Plate Reader - 2052-04_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2689]	B	CN[C@@H]1C[C@@H]2O[C@@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1709437	<	AC50	nM	5.0	CHEMBL4101	Homo sapiens	AC50	uM	0.005
Active	5505463	CHEMBL1738330	PUBCHEM_BIOASSAY: Protein Kinase A Activity Assay Measured in Biochemical System Using Plate Reader - 2052-04_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2689]	B	Nc1nc(-c2cc(O)ccc2[N+](=O)[O-])cc(-c2ccccc2)c1[N+](=O)[O-]		CHEMBL1580664	=	AC50	nM	1115.0	CHEMBL4101	Homo sapiens	AC50	uM	1.115
Active	5505464	CHEMBL1738330	PUBCHEM_BIOASSAY: Protein Kinase A Activity Assay Measured in Biochemical System Using Plate Reader - 2052-04_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2689]	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	AC50	nM	1558.0	CHEMBL4101	Homo sapiens	AC50	uM	1.558
	6198144	CHEMBL1776306	Inhibition of PKAalpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	6221241	CHEMBL1786866	Inhibition of PKACA at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	93.0	CHEMBL4101	Homo sapiens	INH	%	93.0
	6353474	CHEMBL1825786	Inhibition of PRKACA at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	0.0	CHEMBL4101	Homo sapiens	INH	%	0.0
	6384604	CHEMBL1837769	Inhibition of human PKACalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL4101	Homo sapiens	INH	%	35.0
	6384605	CHEMBL1837769	Inhibition of human PKACalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL4101	Homo sapiens	INH	%	35.0
	6384606	CHEMBL1837769	Inhibition of human PKACalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL4101	Homo sapiens	INH	%	35.0
	6384607	CHEMBL1837769	Inhibition of human PKACalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL4101	Homo sapiens	INH	%	35.0
	6384608	CHEMBL1837769	Inhibition of human PKACalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL4101	Homo sapiens	INH	%	35.0
	7567276	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7567735	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7568206	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7568664	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7569249	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7569709	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7570202	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7570629	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7571225	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7571682	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7571716	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7572179	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7572595	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	4000.0	CHEMBL4101	Homo sapiens	Kd	nM	4000.0
	7573206	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7573697	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7574166	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	720.0	CHEMBL4101	Homo sapiens	Kd	nM	720.0
	7574574	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7575203	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7575674	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7576139	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7576547	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7576716	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7577175	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7577653	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7578123	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	3700.0	CHEMBL4101	Homo sapiens	Kd	nM	3700.0
	7578528	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7578724	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	56.0	CHEMBL4101	Homo sapiens	Kd	nM	56.0
	7579098	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7579548	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7580022	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7580491	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7580894	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7581082	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7581467	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7581912	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7582383	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	330.0	CHEMBL4101	Homo sapiens	Kd	nM	330.0
	7583428	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	6900.0	CHEMBL4101	Homo sapiens	Kd	nM	6900.0
	7583825	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7584270	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7584761	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	600.0	CHEMBL4101	Homo sapiens	Kd	nM	600.0
	7585165	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7585758	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7586166	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7586612	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7586641	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	5400.0	CHEMBL4101	Homo sapiens	Kd	nM	5400.0
	7587095	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7587719	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7588138	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	220.0	CHEMBL4101	Homo sapiens	Kd	nM	220.0
	7588620	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7589071	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7589684	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7590133	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7590607	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7591058	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7591637	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7592109	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7592582	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7593035	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7593182	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3700.0	CHEMBL4101	Homo sapiens	Kd	nM	3700.0
	7593617	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7594089	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	19.0	CHEMBL4101	Homo sapiens	Kd	nM	19.0
	7594562	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7595014	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7595150	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7595594	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7596068	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7596539	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7596986	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	19.0	CHEMBL4101	Homo sapiens	Kd	nM	19.0
	7597122	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7597575	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7598048	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7598518	CHEMBL1908578	Binding constant for PKAC-alpha kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4101	Homo sapiens	Kd	nM	10000.0
	7931127	CHEMBL1919464	Inhibition of PRKACA relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	11.0	CHEMBL4101	Homo sapiens	INH	%	11.0
	7984703	CHEMBL1936626	Inhibition of PKAalpha	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	7984704	CHEMBL1936626	Inhibition of PKAalpha	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
Active	7996840	CHEMBL1941734	Inhibition of PKACa at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Active	7996841	CHEMBL1941734	Inhibition of PKACa at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Active	7996842	CHEMBL1941734	Inhibition of PKACa at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Active	7996843	CHEMBL1941734	Inhibition of PKACa at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	8002077	CHEMBL1942175	Inhibition of PRKACA at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	74.0	CHEMBL4101	Homo sapiens	INH	%	74.0
	8002078	CHEMBL1942175	Inhibition of PRKACA at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	58.0	CHEMBL4101	Homo sapiens	INH	%	58.0
	8002079	CHEMBL1942175	Inhibition of PRKACA at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	30.0	CHEMBL4101	Homo sapiens	INH	%	30.0
	8061229	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.31	CHEMBL4101	Homo sapiens	Inhibition	%	1.31
	8061406	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	5.93	CHEMBL4101	Homo sapiens	Inhibition	%	5.93
	8061630	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.59	CHEMBL4101	Homo sapiens	Inhibition	%	1.59
	8061737	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	16.71	CHEMBL4101	Homo sapiens	Inhibition	%	16.71
	8061928	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.99	CHEMBL4101	Homo sapiens	Inhibition	%	0.99
	8062152	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.46	CHEMBL4101	Homo sapiens	Inhibition	%	1.46
	8062268	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.05	CHEMBL4101	Homo sapiens	Inhibition	%	2.05
	8062654	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.48	CHEMBL4101	Homo sapiens	Inhibition	%	1.48
	8062976	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.67	CHEMBL4101	Homo sapiens	Inhibition	%	0.67
	8063108	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.95	CHEMBL4101	Homo sapiens	Inhibition	%	3.95
	8063499	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.26	CHEMBL4101	Homo sapiens	Inhibition	%	1.26
	8063607	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.0	CHEMBL4101	Homo sapiens	Inhibition	%	1.0
	8063831	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.8	CHEMBL4101	Homo sapiens	Inhibition	%	2.8
	8064013	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.01	CHEMBL4101	Homo sapiens	Inhibition	%	1.01
	8064128	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.79	CHEMBL4101	Homo sapiens	Inhibition	%	6.79
	8064352	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	19.61	CHEMBL4101	Homo sapiens	Inhibition	%	19.61
	8064562	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.2	CHEMBL4101	Homo sapiens	Inhibition	%	1.2
	8064700	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.2	CHEMBL4101	Homo sapiens	Inhibition	%	0.2
	8064924	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.87	CHEMBL4101	Homo sapiens	Inhibition	%	1.87
	8065090	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.31	CHEMBL4101	Homo sapiens	Inhibition	%	1.31
	8065430	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.25	CHEMBL4101	Homo sapiens	Inhibition	%	1.25
	8065605	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.39	CHEMBL4101	Homo sapiens	Inhibition	%	2.39
	8065944	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	70.52	CHEMBL4101	Homo sapiens	Inhibition	%	70.52
	8066154	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.21	CHEMBL4101	Homo sapiens	Inhibition	%	1.21
	8066514	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.46	CHEMBL4101	Homo sapiens	Inhibition	%	2.46
	8066680	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.22	CHEMBL4101	Homo sapiens	Inhibition	%	1.22
	8067028	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.19	CHEMBL4101	Homo sapiens	Inhibition	%	1.19
	8067203	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.93	CHEMBL4101	Homo sapiens	Inhibition	%	1.93
	8067548	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.55	CHEMBL4101	Homo sapiens	Inhibition	%	2.55
	8067758	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.19	CHEMBL4101	Homo sapiens	Inhibition	%	4.19
	8068117	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	10.7	CHEMBL4101	Homo sapiens	Inhibition	%	10.7
	8068281	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.96	CHEMBL4101	Homo sapiens	Inhibition	%	0.96
	8068505	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.68	CHEMBL4101	Homo sapiens	Inhibition	%	1.68
	8068630	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.5	CHEMBL4101	Homo sapiens	Inhibition	%	1.5
	8068804	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.3	CHEMBL4101	Homo sapiens	Inhibition	%	1.3
	8069028	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.97	CHEMBL4101	Homo sapiens	Inhibition	%	1.97
	8069153	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	16.03	CHEMBL4101	Homo sapiens	Inhibition	%	16.03
	8069448	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.95	CHEMBL4101	Homo sapiens	Inhibition	%	1.95
	8069833	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.21	CHEMBL4101	Homo sapiens	Inhibition	%	1.21
	8069959	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.64	CHEMBL4101	Homo sapiens	Inhibition	%	2.64
	8070355	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	9.5	CHEMBL4101	Homo sapiens	Inhibition	%	9.5
	8070480	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.32	CHEMBL4101	Homo sapiens	Inhibition	%	1.32
	8070704	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.36	CHEMBL4101	Homo sapiens	Inhibition	%	2.36
	8070778	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	14.04	CHEMBL4101	Homo sapiens	Inhibition	%	14.04
	8071159	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.37	CHEMBL4101	Homo sapiens	Inhibition	%	1.37
	8071285	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.12	CHEMBL4101	Homo sapiens	Inhibition	%	1.12
	8071509	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.28	CHEMBL4101	Homo sapiens	Inhibition	%	1.28
	8071682	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.31	CHEMBL4101	Homo sapiens	Inhibition	%	1.31
	8072031	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.2	CHEMBL4101	Homo sapiens	Inhibition	%	1.2
	8072112	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.27	CHEMBL4101	Homo sapiens	Inhibition	%	0.27
	8072121	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.29	CHEMBL4101	Homo sapiens	Inhibition	%	2.29
	8072345	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	4.75	CHEMBL4101	Homo sapiens	Inhibition	%	4.75
	8072502	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.49	CHEMBL4101	Homo sapiens	Inhibition	%	2.49
	8072851	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.88	CHEMBL4101	Homo sapiens	Inhibition	%	0.88
	8073018	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.05	CHEMBL4101	Homo sapiens	Inhibition	%	2.05
	8073367	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.64	CHEMBL4101	Homo sapiens	Inhibition	%	0.64
	8073710	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.28	CHEMBL4101	Homo sapiens	Inhibition	%	1.28
	8073943	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	8.62	CHEMBL4101	Homo sapiens	Inhibition	%	8.62
	8074095	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.15	CHEMBL4101	Homo sapiens	Inhibition	%	2.15
	8074449	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.93	CHEMBL4101	Homo sapiens	Inhibition	%	0.93
	8074606	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.37	CHEMBL4101	Homo sapiens	Inhibition	%	1.37
	8074830	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.93	CHEMBL4101	Homo sapiens	Inhibition	%	0.93
	8074957	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.01	CHEMBL4101	Homo sapiens	Inhibition	%	0.01
	8075292	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.23	CHEMBL4101	Homo sapiens	Inhibition	%	0.23
	8075529	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	44.87	CHEMBL4101	Homo sapiens	Inhibition	%	44.87
	8075670	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.1	CHEMBL4101	Homo sapiens	Inhibition	%	2.1
	8075894	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.05	CHEMBL4101	Homo sapiens	Inhibition	%	1.05
	8076036	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.69	CHEMBL4101	Homo sapiens	Inhibition	%	0.69
	8076408	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.37	CHEMBL4101	Homo sapiens	Inhibition	%	1.37
	8076542	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.68	CHEMBL4101	Homo sapiens	Inhibition	%	0.68
	8076868	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.67	CHEMBL4101	Homo sapiens	Inhibition	%	1.67
	8077115	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	80.35	CHEMBL4101	Homo sapiens	Inhibition	%	80.35
	8077467	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.18	CHEMBL4101	Homo sapiens	Inhibition	%	2.18
	8077618	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.52	CHEMBL4101	Homo sapiens	Inhibition	%	0.52
	8077985	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-1.08	CHEMBL4101	Homo sapiens	Inhibition	%	-1.08
	8078124	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.2	CHEMBL4101	Homo sapiens	Inhibition	%	-2.2
	8078348	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.83	CHEMBL4101	Homo sapiens	Inhibition	%	-0.83
	8078450	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.54	CHEMBL4101	Homo sapiens	Inhibition	%	1.54
	8078700	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	81.57	CHEMBL4101	Homo sapiens	Inhibition	%	81.57
	8079040	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.76	CHEMBL4101	Homo sapiens	Inhibition	%	1.76
	8079198	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.26	CHEMBL4101	Homo sapiens	Inhibition	%	-0.26
	8079422	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.61	CHEMBL4101	Homo sapiens	Inhibition	%	-0.61
	8079564	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.99	CHEMBL4101	Homo sapiens	Inhibition	%	0.99
	8079927	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.33	CHEMBL4101	Homo sapiens	Inhibition	%	2.33
	8080032	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	18.79	CHEMBL4101	Homo sapiens	Inhibition	%	18.79
	8080256	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.25	CHEMBL4101	Homo sapiens	Inhibition	%	1.25
	8080284	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	6.49	CHEMBL4101	Homo sapiens	Inhibition	%	6.49
	8080508	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	11.83	CHEMBL4101	Homo sapiens	Inhibition	%	11.83
	8080623	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.11	CHEMBL4101	Homo sapiens	Inhibition	%	2.11
	8081011	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.37	CHEMBL4101	Homo sapiens	Inhibition	%	-0.37
	8081146	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.53	CHEMBL4101	Homo sapiens	Inhibition	%	0.53
	8081370	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.15	CHEMBL4101	Homo sapiens	Inhibition	%	1.15
	8081514	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.51	CHEMBL4101	Homo sapiens	Inhibition	%	3.51
	8081841	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.73	CHEMBL4101	Homo sapiens	Inhibition	%	1.73
	8082093	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	19.54	CHEMBL4101	Homo sapiens	Inhibition	%	19.54
	8082206	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.43	CHEMBL4101	Homo sapiens	Inhibition	%	1.43
	8082430	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.06	CHEMBL4101	Homo sapiens	Inhibition	%	3.06
	8082603	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	20.21	CHEMBL4101	Homo sapiens	Inhibition	%	20.21
	8082950	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.14	CHEMBL4101	Homo sapiens	Inhibition	%	1.14
	8083106	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.3	CHEMBL4101	Homo sapiens	Inhibition	%	2.3
	8083429	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.91	CHEMBL4101	Homo sapiens	Inhibition	%	0.91
	8083683	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%		CHEMBL4101	Homo sapiens	Inhibition	%	
	8084017	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.95	CHEMBL4101	Homo sapiens	Inhibition	%	7.95
	8084202	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.4	CHEMBL4101	Homo sapiens	Inhibition	%	1.4
	8084544	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.45	CHEMBL4101	Homo sapiens	Inhibition	%	1.45
	8084705	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.8	CHEMBL4101	Homo sapiens	Inhibition	%	2.8
	8085027	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.02	CHEMBL4101	Homo sapiens	Inhibition	%	1.02
	8085283	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.54	CHEMBL4101	Homo sapiens	Inhibition	%	-0.54
	8085615	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.92	CHEMBL4101	Homo sapiens	Inhibition	%	2.92
	8085804	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	3.13	CHEMBL4101	Homo sapiens	Inhibition	%	3.13
	8086143	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.92	CHEMBL4101	Homo sapiens	Inhibition	%	1.92
	8086305	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.53	CHEMBL4101	Homo sapiens	Inhibition	%	-1.53
	8086529	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.39	CHEMBL4101	Homo sapiens	Inhibition	%	1.39
	8086628	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.35	CHEMBL4101	Homo sapiens	Inhibition	%	0.35
	8086852	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.02	CHEMBL4101	Homo sapiens	Inhibition	%	1.02
	8087063	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-1.47	CHEMBL4101	Homo sapiens	Inhibition	%	-1.47
	8087221	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.1	CHEMBL4101	Homo sapiens	Inhibition	%	2.1
	8087559	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.58	CHEMBL4101	Homo sapiens	Inhibition	%	1.58
	8087697	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.56	CHEMBL4101	Homo sapiens	Inhibition	%	5.56
	8087921	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	7.46	CHEMBL4101	Homo sapiens	Inhibition	%	7.46
	8088063	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	8.74	CHEMBL4101	Homo sapiens	Inhibition	%	8.74
	8088435	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.07	CHEMBL4101	Homo sapiens	Inhibition	%	-0.07
	8088563	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.37	CHEMBL4101	Homo sapiens	Inhibition	%	4.37
	8088880	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	18.5	CHEMBL4101	Homo sapiens	Inhibition	%	18.5
	8089232	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.18	CHEMBL4101	Homo sapiens	Inhibition	%	9.18
	8089380	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.47	CHEMBL4101	Homo sapiens	Inhibition	%	0.47
	8089724	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.17	CHEMBL4101	Homo sapiens	Inhibition	%	1.17
	8089904	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.17	CHEMBL4101	Homo sapiens	Inhibition	%	2.17
	8090128	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-2.7	CHEMBL4101	Homo sapiens	Inhibition	%	-2.7
	8090293	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.83	CHEMBL4101	Homo sapiens	Inhibition	%	2.83
	8090460	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.1	CHEMBL4101	Homo sapiens	Inhibition	%	2.1
	8090823	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.4	CHEMBL4101	Homo sapiens	Inhibition	%	1.4
	8091028	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.17	CHEMBL4101	Homo sapiens	Inhibition	%	2.17
	8091389	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.92	CHEMBL4101	Homo sapiens	Inhibition	%	2.92
	8091544	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.49	CHEMBL4101	Homo sapiens	Inhibition	%	1.49
	8091768	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.6	CHEMBL4101	Homo sapiens	Inhibition	%	0.6
	8091884	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.65	CHEMBL4101	Homo sapiens	Inhibition	%	3.65
	8092245	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	43.59	CHEMBL4101	Homo sapiens	Inhibition	%	43.59
	8092396	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.96	CHEMBL4101	Homo sapiens	Inhibition	%	1.96
	8092768	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.34	CHEMBL4101	Homo sapiens	Inhibition	%	1.34
	8092897	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.38	CHEMBL4101	Homo sapiens	Inhibition	%	4.38
	8093121	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.47	CHEMBL4101	Homo sapiens	Inhibition	%	-1.47
	8093209	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.3	CHEMBL4101	Homo sapiens	Inhibition	%	5.3
	8093573	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	77.47	CHEMBL4101	Homo sapiens	Inhibition	%	77.47
	8093712	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.74	CHEMBL4101	Homo sapiens	Inhibition	%	3.74
	8093936	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.91	CHEMBL4101	Homo sapiens	Inhibition	%	-3.91
	8094056	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.75	CHEMBL4101	Homo sapiens	Inhibition	%	1.75
	8094460	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.88	CHEMBL4101	Homo sapiens	Inhibition	%	1.88
	8094635	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.85	CHEMBL4101	Homo sapiens	Inhibition	%	7.85
	8094791	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.12	CHEMBL4101	Homo sapiens	Inhibition	%	2.12
	8095015	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.59	CHEMBL4101	Homo sapiens	Inhibition	%	1.59
	8095155	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.04	CHEMBL4101	Homo sapiens	Inhibition	%	2.04
	8095358	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.45	CHEMBL4101	Homo sapiens	Inhibition	%	2.45
	8095582	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.59	CHEMBL4101	Homo sapiens	Inhibition	%	1.59
	8095723	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.79	CHEMBL4101	Homo sapiens	Inhibition	%	2.79
	8096095	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.11	CHEMBL4101	Homo sapiens	Inhibition	%	-0.11
	8096212	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.76	CHEMBL4101	Homo sapiens	Inhibition	%	2.76
	8096436	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.59	CHEMBL4101	Homo sapiens	Inhibition	%	6.59
	8096575	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.94	CHEMBL4101	Homo sapiens	Inhibition	%	2.94
	8096731	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.98	CHEMBL4101	Homo sapiens	Inhibition	%	1.98
	8096955	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.54	CHEMBL4101	Homo sapiens	Inhibition	%	2.54
	8097102	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.04	CHEMBL4101	Homo sapiens	Inhibition	%	1.04
	8097409	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.41	CHEMBL4101	Homo sapiens	Inhibition	%	1.41
	8097633	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.57	CHEMBL4101	Homo sapiens	Inhibition	%	1.57
	8097783	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	79.32	CHEMBL4101	Homo sapiens	Inhibition	%	79.32
	8098140	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.18	CHEMBL4101	Homo sapiens	Inhibition	%	0.18
	8098260	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.47	CHEMBL4101	Homo sapiens	Inhibition	%	2.47
	8098484	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.86	CHEMBL4101	Homo sapiens	Inhibition	%	0.86
	8098664	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.25	CHEMBL4101	Homo sapiens	Inhibition	%	1.25
	8098849	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.44	CHEMBL4101	Homo sapiens	Inhibition	%	7.44
	8099217	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.39	CHEMBL4101	Homo sapiens	Inhibition	%	2.39
	8099359	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.04	CHEMBL4101	Homo sapiens	Inhibition	%	1.04
	8099583	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.7	CHEMBL4101	Homo sapiens	Inhibition	%	1.7
	8099777	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.4	CHEMBL4101	Homo sapiens	Inhibition	%	0.4
	8099924	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.22	CHEMBL4101	Homo sapiens	Inhibition	%	3.22
	8100294	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.28	CHEMBL4101	Homo sapiens	Inhibition	%	-3.28
	8100634	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.63	CHEMBL4101	Homo sapiens	Inhibition	%	2.63
	8100774	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	7.99	CHEMBL4101	Homo sapiens	Inhibition	%	7.99
	8101158	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.05	CHEMBL4101	Homo sapiens	Inhibition	%	3.05
	8101300	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.33	CHEMBL4101	Homo sapiens	Inhibition	%	-0.33
	8101709	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.0	CHEMBL4101	Homo sapiens	Inhibition	%	-1.0
	8101962	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.93	CHEMBL4101	Homo sapiens	Inhibition	%	3.93
	8102117	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	7.26	CHEMBL4101	Homo sapiens	Inhibition	%	7.26
	8102472	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.79	CHEMBL4101	Homo sapiens	Inhibition	%	0.79
	8102816	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	4.08	CHEMBL4101	Homo sapiens	Inhibition	%	4.08
	8102994	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.55	CHEMBL4101	Homo sapiens	Inhibition	%	1.55
	8103190	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	81.31	CHEMBL4101	Homo sapiens	Inhibition	%	81.31
	8103414	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	82.45	CHEMBL4101	Homo sapiens	Inhibition	%	82.45
	8103552	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.44	CHEMBL4101	Homo sapiens	Inhibition	%	1.44
	8103926	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.01	CHEMBL4101	Homo sapiens	Inhibition	%	2.01
	8104111	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.12	CHEMBL4101	Homo sapiens	Inhibition	%	2.12
	8104259	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.93	CHEMBL4101	Homo sapiens	Inhibition	%	2.93
	8104483	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.4	CHEMBL4101	Homo sapiens	Inhibition	%	3.4
	8104629	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-2.27	CHEMBL4101	Homo sapiens	Inhibition	%	-2.27
	8104967	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.75	CHEMBL4101	Homo sapiens	Inhibition	%	5.75
	8105107	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	7.91	CHEMBL4101	Homo sapiens	Inhibition	%	7.91
	8105331	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	44.73	CHEMBL4101	Homo sapiens	Inhibition	%	44.73
	8105497	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.89	CHEMBL4101	Homo sapiens	Inhibition	%	-1.89
	8105635	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.26	CHEMBL4101	Homo sapiens	Inhibition	%	-0.26
	8105859	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.51	CHEMBL4101	Homo sapiens	Inhibition	%	1.51
	8105915	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.17	CHEMBL4101	Homo sapiens	Inhibition	%	2.17
	8106139	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.12	CHEMBL4101	Homo sapiens	Inhibition	%	4.12
	8106304	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.76	CHEMBL4101	Homo sapiens	Inhibition	%	-2.76
	8106460	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	10.72	CHEMBL4101	Homo sapiens	Inhibition	%	10.72
	8106684	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	7.1	CHEMBL4101	Homo sapiens	Inhibition	%	7.1
	8106813	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.82	CHEMBL4101	Homo sapiens	Inhibition	%	1.82
	8107158	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	5.34	CHEMBL4101	Homo sapiens	Inhibition	%	5.34
	8107330	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.16	CHEMBL4101	Homo sapiens	Inhibition	%	2.16
	8107755	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	12.61	CHEMBL4101	Homo sapiens	Inhibition	%	12.61
	8107890	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.76	CHEMBL4101	Homo sapiens	Inhibition	%	0.76
	8108272	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.29	CHEMBL4101	Homo sapiens	Inhibition	%	2.29
	8108447	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.79	CHEMBL4101	Homo sapiens	Inhibition	%	0.79
	8108818	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	-1.07	CHEMBL4101	Homo sapiens	Inhibition	%	-1.07
	8108960	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.54	CHEMBL4101	Homo sapiens	Inhibition	%	0.54
	8109298	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.13	CHEMBL4101	Homo sapiens	Inhibition	%	4.13
	8109652	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.78	CHEMBL4101	Homo sapiens	Inhibition	%	0.78
	8109823	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-4.19	CHEMBL4101	Homo sapiens	Inhibition	%	-4.19
	8110179	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.67	CHEMBL4101	Homo sapiens	Inhibition	%	1.67
	8110458	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.21	CHEMBL4101	Homo sapiens	Inhibition	%	3.21
	8110624	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.98	CHEMBL4101	Homo sapiens	Inhibition	%	-2.98
	8111006	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%		CHEMBL4101	Homo sapiens	Inhibition	%	
	8111129	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.93	CHEMBL4101	Homo sapiens	Inhibition	%	2.93
	8111353	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.86	CHEMBL4101	Homo sapiens	Inhibition	%	0.86
	8111480	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	68.66	CHEMBL4101	Homo sapiens	Inhibition	%	68.66
	8111646	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.95	CHEMBL4101	Homo sapiens	Inhibition	%	1.95
	8111870	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.87	CHEMBL4101	Homo sapiens	Inhibition	%	0.87
	8112075	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	13.78	CHEMBL4101	Homo sapiens	Inhibition	%	13.78
	8112212	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.69	CHEMBL4101	Homo sapiens	Inhibition	%	0.69
	8112436	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.34	CHEMBL4101	Homo sapiens	Inhibition	%	-0.34
	8112604	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.02	CHEMBL4101	Homo sapiens	Inhibition	%	3.02
	8112776	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.55	CHEMBL4101	Homo sapiens	Inhibition	%	1.55
	8113000	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.02	CHEMBL4101	Homo sapiens	Inhibition	%	1.02
	8113152	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	11.59	CHEMBL4101	Homo sapiens	Inhibition	%	11.59
	8113288	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.2	CHEMBL4101	Homo sapiens	Inhibition	%	-0.2
	8113512	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.81	CHEMBL4101	Homo sapiens	Inhibition	%	-0.81
	8113636	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	17.54	CHEMBL4101	Homo sapiens	Inhibition	%	17.54
	8113976	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	5.64	CHEMBL4101	Homo sapiens	Inhibition	%	5.64
	8114152	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.97	CHEMBL4101	Homo sapiens	Inhibition	%	1.97
	8114376	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.62	CHEMBL4101	Homo sapiens	Inhibition	%	4.62
	8114508	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	0.8	CHEMBL4101	Homo sapiens	Inhibition	%	0.8
	8114784	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.86	CHEMBL4101	Homo sapiens	Inhibition	%	1.86
	8114950	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.57	CHEMBL4101	Homo sapiens	Inhibition	%	0.57
	8115174	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.31	CHEMBL4101	Homo sapiens	Inhibition	%	1.31
	8115339	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.4	CHEMBL4101	Homo sapiens	Inhibition	%	2.4
	8115683	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.17	CHEMBL4101	Homo sapiens	Inhibition	%	1.17
	8115816	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	81.24	CHEMBL4101	Homo sapiens	Inhibition	%	81.24
	8116199	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.58	CHEMBL4101	Homo sapiens	Inhibition	%	1.58
	8116402	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	62.43	CHEMBL4101	Homo sapiens	Inhibition	%	62.43
	8116760	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.46	CHEMBL4101	Homo sapiens	Inhibition	%	1.46
	8116932	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.59	CHEMBL4101	Homo sapiens	Inhibition	%	3.59
	8117327	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.41	CHEMBL4101	Homo sapiens	Inhibition	%	1.41
	8117485	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	49.24	CHEMBL4101	Homo sapiens	Inhibition	%	49.24
	8117839	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.12	CHEMBL4101	Homo sapiens	Inhibition	%	1.12
	8117977	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.98	CHEMBL4101	Homo sapiens	Inhibition	%	-0.98
	8118201	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	9.25	CHEMBL4101	Homo sapiens	Inhibition	%	9.25
	8118317	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.03	CHEMBL4101	Homo sapiens	Inhibition	%	3.03
	8118713	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.22	CHEMBL4101	Homo sapiens	Inhibition	%	6.22
	8118849	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.84	CHEMBL4101	Homo sapiens	Inhibition	%	1.84
	8119120	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.08	CHEMBL4101	Homo sapiens	Inhibition	%	1.08
	8119503	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.37	CHEMBL4101	Homo sapiens	Inhibition	%	1.37
	8119670	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.87	CHEMBL4101	Homo sapiens	Inhibition	%	4.87
	8120013	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.29	CHEMBL4101	Homo sapiens	Inhibition	%	1.29
	8120152	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	4.47	CHEMBL4101	Homo sapiens	Inhibition	%	4.47
	8120376	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	7.16	CHEMBL4101	Homo sapiens	Inhibition	%	7.16
	8120536	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.31	CHEMBL4101	Homo sapiens	Inhibition	%	0.31
	8120737	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	89.89	CHEMBL4101	Homo sapiens	Inhibition	%	89.89
	8121089	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.47	CHEMBL4101	Homo sapiens	Inhibition	%	0.47
	8121261	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.03	CHEMBL4101	Homo sapiens	Inhibition	%	4.03
	8121485	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	5.91	CHEMBL4101	Homo sapiens	Inhibition	%	5.91
	8121652	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.07	CHEMBL4101	Homo sapiens	Inhibition	%	1.07
	8121815	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.4	CHEMBL4101	Homo sapiens	Inhibition	%	1.4
	8122039	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.48	CHEMBL4101	Homo sapiens	Inhibition	%	4.48
	8122160	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.25	CHEMBL4101	Homo sapiens	Inhibition	%	-0.25
	8122522	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.9	CHEMBL4101	Homo sapiens	Inhibition	%	2.9
	8122642	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.3	CHEMBL4101	Homo sapiens	Inhibition	%	4.3
	8123033	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	35.39	CHEMBL4101	Homo sapiens	Inhibition	%	35.39
	8123175	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-1.97	CHEMBL4101	Homo sapiens	Inhibition	%	-1.97
	8123399	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-1.35	CHEMBL4101	Homo sapiens	Inhibition	%	-1.35
	8123453	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.43	CHEMBL4101	Homo sapiens	Inhibition	%	-0.43
	8123677	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.88	CHEMBL4101	Homo sapiens	Inhibition	%	0.88
	8123827	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.88	CHEMBL4101	Homo sapiens	Inhibition	%	1.88
	8123994	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.92	CHEMBL4101	Homo sapiens	Inhibition	%	-1.92
	8124218	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.18	CHEMBL4101	Homo sapiens	Inhibition	%	0.18
	8124337	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.16	CHEMBL4101	Homo sapiens	Inhibition	%	1.16
	8124700	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.2	CHEMBL4101	Homo sapiens	Inhibition	%	3.2
	8124865	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.15	CHEMBL4101	Homo sapiens	Inhibition	%	1.15
	8125066	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	25.87	CHEMBL4101	Homo sapiens	Inhibition	%	25.87
	8125290	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	75.05	CHEMBL4101	Homo sapiens	Inhibition	%	75.05
	8125420	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.44	CHEMBL4101	Homo sapiens	Inhibition	%	-0.44
	8125812	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.98	CHEMBL4101	Homo sapiens	Inhibition	%	2.98
	8125976	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.16	CHEMBL4101	Homo sapiens	Inhibition	%	0.16
	8126364	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-0.94	CHEMBL4101	Homo sapiens	Inhibition	%	-0.94
	8126479	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.17	CHEMBL4101	Homo sapiens	Inhibition	%	-1.17
	8126839	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.91	CHEMBL4101	Homo sapiens	Inhibition	%	6.91
	8126961	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.74	CHEMBL4101	Homo sapiens	Inhibition	%	4.74
	8127185	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	24.86	CHEMBL4101	Homo sapiens	Inhibition	%	24.86
	8127352	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.45	CHEMBL4101	Homo sapiens	Inhibition	%	2.45
	8127718	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.38	CHEMBL4101	Homo sapiens	Inhibition	%	2.38
	8128006	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.04	CHEMBL4101	Homo sapiens	Inhibition	%	-0.04
	8128158	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.98	CHEMBL4101	Homo sapiens	Inhibition	%	1.98
	8128549	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.4	CHEMBL4101	Homo sapiens	Inhibition	%	1.4
	8128668	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	6.04	CHEMBL4101	Homo sapiens	Inhibition	%	6.04
	8129029	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	4.75	CHEMBL4101	Homo sapiens	Inhibition	%	4.75
	8129200	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.75	CHEMBL4101	Homo sapiens	Inhibition	%	2.75
	8129424	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	20.98	CHEMBL4101	Homo sapiens	Inhibition	%	20.98
	8129613	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.2	CHEMBL4101	Homo sapiens	Inhibition	%	1.2
	8129752	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.38	CHEMBL4101	Homo sapiens	Inhibition	%	0.38
	8130137	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.52	CHEMBL4101	Homo sapiens	Inhibition	%	2.52
	8130309	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.64	CHEMBL4101	Homo sapiens	Inhibition	%	0.64
	8130693	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.26	CHEMBL4101	Homo sapiens	Inhibition	%	4.26
	8130809	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.2	CHEMBL4101	Homo sapiens	Inhibition	%	2.2
	8131033	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.67	CHEMBL4101	Homo sapiens	Inhibition	%	3.67
	8131172	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.95	CHEMBL4101	Homo sapiens	Inhibition	%	2.95
	8131516	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.91	CHEMBL4101	Homo sapiens	Inhibition	%	0.91
	8131683	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	6.7	CHEMBL4101	Homo sapiens	Inhibition	%	6.7
	8132048	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.85	CHEMBL4101	Homo sapiens	Inhibition	%	4.85
	8132334	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.93	CHEMBL4101	Homo sapiens	Inhibition	%	-0.93
	8132481	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.93	CHEMBL4101	Homo sapiens	Inhibition	%	0.93
	8132705	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.32	CHEMBL4101	Homo sapiens	Inhibition	%	7.32
	8132873	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.17	CHEMBL4101	Homo sapiens	Inhibition	%	3.17
	8132994	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.38	CHEMBL4101	Homo sapiens	Inhibition	%	0.38
	8133218	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.31	CHEMBL4101	Homo sapiens	Inhibition	%	1.31
	8133356	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.6	CHEMBL4101	Homo sapiens	Inhibition	%	1.6
	8133752	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.5	CHEMBL4101	Homo sapiens	Inhibition	%	-0.5
	8133932	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.5	CHEMBL4101	Homo sapiens	Inhibition	%	4.5
	8134080	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.06	CHEMBL4101	Homo sapiens	Inhibition	%	-0.06
	8134304	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.18	CHEMBL4101	Homo sapiens	Inhibition	%	0.18
	8134464	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.1	CHEMBL4101	Homo sapiens	Inhibition	%	2.1
	8134648	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.0	CHEMBL4101	Homo sapiens	Inhibition	%	-2.0
	8134872	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.29	CHEMBL4101	Homo sapiens	Inhibition	%	0.29
	8135032	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.63	CHEMBL4101	Homo sapiens	Inhibition	%	1.63
	8135371	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.37	CHEMBL4101	Homo sapiens	Inhibition	%	1.37
	8135512	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.69	CHEMBL4101	Homo sapiens	Inhibition	%	6.69
	8135857	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	15.19	CHEMBL4101	Homo sapiens	Inhibition	%	15.19
	8136025	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.27	CHEMBL4101	Homo sapiens	Inhibition	%	1.27
	8136249	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.21	CHEMBL4101	Homo sapiens	Inhibition	%	1.21
	8136393	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.76	CHEMBL4101	Homo sapiens	Inhibition	%	6.76
	8136683	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.21	CHEMBL4101	Homo sapiens	Inhibition	%	-3.21
	8137042	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	43.13	CHEMBL4101	Homo sapiens	Inhibition	%	43.13
	8137205	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.59	CHEMBL4101	Homo sapiens	Inhibition	%	1.59
	8137549	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.91	CHEMBL4101	Homo sapiens	Inhibition	%	-2.91
	8137697	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.23	CHEMBL4101	Homo sapiens	Inhibition	%	3.23
	8138087	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.91	CHEMBL4101	Homo sapiens	Inhibition	%	0.91
	8138266	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.46	CHEMBL4101	Homo sapiens	Inhibition	%	1.46
	8138638	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.08	CHEMBL4101	Homo sapiens	Inhibition	%	-2.08
	8138796	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.23	CHEMBL4101	Homo sapiens	Inhibition	%	2.23
	8139205	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.28	CHEMBL4101	Homo sapiens	Inhibition	%	2.28
	8139364	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.8	CHEMBL4101	Homo sapiens	Inhibition	%	1.8
	8139702	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.5	CHEMBL4101	Homo sapiens	Inhibition	%	1.5
	8139843	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.27	CHEMBL4101	Homo sapiens	Inhibition	%	2.27
	8140067	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.13	CHEMBL4101	Homo sapiens	Inhibition	%	3.13
	8140190	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.08	CHEMBL4101	Homo sapiens	Inhibition	%	4.08
	8140573	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.9	CHEMBL4101	Homo sapiens	Inhibition	%	0.9
	8140716	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	37.94	CHEMBL4101	Homo sapiens	Inhibition	%	37.94
	8141018	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.41	CHEMBL4101	Homo sapiens	Inhibition	%	1.41
	8141372	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.78	CHEMBL4101	Homo sapiens	Inhibition	%	1.78
	8141532	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.62	CHEMBL4101	Homo sapiens	Inhibition	%	3.62
	8141875	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.45	CHEMBL4101	Homo sapiens	Inhibition	%	-3.45
	8142036	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.73	CHEMBL4101	Homo sapiens	Inhibition	%	0.73
	8142260	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.32	CHEMBL4101	Homo sapiens	Inhibition	%	2.32
	8142428	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.41	CHEMBL4101	Homo sapiens	Inhibition	%	-0.41
	8142604	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.51	CHEMBL4101	Homo sapiens	Inhibition	%	0.51
	8142828	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.47	CHEMBL4101	Homo sapiens	Inhibition	%	1.47
	8142977	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.32	CHEMBL4101	Homo sapiens	Inhibition	%	-1.32
	8143132	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.59	CHEMBL4101	Homo sapiens	Inhibition	%	3.59
	8143356	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.77	CHEMBL4101	Homo sapiens	Inhibition	%	2.77
	8143543	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.5	CHEMBL4101	Homo sapiens	Inhibition	%	2.5
	8143702	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.43	CHEMBL4101	Homo sapiens	Inhibition	%	2.43
	8143926	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.26	CHEMBL4101	Homo sapiens	Inhibition	%	4.26
	8144040	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.58	CHEMBL4101	Homo sapiens	Inhibition	%	-1.58
	8144403	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.03	CHEMBL4101	Homo sapiens	Inhibition	%	4.03
	8144533	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	10.35	CHEMBL4101	Homo sapiens	Inhibition	%	10.35
	8144757	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.89	CHEMBL4101	Homo sapiens	Inhibition	%	8.89
	8144910	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.32	CHEMBL4101	Homo sapiens	Inhibition	%	0.32
	8145047	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.48	CHEMBL4101	Homo sapiens	Inhibition	%	2.48
	8145271	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.82	CHEMBL4101	Homo sapiens	Inhibition	%	6.82
	8145360	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.85	CHEMBL4101	Homo sapiens	Inhibition	%	0.85
	8145584	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.8	CHEMBL4101	Homo sapiens	Inhibition	%	1.8
	8145708	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.07	CHEMBL4101	Homo sapiens	Inhibition	%	4.07
	8145869	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.36	CHEMBL4101	Homo sapiens	Inhibition	%	2.36
	8146093	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.01	CHEMBL4101	Homo sapiens	Inhibition	%	3.01
	8146213	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.04	CHEMBL4101	Homo sapiens	Inhibition	%	-0.04
	8146597	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.62	CHEMBL4101	Homo sapiens	Inhibition	%	4.62
	8146764	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.15	CHEMBL4101	Homo sapiens	Inhibition	%	1.15
	8147157	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.8	CHEMBL4101	Homo sapiens	Inhibition	%	2.8
	8147299	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.63	CHEMBL4101	Homo sapiens	Inhibition	%	1.63
	8147676	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.04	CHEMBL4101	Homo sapiens	Inhibition	%	2.04
	8147863	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.68	CHEMBL4101	Homo sapiens	Inhibition	%	1.68
	8148245	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.19	CHEMBL4101	Homo sapiens	Inhibition	%	2.19
	8148359	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.94	CHEMBL4101	Homo sapiens	Inhibition	%	-1.94
	8148583	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.41	CHEMBL4101	Homo sapiens	Inhibition	%	2.41
	8148722	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	20.7	CHEMBL4101	Homo sapiens	Inhibition	%	20.7
	8149084	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	42.97	CHEMBL4101	Homo sapiens	Inhibition	%	42.97
	8149243	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.08	CHEMBL4101	Homo sapiens	Inhibition	%	-3.08
	8149601	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	42.45	CHEMBL4101	Homo sapiens	Inhibition	%	42.45
	8149923	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.69	CHEMBL4101	Homo sapiens	Inhibition	%	1.69
	8150048	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.33	CHEMBL4101	Homo sapiens	Inhibition	%	-0.33
	8150432	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.13	CHEMBL4101	Homo sapiens	Inhibition	%	1.13
	8150552	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.01	CHEMBL4101	Homo sapiens	Inhibition	%	2.01
	8150776	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.15	CHEMBL4101	Homo sapiens	Inhibition	%	0.15
	8150941	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.81	CHEMBL4101	Homo sapiens	Inhibition	%	3.81
	8151104	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.46	CHEMBL4101	Homo sapiens	Inhibition	%	-2.46
	8151328	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.47	CHEMBL4101	Homo sapiens	Inhibition	%	0.47
	8151505	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.78	CHEMBL4101	Homo sapiens	Inhibition	%	0.78
	8151643	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.52	CHEMBL4101	Homo sapiens	Inhibition	%	0.52
	8151867	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.32	CHEMBL4101	Homo sapiens	Inhibition	%	1.32
	8152021	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.61	CHEMBL4101	Homo sapiens	Inhibition	%	2.61
	8152209	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.85	CHEMBL4101	Homo sapiens	Inhibition	%	0.85
	8152433	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-1.08	CHEMBL4101	Homo sapiens	Inhibition	%	-1.08
	8152591	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.41	CHEMBL4101	Homo sapiens	Inhibition	%	3.41
	8152929	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.84	CHEMBL4101	Homo sapiens	Inhibition	%	0.84
	8153068	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.2	CHEMBL4101	Homo sapiens	Inhibition	%	1.2
	8153429	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.17	CHEMBL4101	Homo sapiens	Inhibition	%	4.17
	8153586	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.11	CHEMBL4101	Homo sapiens	Inhibition	%	-3.11
	8153810	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.69	CHEMBL4101	Homo sapiens	Inhibition	%	0.69
	8153943	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	78.2	CHEMBL4101	Homo sapiens	Inhibition	%	78.2
	8154264	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.16	CHEMBL4101	Homo sapiens	Inhibition	%	3.16
	8154390	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.09	CHEMBL4101	Homo sapiens	Inhibition	%	0.09
	8154614	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.14	CHEMBL4101	Homo sapiens	Inhibition	%	9.14
	8154773	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.28	CHEMBL4101	Homo sapiens	Inhibition	%	0.28
	8155117	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.25	CHEMBL4101	Homo sapiens	Inhibition	%	1.25
	8155293	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.74	CHEMBL4101	Homo sapiens	Inhibition	%	0.74
	8155678	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.63	CHEMBL4101	Homo sapiens	Inhibition	%	3.63
	8155856	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.73	CHEMBL4101	Homo sapiens	Inhibition	%	1.73
	8156218	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.22	CHEMBL4101	Homo sapiens	Inhibition	%	1.22
	8156430	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.76	CHEMBL4101	Homo sapiens	Inhibition	%	1.76
	8156580	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.88	CHEMBL4101	Homo sapiens	Inhibition	%	1.88
	8156804	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.27	CHEMBL4101	Homo sapiens	Inhibition	%	1.27
	8156947	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.27	CHEMBL4101	Homo sapiens	Inhibition	%	3.27
	8157291	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	26.65	CHEMBL4101	Homo sapiens	Inhibition	%	26.65
	8157432	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.66	CHEMBL4101	Homo sapiens	Inhibition	%	2.66
	8157656	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.72	CHEMBL4101	Homo sapiens	Inhibition	%	2.72
	8157786	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.28	CHEMBL4101	Homo sapiens	Inhibition	%	1.28
	8158171	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.46	CHEMBL4101	Homo sapiens	Inhibition	%	-1.46
	8158421	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	49.14	CHEMBL4101	Homo sapiens	Inhibition	%	49.14
	8158579	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.65	CHEMBL4101	Homo sapiens	Inhibition	%	-0.65
	8158972	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.93	CHEMBL4101	Homo sapiens	Inhibition	%	0.93
	8159107	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.39	CHEMBL4101	Homo sapiens	Inhibition	%	2.39
	8159451	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.65	CHEMBL4101	Homo sapiens	Inhibition	%	-0.65
	8159806	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.2	CHEMBL4101	Homo sapiens	Inhibition	%	2.2
	8159947	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	5.08	CHEMBL4101	Homo sapiens	Inhibition	%	5.08
	8160308	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.82	CHEMBL4101	Homo sapiens	Inhibition	%	1.82
	8160458	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	4.16	CHEMBL4101	Homo sapiens	Inhibition	%	4.16
	8160752	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.5	CHEMBL4101	Homo sapiens	Inhibition	%	1.5
	8161126	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.06	CHEMBL4101	Homo sapiens	Inhibition	%	4.06
	8161269	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	1.74	CHEMBL4101	Homo sapiens	Inhibition	%	1.74
	8161493	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.09	CHEMBL4101	Homo sapiens	Inhibition	%	7.09
	8161618	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.52	CHEMBL4101	Homo sapiens	Inhibition	%	1.52
	8161980	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.01	CHEMBL4101	Homo sapiens	Inhibition	%	5.01
	8162110	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.88	CHEMBL4101	Homo sapiens	Inhibition	%	1.88
	8162494	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.98	CHEMBL4101	Homo sapiens	Inhibition	%	-0.98
	8162747	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	82.22	CHEMBL4101	Homo sapiens	Inhibition	%	82.22
	8162895	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.64	CHEMBL4101	Homo sapiens	Inhibition	%	2.64
	8163119	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	11.83	CHEMBL4101	Homo sapiens	Inhibition	%	11.83
	8163288	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.59	CHEMBL4101	Homo sapiens	Inhibition	%	1.59
	8163422	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.33	CHEMBL4101	Homo sapiens	Inhibition	%	3.33
	8163646	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.75	CHEMBL4101	Homo sapiens	Inhibition	%	2.75
	8163769	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	13.2	CHEMBL4101	Homo sapiens	Inhibition	%	13.2
	8164127	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.23	CHEMBL4101	Homo sapiens	Inhibition	%	2.23
	8164267	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.29	CHEMBL4101	Homo sapiens	Inhibition	%	0.29
	8164491	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	4.01	CHEMBL4101	Homo sapiens	Inhibition	%	4.01
	8164646	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.6	CHEMBL4101	Homo sapiens	Inhibition	%	2.6
	8164790	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	48.44	CHEMBL4101	Homo sapiens	Inhibition	%	48.44
	8165014	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.42	CHEMBL4101	Homo sapiens	Inhibition	%	1.42
	8165084	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.72	CHEMBL4101	Homo sapiens	Inhibition	%	1.72
	8165308	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.56	CHEMBL4101	Homo sapiens	Inhibition	%	2.56
	8165449	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.04	CHEMBL4101	Homo sapiens	Inhibition	%	1.04
	8165816	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.91	CHEMBL4101	Homo sapiens	Inhibition	%	0.91
	8165942	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.92	CHEMBL4101	Homo sapiens	Inhibition	%	2.92
	8166304	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	6.49	CHEMBL4101	Homo sapiens	Inhibition	%	6.49
	8166434	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.46	CHEMBL4101	Homo sapiens	Inhibition	%	2.46
	8166658	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.88	CHEMBL4101	Homo sapiens	Inhibition	%	6.88
	8166759	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	14.03	CHEMBL4101	Homo sapiens	Inhibition	%	14.03
	8167071	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	17.5	CHEMBL4101	Homo sapiens	Inhibition	%	17.5
	8167436	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.98	CHEMBL4101	Homo sapiens	Inhibition	%	2.98
	8167600	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.98	CHEMBL4101	Homo sapiens	Inhibition	%	1.98
	8167957	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.34	CHEMBL4101	Homo sapiens	Inhibition	%	6.34
	8168081	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.81	CHEMBL4101	Homo sapiens	Inhibition	%	3.81
	8168305	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	30.38	CHEMBL4101	Homo sapiens	Inhibition	%	30.38
	8168446	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.22	CHEMBL4101	Homo sapiens	Inhibition	%	2.22
	8168806	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.94	CHEMBL4101	Homo sapiens	Inhibition	%	-0.94
	8168970	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	12.81	CHEMBL4101	Homo sapiens	Inhibition	%	12.81
	8169336	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.85	CHEMBL4101	Homo sapiens	Inhibition	%	1.85
	8169640	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.18	CHEMBL4101	Homo sapiens	Inhibition	%	2.18
	8169774	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.86	CHEMBL4101	Homo sapiens	Inhibition	%	2.86
	8170143	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.7	CHEMBL4101	Homo sapiens	Inhibition	%	0.7
	8170268	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.54	CHEMBL4101	Homo sapiens	Inhibition	%	1.54
	8170492	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.59	CHEMBL4101	Homo sapiens	Inhibition	%	2.59
	8170632	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	44.06	CHEMBL4101	Homo sapiens	Inhibition	%	44.06
	8170991	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.64	CHEMBL4101	Homo sapiens	Inhibition	%	1.64
	8171188	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.38	CHEMBL4101	Homo sapiens	Inhibition	%	2.38
	8171405	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	65.82	CHEMBL4101	Homo sapiens	Inhibition	%	65.82
	8171770	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.67	CHEMBL4101	Homo sapiens	Inhibition	%	8.67
	8171923	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.81	CHEMBL4101	Homo sapiens	Inhibition	%	-1.81
	8172147	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.91	CHEMBL4101	Homo sapiens	Inhibition	%	-1.91
	8172279	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.27	CHEMBL4101	Homo sapiens	Inhibition	%	2.27
	8172631	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.39	CHEMBL4101	Homo sapiens	Inhibition	%	0.39
	8172773	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.01	CHEMBL4101	Homo sapiens	Inhibition	%	2.01
	8173133	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.85	CHEMBL4101	Homo sapiens	Inhibition	%	0.85
	8173298	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.96	CHEMBL4101	Homo sapiens	Inhibition	%	1.96
	8173522	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.25	CHEMBL4101	Homo sapiens	Inhibition	%	4.25
	8173663	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.62	CHEMBL4101	Homo sapiens	Inhibition	%	1.62
	8173974	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	7.07	CHEMBL4101	Homo sapiens	Inhibition	%	7.07
	8174106	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.8	CHEMBL4101	Homo sapiens	Inhibition	%	1.8
	8174330	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.3	CHEMBL4101	Homo sapiens	Inhibition	%	2.3
	8174478	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.93	CHEMBL4101	Homo sapiens	Inhibition	%	0.93
	8174824	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.62	CHEMBL4101	Homo sapiens	Inhibition	%	1.62
	8174967	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%		CHEMBL4101	Homo sapiens	Inhibition	%	
	8175327	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.72	CHEMBL4101	Homo sapiens	Inhibition	%	1.72
	8175583	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.31	CHEMBL4101	Homo sapiens	Inhibition	%	4.31
	8175746	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.03	CHEMBL4101	Homo sapiens	Inhibition	%	2.03
	8175970	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.18	CHEMBL4101	Homo sapiens	Inhibition	%	6.18
	8176123	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.43	CHEMBL4101	Homo sapiens	Inhibition	%	10.43
	8176496	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.77	CHEMBL4101	Homo sapiens	Inhibition	%	1.77
	8176628	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.1	CHEMBL4101	Homo sapiens	Inhibition	%	4.1
	8176982	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.32	CHEMBL4101	Homo sapiens	Inhibition	%	4.32
	8177124	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-1.63	CHEMBL4101	Homo sapiens	Inhibition	%	-1.63
	8177348	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-1.78	CHEMBL4101	Homo sapiens	Inhibition	%	-1.78
	8177486	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.03	CHEMBL4101	Homo sapiens	Inhibition	%	4.03
	8177874	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.65	CHEMBL4101	Homo sapiens	Inhibition	%	1.65
	8178014	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.19	CHEMBL4101	Homo sapiens	Inhibition	%	1.19
	8178326	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.32	CHEMBL4101	Homo sapiens	Inhibition	%	2.32
	8178677	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.66	CHEMBL4101	Homo sapiens	Inhibition	%	1.66
	8178826	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.36	CHEMBL4101	Homo sapiens	Inhibition	%	0.36
	8179173	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.22	CHEMBL4101	Homo sapiens	Inhibition	%	1.22
	8179317	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	5.56	CHEMBL4101	Homo sapiens	Inhibition	%	5.56
	8179541	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	8.91	CHEMBL4101	Homo sapiens	Inhibition	%	8.91
	8179678	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.67	CHEMBL4101	Homo sapiens	Inhibition	%	0.67
	8179935	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.6	CHEMBL4101	Homo sapiens	Inhibition	%	2.6
	8180313	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.47	CHEMBL4101	Homo sapiens	Inhibition	%	-2.47
	8180469	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	56.08	CHEMBL4101	Homo sapiens	Inhibition	%	56.08
	8180841	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.6	CHEMBL4101	Homo sapiens	Inhibition	%	1.6
	8180974	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.25	CHEMBL4101	Homo sapiens	Inhibition	%	3.25
	8181198	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	11.92	CHEMBL4101	Homo sapiens	Inhibition	%	11.92
	8181329	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.19	CHEMBL4101	Homo sapiens	Inhibition	%	-1.19
	8181693	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.89	CHEMBL4101	Homo sapiens	Inhibition	%	1.89
	8181832	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	17.17	CHEMBL4101	Homo sapiens	Inhibition	%	17.17
	8182056	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.99	CHEMBL4101	Homo sapiens	Inhibition	%	1.99
	8182219	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.75	CHEMBL4101	Homo sapiens	Inhibition	%	3.75
	8182359	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.44	CHEMBL4101	Homo sapiens	Inhibition	%	1.44
	8182583	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.2	CHEMBL4101	Homo sapiens	Inhibition	%	1.2
	8182675	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.73	CHEMBL4101	Homo sapiens	Inhibition	%	4.73
	8183021	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.69	CHEMBL4101	Homo sapiens	Inhibition	%	3.69
	8183170	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.07	CHEMBL4101	Homo sapiens	Inhibition	%	1.07
	8183394	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.26	CHEMBL4101	Homo sapiens	Inhibition	%	1.26
	8183523	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.1	CHEMBL4101	Homo sapiens	Inhibition	%	6.1
	8183889	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.49	CHEMBL4101	Homo sapiens	Inhibition	%	3.49
	8184025	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.36	CHEMBL4101	Homo sapiens	Inhibition	%	1.36
	8184249	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-3.29	CHEMBL4101	Homo sapiens	Inhibition	%	-3.29
	8184291	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.51	CHEMBL4101	Homo sapiens	Inhibition	%	1.51
	8184515	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.28	CHEMBL4101	Homo sapiens	Inhibition	%	3.28
	8184662	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.52	CHEMBL4101	Homo sapiens	Inhibition	%	-0.52
	8184819	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.22	CHEMBL4101	Homo sapiens	Inhibition	%	2.22
	8185043	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	7.13	CHEMBL4101	Homo sapiens	Inhibition	%	7.13
	8185192	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.53	CHEMBL4101	Homo sapiens	Inhibition	%	0.53
	8185547	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.23	CHEMBL4101	Homo sapiens	Inhibition	%	-0.23
	8185678	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.61	CHEMBL4101	Homo sapiens	Inhibition	%	2.61
	8185902	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.83	CHEMBL4101	Homo sapiens	Inhibition	%	1.83
	8186041	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.35	CHEMBL4101	Homo sapiens	Inhibition	%	2.35
	8186406	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.24	CHEMBL4101	Homo sapiens	Inhibition	%	3.24
	8186570	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.7	CHEMBL4101	Homo sapiens	Inhibition	%	1.7
	8186933	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.31	CHEMBL4101	Homo sapiens	Inhibition	%	2.31
	8187031	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.78	CHEMBL4101	Homo sapiens	Inhibition	%	1.78
	8187255	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.91	CHEMBL4101	Homo sapiens	Inhibition	%	2.91
	8187379	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.61	CHEMBL4101	Homo sapiens	Inhibition	%	1.61
	8187751	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.89	CHEMBL4101	Homo sapiens	Inhibition	%	1.89
	8187880	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.96	CHEMBL4101	Homo sapiens	Inhibition	%	6.96
	8188104	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.14	CHEMBL4101	Homo sapiens	Inhibition	%	3.14
	8188247	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.12	CHEMBL4101	Homo sapiens	Inhibition	%	4.12
	8188606	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.93	CHEMBL4101	Homo sapiens	Inhibition	%	-0.93
	8188880	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.03	CHEMBL4101	Homo sapiens	Inhibition	%	3.03
	8189028	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.05	CHEMBL4101	Homo sapiens	Inhibition	%	1.05
	8189408	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.79	CHEMBL4101	Homo sapiens	Inhibition	%	2.79
	8189557	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.58	CHEMBL4101	Homo sapiens	Inhibition	%	0.58
	8189913	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.04	CHEMBL4101	Homo sapiens	Inhibition	%	-0.04
	8190269	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.05	CHEMBL4101	Homo sapiens	Inhibition	%	1.05
	8190409	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.43	CHEMBL4101	Homo sapiens	Inhibition	%	2.43
	8190770	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.28	CHEMBL4101	Homo sapiens	Inhibition	%	2.28
	8190934	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.99	CHEMBL4101	Homo sapiens	Inhibition	%	1.99
	8191296	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.69	CHEMBL4101	Homo sapiens	Inhibition	%	5.69
	8191616	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.58	CHEMBL4101	Homo sapiens	Inhibition	%	3.58
	8191738	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.17	CHEMBL4101	Homo sapiens	Inhibition	%	3.17
	8191962	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.15	CHEMBL4101	Homo sapiens	Inhibition	%	1.15
	8192111	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.06	CHEMBL4101	Homo sapiens	Inhibition	%	1.06
	8192464	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.15	CHEMBL4101	Homo sapiens	Inhibition	%	3.15
	8192608	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.12	CHEMBL4101	Homo sapiens	Inhibition	%	4.12
	8192968	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.6	CHEMBL4101	Homo sapiens	Inhibition	%	0.6
	8193240	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.46	CHEMBL4101	Homo sapiens	Inhibition	%	1.46
	8193385	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.87	CHEMBL4101	Homo sapiens	Inhibition	%	3.87
	8193609	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.08	CHEMBL4101	Homo sapiens	Inhibition	%	-0.08
	8193766	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.62	CHEMBL4101	Homo sapiens	Inhibition	%	1.62
	8193915	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.34	CHEMBL4101	Homo sapiens	Inhibition	%	-0.34
	8194139	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.34	CHEMBL4101	Homo sapiens	Inhibition	%	1.34
	8194270	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.17	CHEMBL4101	Homo sapiens	Inhibition	%	2.17
	8194625	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.84	CHEMBL4101	Homo sapiens	Inhibition	%	1.84
	8194768	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.13	CHEMBL4101	Homo sapiens	Inhibition	%	6.13
	8194992	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.66	CHEMBL4101	Homo sapiens	Inhibition	%	3.66
	8195125	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.71	CHEMBL4101	Homo sapiens	Inhibition	%	4.71
	8195289	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.97	CHEMBL4101	Homo sapiens	Inhibition	%	1.97
	8195513	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.78	CHEMBL4101	Homo sapiens	Inhibition	%	4.78
	8195652	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.99	CHEMBL4101	Homo sapiens	Inhibition	%	1.99
	8195974	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	20.95	CHEMBL4101	Homo sapiens	Inhibition	%	20.95
	8196315	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.76	CHEMBL4101	Homo sapiens	Inhibition	%	2.76
	8196465	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.83	CHEMBL4101	Homo sapiens	Inhibition	%	1.83
	8196817	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.85	CHEMBL4101	Homo sapiens	Inhibition	%	-0.85
	8196958	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.53	CHEMBL4101	Homo sapiens	Inhibition	%	3.53
	8197182	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.4	CHEMBL4101	Homo sapiens	Inhibition	%	1.4
	8197319	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	3.91	CHEMBL4101	Homo sapiens	Inhibition	%	3.91
	8197594	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.06	CHEMBL4101	Homo sapiens	Inhibition	%	3.06
	8197958	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.94	CHEMBL4101	Homo sapiens	Inhibition	%	-0.94
	8198115	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.98	CHEMBL4101	Homo sapiens	Inhibition	%	-0.98
	8198477	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.9	CHEMBL4101	Homo sapiens	Inhibition	%	1.9
	8198607	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.17	CHEMBL4101	Homo sapiens	Inhibition	%	3.17
	8198831	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.01	CHEMBL4101	Homo sapiens	Inhibition	%	2.01
	8198962	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.95	CHEMBL4101	Homo sapiens	Inhibition	%	1.95
	8199334	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.62	CHEMBL4101	Homo sapiens	Inhibition	%	2.62
	8199468	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.03	CHEMBL4101	Homo sapiens	Inhibition	%	2.03
	8199855	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.82	CHEMBL4101	Homo sapiens	Inhibition	%	1.82
	8199993	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.95	CHEMBL4101	Homo sapiens	Inhibition	%	1.95
	8200217	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.65	CHEMBL4101	Homo sapiens	Inhibition	%	1.65
	8200321	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.67	CHEMBL4101	Homo sapiens	Inhibition	%	1.67
	8200660	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.43	CHEMBL4101	Homo sapiens	Inhibition	%	1.43
	8200810	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.25	CHEMBL4101	Homo sapiens	Inhibition	%	4.25
	8201034	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.21	CHEMBL4101	Homo sapiens	Inhibition	%	1.21
	8201164	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.23	CHEMBL4101	Homo sapiens	Inhibition	%	-2.23
	8201523	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.52	CHEMBL4101	Homo sapiens	Inhibition	%	0.52
	8201656	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.01	CHEMBL4101	Homo sapiens	Inhibition	%	2.01
	8201935	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.79	CHEMBL4101	Homo sapiens	Inhibition	%	1.79
	8202299	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.95	CHEMBL4101	Homo sapiens	Inhibition	%	-0.95
	8202466	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.45	CHEMBL4101	Homo sapiens	Inhibition	%	0.45
	8202815	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.54	CHEMBL4101	Homo sapiens	Inhibition	%	2.54
	8203169	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.06	CHEMBL4101	Homo sapiens	Inhibition	%	3.06
	8203300	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-2.27	CHEMBL4101	Homo sapiens	Inhibition	%	-2.27
	8203670	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.68	CHEMBL4101	Homo sapiens	Inhibition	%	2.68
	8203804	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.57	CHEMBL4101	Homo sapiens	Inhibition	%	2.57
	8204028	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.05	CHEMBL4101	Homo sapiens	Inhibition	%	2.05
	8204194	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.63	CHEMBL4101	Homo sapiens	Inhibition	%	3.63
	8204555	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.73	CHEMBL4101	Homo sapiens	Inhibition	%	0.73
	8204660	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.52	CHEMBL4101	Homo sapiens	Inhibition	%	2.52
	8204884	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.57	CHEMBL4101	Homo sapiens	Inhibition	%	0.57
	8204999	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.96	CHEMBL4101	Homo sapiens	Inhibition	%	5.96
	8205372	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.42	CHEMBL4101	Homo sapiens	Inhibition	%	1.42
	8205508	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.12	CHEMBL4101	Homo sapiens	Inhibition	%	3.12
	8205871	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.31	CHEMBL4101	Homo sapiens	Inhibition	%	1.31
	8206003	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	21.78	CHEMBL4101	Homo sapiens	Inhibition	%	21.78
	8206227	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.4	CHEMBL4101	Homo sapiens	Inhibition	%	-1.4
	8206279	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.53	CHEMBL4101	Homo sapiens	Inhibition	%	2.53
	8206503	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.01	CHEMBL4101	Homo sapiens	Inhibition	%	-1.01
	8206646	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.7	CHEMBL4101	Homo sapiens	Inhibition	%	-0.7
	8206826	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.1	CHEMBL4101	Homo sapiens	Inhibition	%	2.1
	8207050	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.18	CHEMBL4101	Homo sapiens	Inhibition	%	3.18
	8207176	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.34	CHEMBL4101	Homo sapiens	Inhibition	%	2.34
	8207530	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.91	CHEMBL4101	Homo sapiens	Inhibition	%	2.91
	8207662	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.54	CHEMBL4101	Homo sapiens	Inhibition	%	-0.54
	8207886	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.81	CHEMBL4101	Homo sapiens	Inhibition	%	1.81
	8208031	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.3	CHEMBL4101	Homo sapiens	Inhibition	%	5.3
	8208387	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.35	CHEMBL4101	Homo sapiens	Inhibition	%	3.35
	8208553	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.18	CHEMBL4101	Homo sapiens	Inhibition	%	7.18
	8208910	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.45	CHEMBL4101	Homo sapiens	Inhibition	%	5.45
	8209239	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.3	CHEMBL4101	Homo sapiens	Inhibition	%	1.3
	8209355	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.32	CHEMBL4101	Homo sapiens	Inhibition	%	1.32
	8209579	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.89	CHEMBL4101	Homo sapiens	Inhibition	%	1.89
	8209729	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.34	CHEMBL4101	Homo sapiens	Inhibition	%	1.34
	8209865	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.17	CHEMBL4101	Homo sapiens	Inhibition	%	9.17
	8210089	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.29	CHEMBL4101	Homo sapiens	Inhibition	%	2.29
	8210230	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.41	CHEMBL4101	Homo sapiens	Inhibition	%	0.41
	8210590	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.75	CHEMBL4101	Homo sapiens	Inhibition	%	1.75
	8210849	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.62	CHEMBL4101	Homo sapiens	Inhibition	%	0.62
	8210993	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.59	CHEMBL4101	Homo sapiens	Inhibition	%	1.59
	8211387	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.86	CHEMBL4101	Homo sapiens	Inhibition	%	1.86
	8211510	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.12	CHEMBL4101	Homo sapiens	Inhibition	%	4.12
	8211734	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-1.57	CHEMBL4101	Homo sapiens	Inhibition	%	-1.57
	8211863	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.49	CHEMBL4101	Homo sapiens	Inhibition	%	5.49
	8212219	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.34	CHEMBL4101	Homo sapiens	Inhibition	%	3.34
	8212360	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.56	CHEMBL4101	Homo sapiens	Inhibition	%	1.56
	8212584	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.1	CHEMBL4101	Homo sapiens	Inhibition	%	5.1
	8212717	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.83	CHEMBL4101	Homo sapiens	Inhibition	%	1.83
	8212887	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	45.94	CHEMBL4101	Homo sapiens	Inhibition	%	45.94
	8213111	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.26	CHEMBL4101	Homo sapiens	Inhibition	%	1.26
	8213240	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	36.2	CHEMBL4101	Homo sapiens	Inhibition	%	36.2
	8213568	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.8	CHEMBL4101	Homo sapiens	Inhibition	%	-1.8
	8213905	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.46	CHEMBL4101	Homo sapiens	Inhibition	%	1.46
	8214052	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.63	CHEMBL4101	Homo sapiens	Inhibition	%	1.63
	8214413	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	1.54	CHEMBL4101	Homo sapiens	Inhibition	%	1.54
	8214547	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-1.93	CHEMBL4101	Homo sapiens	Inhibition	%	-1.93
	8214771	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.05	CHEMBL4101	Homo sapiens	Inhibition	%	-0.05
	8214923	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.85	CHEMBL4101	Homo sapiens	Inhibition	%	7.85
	8215174	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.31	CHEMBL4101	Homo sapiens	Inhibition	%	3.31
	8215327	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.74	CHEMBL4101	Homo sapiens	Inhibition	%	0.74
	8215551	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.5	CHEMBL4101	Homo sapiens	Inhibition	%	1.5
	8215715	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.48	CHEMBL4101	Homo sapiens	Inhibition	%	1.48
	8216058	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.73	CHEMBL4101	Homo sapiens	Inhibition	%	0.73
	8216177	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.12	CHEMBL4101	Homo sapiens	Inhibition	%	3.12
	8216401	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	6.29	CHEMBL4101	Homo sapiens	Inhibition	%	6.29
	8216537	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.16	CHEMBL4101	Homo sapiens	Inhibition	%	2.16
	8216899	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.09	CHEMBL4101	Homo sapiens	Inhibition	%	2.09
	8217033	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.07	CHEMBL4101	Homo sapiens	Inhibition	%	2.07
	8217431	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	5.43	CHEMBL4101	Homo sapiens	Inhibition	%	5.43
	8217562	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.29	CHEMBL4101	Homo sapiens	Inhibition	%	2.29
	8217887	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.57	CHEMBL4101	Homo sapiens	Inhibition	%	-1.57
	8218226	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.29	CHEMBL4101	Homo sapiens	Inhibition	%	4.29
	8218353	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.29	CHEMBL4101	Homo sapiens	Inhibition	%	2.29
	8218577	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	11.43	CHEMBL4101	Homo sapiens	Inhibition	%	11.43
	8218720	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.34	CHEMBL4101	Homo sapiens	Inhibition	%	3.34
	8219075	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.01	CHEMBL4101	Homo sapiens	Inhibition	%	1.01
	8219235	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.77	CHEMBL4101	Homo sapiens	Inhibition	%	3.77
	8219485	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	9.33	CHEMBL4101	Homo sapiens	Inhibition	%	9.33
	8219870	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.74	CHEMBL4101	Homo sapiens	Inhibition	%	1.74
	8220039	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.87	CHEMBL4101	Homo sapiens	Inhibition	%	2.87
	8220392	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.44	CHEMBL4101	Homo sapiens	Inhibition	%	2.44
	8220730	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	21.8	CHEMBL4101	Homo sapiens	Inhibition	%	21.8
	8220868	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.57	CHEMBL4101	Homo sapiens	Inhibition	%	4.57
	8221228	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	35.89	CHEMBL4101	Homo sapiens	Inhibition	%	35.89
	8221361	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.49	CHEMBL4101	Homo sapiens	Inhibition	%	1.49
	8221585	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.03	CHEMBL4101	Homo sapiens	Inhibition	%	2.03
	8221750	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.2	CHEMBL4101	Homo sapiens	Inhibition	%	3.2
	8221881	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.77	CHEMBL4101	Homo sapiens	Inhibition	%	3.77
	8222105	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.49	CHEMBL4101	Homo sapiens	Inhibition	%	1.49
	8222203	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.47	CHEMBL4101	Homo sapiens	Inhibition	%	1.47
	8222561	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.3	CHEMBL4101	Homo sapiens	Inhibition	%	1.3
	8222903	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.3	CHEMBL4101	Homo sapiens	Inhibition	%	3.3
	8223047	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.14	CHEMBL4101	Homo sapiens	Inhibition	%	4.14
	8223400	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.45	CHEMBL4101	Homo sapiens	Inhibition	%	1.45
	8223561	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.69	CHEMBL4101	Homo sapiens	Inhibition	%	4.69
	8223785	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.52	CHEMBL4101	Homo sapiens	Inhibition	%	1.52
	8223811	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	8.44	CHEMBL4101	Homo sapiens	Inhibition	%	8.44
	8224035	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	29.77	CHEMBL4101	Homo sapiens	Inhibition	%	29.77
	8224197	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-2.06	CHEMBL4101	Homo sapiens	Inhibition	%	-2.06
	8224367	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.64	CHEMBL4101	Homo sapiens	Inhibition	%	1.64
	8224591	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.32	CHEMBL4101	Homo sapiens	Inhibition	%	2.32
	8224726	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.09	CHEMBL4101	Homo sapiens	Inhibition	%	4.09
	8225064	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	71.03	CHEMBL4101	Homo sapiens	Inhibition	%	71.03
	8225198	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.0	CHEMBL4101	Homo sapiens	Inhibition	%	3.0
	8225422	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.6	CHEMBL4101	Homo sapiens	Inhibition	%	2.6
	8225560	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.49	CHEMBL4101	Homo sapiens	Inhibition	%	1.49
	8225919	CHEMBL1961896	GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.3	CHEMBL4101	Homo sapiens	Inhibition	%	2.3
	8226077	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	30.24	CHEMBL4101	Homo sapiens	Inhibition	%	30.24
	8226426	CHEMBL1961897	GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.74	CHEMBL4101	Homo sapiens	Inhibition	%	2.74
active	9644907	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9644908	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
inactive	9644909	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644910	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644911	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644912	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
active	9644913	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3F)ccc21		CHEMBL1989293	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9644914	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644915	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	<	Ki	nM	19952.62	CHEMBL4101	Homo sapiens	pKi		4.7
active	9644916	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9644917	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644918	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644919	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644920	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644921	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	25.12	CHEMBL4101	Homo sapiens	pKi		7.6
active	9644922	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
active	9644923	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9644924	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Cn2cc(-c3ccc4[nH]nc(-c5cn(Cc6ccccc6)nn5)c4c3)nn2)cc1		CHEMBL1964288	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644925	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644926	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9644927	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644928	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
active	9644929	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	=	Ki	nM	39810.72	CHEMBL4101	Homo sapiens	pKi		4.4
inactive	9644930	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644931	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
active	9644932	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
inactive	9644933	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644934	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9644935	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644936	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644937	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccccc1C(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1997643	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644938	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9644939	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644940	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	25118.86	CHEMBL4101	Homo sapiens	pKi		4.6
inactive	9644941	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(-c2ccc3c(c2)C(=O)NC3)c1		CHEMBL1968394	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9644942	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9644943	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9644944	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9644945	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644946	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644947	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644948	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644949	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644950	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9644951	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644952	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9644953	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644954	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644955	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9644956	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9644957	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644958	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644959	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644960	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9644961	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644962	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644963	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644964	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644965	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1cc(-c2ccc(F)cc2)[nH]c2c(-c3ccc(F)cc3)cnn12		CHEMBL2004443	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644966	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644967	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644968	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644969	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644970	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9644971	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644972	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644973	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCNc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1968459	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9644974	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9644975	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9644976	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
inactive	9644977	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644978	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644979	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644980	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9644981	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9644982	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644983	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9644984	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644985	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644986	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644987	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644988	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9644989	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644990	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644991	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9644992	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9644993	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)C1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1965702	=	Ki	nM	19.95	CHEMBL4101	Homo sapiens	pKi		7.7
inactive	9644994	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9644995	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
active	9644996	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
active	9644997	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)Oc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL2002456	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
active	9644998	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9644999	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9645000	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9645001	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9645002	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9645003	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9645004	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9645005	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9645006	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9645007	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9645008	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)CNC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2006456	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
active	9645009	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	25118.86	CHEMBL4101	Homo sapiens	pKi		4.6
inactive	9645010	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9645011	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1964340	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9645012	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9645013	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9645014	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9645015	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9645016	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9645017	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)CCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1967662	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
inactive	9645018	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9649033	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649034	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649035	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649036	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649037	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
inactive	9649038	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649039	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649040	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9649041	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649042	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1F		CHEMBL243518	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649043	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649044	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	=	Ki	nM	12.59	CHEMBL4101	Homo sapiens	pKi		7.9
active	9649045	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1C(F)(F)F		CHEMBL1997554	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9649046	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
active	9649047	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
active	9649048	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
active	9649049	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9649050	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649051	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649052	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9649053	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9649054	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649055	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649056	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649057	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649058	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649059	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649060	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9649061	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649062	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649063	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649064	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649065	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
active	9649066	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCC(C)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998068	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9649067	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649068	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649069	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9649070	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9649071	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649072	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649073	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649074	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
active	9649075	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9649076	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9649077	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649078	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649079	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)n1ncc2cc(N)ccc21		CHEMBL1972454	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9649080	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649081	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9649082	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649083	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9649084	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9649085	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649086	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649087	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649088	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649089	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649090	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649091	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649092	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649093	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	0.7943	CHEMBL4101	Homo sapiens	pKi		9.1
inactive	9649094	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649095	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649096	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649097	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9649098	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649099	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9649100	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649101	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649102	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649103	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649104	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	10000.0	CHEMBL4101	Homo sapiens	pKi		5.0
inactive	9649105	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649106	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649107	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9649108	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649109	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649110	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9649111	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9649112	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649113	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1995932	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9649114	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649115	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649116	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649117	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3cncc(OCCNS(C)(=O)=O)c3)cc12		CHEMBL1967704	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
active	9649118	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9649119	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649120	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649121	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649122	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649123	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
active	9649124	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9649125	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649126	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1ccc(-c2c(-c3ccc4[nH]nc(N)c4c3)nnn2Cc2ccccc2)cc1		CHEMBL1969221	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
active	9649127	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
active	9649128	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9649129	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649130	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649131	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649132	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
active	9649133	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9649134	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
active	9649135	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9649136	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNCC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1996980	=	Ki	nM	12.59	CHEMBL4101	Homo sapiens	pKi		7.9
active	9649137	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(Cc1ccccc1)c1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1969920	=	Ki	nM	39.81	CHEMBL4101	Homo sapiens	pKi		7.4
inactive	9649138	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649139	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649140	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	19952.62	CHEMBL4101	Homo sapiens	pKi		4.7
inactive	9649141	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649142	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649143	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649144	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649145	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649146	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649147	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649148	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649149	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
inactive	9649150	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649151	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9649152	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649153	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc(F)cc2)n1		CHEMBL1992231	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9649154	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9649155	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649156	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649157	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCNc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1983157	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9649158	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649159	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9649160	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649161	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649162	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	19952.62	CHEMBL4101	Homo sapiens	pKi		4.7
inactive	9649163	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649164	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9649165	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649166	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649167	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649168	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCOc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1996447	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649169	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649170	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
inactive	9649171	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649172	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649173	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649174	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649175	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649176	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
active	9649177	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	25.12	CHEMBL4101	Homo sapiens	pKi		7.6
inactive	9649178	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649179	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	10000.0	CHEMBL4101	Homo sapiens	pKi		5.0
inactive	9649180	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649181	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	39.81	CHEMBL4101	Homo sapiens	pKi		7.4
active	9649182	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9649183	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649184	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9649185	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649186	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649187	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649188	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649189	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9649190	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9649191	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	10.0	CHEMBL4101	Homo sapiens	pKi		8.0
active	9649192	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	=	Ki	nM	3.162	CHEMBL4101	Homo sapiens	pKi		8.5
active	9649193	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
inactive	9649194	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649195	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649196	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
active	9649197	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9649198	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649199	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	=	Ki	nM	39810.72	CHEMBL4101	Homo sapiens	pKi		4.4
inactive	9649200	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649201	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649202	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9649203	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649204	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
active	9649205	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9649206	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9649207	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649208	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9649209	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1cccc(-c2c[nH]c3ncccc23)c1		CHEMBL1993648	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9649210	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
active	9649211	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9649212	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc(-c2ccnc(N)n2)cc1N1CCCCC1		CHEMBL1971951	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649213	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccccc1)Nc1ccccn1		CHEMBL143703	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9649214	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649215	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649216	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649217	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649218	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1cc(-c2ccncc2)nc(NCc2cc(F)cc(F)c2)[nH]1		CHEMBL2003682	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
inactive	9649219	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649220	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649221	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649222	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9649223	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649224	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649225	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9649226	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649227	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCN(CCOC)c1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985654	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
active	9649228	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	39810.72	CHEMBL4101	Homo sapiens	pKi		4.4
inactive	9649229	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649230	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	31622.78	CHEMBL4101	Homo sapiens	pKi		4.5
active	9649231	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNCCOc1cncc(-c2ccc3[nH]nc(C)c3c2)c1		CHEMBL1983855	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
active	9649232	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9649233	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649234	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9649235	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649236	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649237	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649238	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649239	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9649240	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649241	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3C3CC3)cc12		CHEMBL2004631	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9649242	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649243	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9649244	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9649245	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9649246	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9649247	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9649248	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
inactive	9649249	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649250	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9649251	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	7.943	CHEMBL4101	Homo sapiens	pKi		8.1
inactive	9649252	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9649253	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649254	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649255	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649256	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(Cl)cc1		CHEMBL1987073	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9649257	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649258	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649259	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9649260	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649261	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649262	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc(Nc2ncnc3[nH]cc(-c4ccccc4)c23)cc1		CHEMBL1975440	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9649263	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649264	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9649265	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649266	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9649267	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9649268	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9649269	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
inactive	9649270	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9649271	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9653285	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653286	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653287	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653288	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9653289	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
active	9653290	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9653291	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653292	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653293	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653294	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
active	9653295	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9653296	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1cc(-c2cccc(F)c2)[nH]c2c(-c3ccc(F)cc3)cnn12		CHEMBL2004156	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653297	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9653298	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653299	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653300	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653301	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653302	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653303	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OC1CCCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1976936	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9653304	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653305	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
active	9653306	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Cn2cc(-c3ccc4[nH]nc(-c5ccccc5)c4c3)nn2)cc1		CHEMBL1982400	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9653307	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9653308	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	12.59	CHEMBL4101	Homo sapiens	pKi		7.9
active	9653309	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9653310	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653311	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653312	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653313	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653314	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1cccc(F)c1		CHEMBL1982982	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653315	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653316	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653317	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9653318	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653319	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3Cl)ccc21		CHEMBL1987745	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9653320	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653321	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9653322	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1972583	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9653323	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	10000.0	CHEMBL4101	Homo sapiens	pKi		5.0
inactive	9653324	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653325	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653326	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9653327	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653328	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653329	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
active	9653330	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9653331	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	=	Ki	nM	39810.72	CHEMBL4101	Homo sapiens	pKi		4.4
inactive	9653332	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9653333	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653334	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653335	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	12.59	CHEMBL4101	Homo sapiens	pKi		7.9
inactive	9653336	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653337	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653338	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
active	9653339	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653340	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653341	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653342	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653343	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
active	9653344	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9653345	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653346	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653347	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9653348	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653349	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653350	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9653351	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653352	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653353	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653354	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9653355	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653356	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653357	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653358	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653359	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1992363	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
active	9653360	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9653361	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653362	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
inactive	9653363	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653364	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653365	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1982271	=	Ki	nM	25.12	CHEMBL4101	Homo sapiens	pKi		7.6
inactive	9653366	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	19952.62	CHEMBL4101	Homo sapiens	pKi		4.7
active	9653367	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9653368	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653369	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653370	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653371	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653372	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653373	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653374	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	19952.62	CHEMBL4101	Homo sapiens	pKi		4.7
inactive	9653375	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1sc2[nH]c(=O)n3nc(-c4ccncc4)nc3c2c1C		CHEMBL1980592	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653376	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653377	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653378	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653379	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	15848.93	CHEMBL4101	Homo sapiens	pKi		4.8
active	9653380	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
inactive	9653381	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653382	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=[N+]([O-])c1cccc(-c2nnc3ccc(N4CCCCC4)nn23)c1		CHEMBL2003637	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653383	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL1986666	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9653384	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653385	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653386	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9653387	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9653388	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653389	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653390	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653391	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653392	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	15.85	CHEMBL4101	Homo sapiens	pKi		7.8
inactive	9653393	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653394	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653395	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653396	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653397	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9653398	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653399	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9653400	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653401	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9653402	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653403	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
active	9653404	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
inactive	9653405	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653406	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653407	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C(=Cc1ccc2nccn2n1)c1ccccc1		CHEMBL1988622	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9653408	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9653409	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653410	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9653411	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9653412	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653413	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Nc1nccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL2002432	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653414	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	5.012	CHEMBL4101	Homo sapiens	pKi		8.3
active	9653415	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1987948	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9653416	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9653417	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653418	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653419	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653420	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653421	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
inactive	9653422	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(-c2ccc3c(c2)CNC3=O)ccc1F		CHEMBL1976290	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9653423	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653424	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9653425	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653426	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9653427	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653428	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653429	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653430	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653431	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
active	9653432	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9653433	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9653434	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653435	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653436	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653437	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653438	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653439	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653440	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653441	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
active	9653442	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	10.0	CHEMBL4101	Homo sapiens	pKi		8.0
inactive	9653443	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653444	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653445	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653446	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9653447	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1970821	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
active	9653448	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9653449	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653450	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653451	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005509	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
inactive	9653452	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653453	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653454	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653455	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653456	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653457	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653458	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCNc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682554	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9653459	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9653460	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653461	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(CNc2cc(-c3c[nH]c4ncccc34)cc(F)n2)cc1		CHEMBL1986855	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9653462	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653463	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3)ccc21		CHEMBL1989136	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653464	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653465	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653466	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653467	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653468	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653469	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9653470	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1csc2c1NCCC2=O		CHEMBL1973399	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9653471	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9653472	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653473	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
active	9653474	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
active	9653475	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccc(-c2ccccc2)n1		CHEMBL1834385	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9653476	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653477	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9653478	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653479	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
active	9653480	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9653481	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9653482	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653483	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	1.259	CHEMBL4101	Homo sapiens	pKi		8.9
active	9653484	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
active	9653485	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
inactive	9653486	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653487	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653488	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653489	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
inactive	9653490	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653491	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653492	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CCCOc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1988662	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9653493	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653494	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653495	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653496	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9653497	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9653498	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653499	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653500	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
active	9653501	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	39810.72	CHEMBL4101	Homo sapiens	pKi		4.4
inactive	9653502	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653503	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9653504	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653505	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9653506	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653507	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653508	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653509	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1983589	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
active	9653510	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
active	9653511	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005718	=	Ki	nM	39.81	CHEMBL4101	Homo sapiens	pKi		7.4
active	9653512	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9653513	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	31622.78	CHEMBL4101	Homo sapiens	pKi		4.5
inactive	9653514	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653515	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9653516	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
active	9653517	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	12.59	CHEMBL4101	Homo sapiens	pKi		7.9
inactive	9653518	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653519	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9653520	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9653521	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9653522	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
inactive	9653523	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657532	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657533	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657534	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
inactive	9657535	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657536	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657537	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
active	9657538	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(F)n1		CHEMBL1987261	=	Ki	nM	39.81	CHEMBL4101	Homo sapiens	pKi		7.4
active	9657539	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
active	9657540	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9657541	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657542	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9657543	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657544	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
active	9657545	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9657546	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657547	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657548	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	19.95	CHEMBL4101	Homo sapiens	pKi		7.7
inactive	9657549	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657550	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1977128	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9657551	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657552	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657553	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657554	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657555	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9657556	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657557	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657558	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9657559	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657560	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657561	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657562	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657563	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657564	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9657565	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9657566	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657567	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9657568	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657569	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657570	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
active	9657571	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(Nc1nccc(-c2c[nH]c3ncccc23)n1)c1ccccc1		CHEMBL1999279	=	Ki	nM	12.59	CHEMBL4101	Homo sapiens	pKi		7.9
active	9657572	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
active	9657573	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
inactive	9657574	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657575	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657576	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657577	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
active	9657578	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9657579	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657580	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
inactive	9657581	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657582	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9657583	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657584	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657585	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9657586	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657587	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9657588	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657589	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657590	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657591	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1980178	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9657592	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
inactive	9657593	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657594	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(-c2ccc3c(c2)Nc2ccccc2NC3=O)ccn1		CHEMBL1981511	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657595	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657596	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657597	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9657598	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657599	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9657600	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657601	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657602	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657603	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657604	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)c1c[nH]n2c(=O)cc(-c3ccncc3)nc12		CHEMBL1990708	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657605	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
inactive	9657606	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657607	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9657608	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657609	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9657610	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1972290	=	Ki	nM	15.85	CHEMBL4101	Homo sapiens	pKi		7.8
active	9657611	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
active	9657612	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9657613	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657614	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1984548	=	Ki	nM	25.12	CHEMBL4101	Homo sapiens	pKi		7.6
active	9657615	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9657616	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9657617	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657618	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657619	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657620	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9657621	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657622	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9657623	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657624	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657625	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657626	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9657627	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657628	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657629	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657630	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657631	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657632	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1972339	=	Ki	nM	6.31	CHEMBL4101	Homo sapiens	pKi		8.2
inactive	9657633	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657634	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657635	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9657636	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657637	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(Cl)c1		CHEMBL1983595	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9657638	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
inactive	9657639	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657640	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657641	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9657642	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657643	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657644	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9657645	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9657646	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9657647	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657648	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	39810.72	CHEMBL4101	Homo sapiens	pKi		4.4
active	9657649	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9657650	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657651	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2ccccc2)c2nc(-c3ccncc3)cc(=O)n21		CHEMBL1986767	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
inactive	9657652	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657653	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9657654	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657655	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657656	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	15.85	CHEMBL4101	Homo sapiens	pKi		7.8
active	9657657	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9657658	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCCc2[nH]c(-c3ccnc(Cl)c3)cc21		CHEMBL226232	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657659	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9657660	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657661	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657662	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9657663	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657664	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657665	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657666	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657667	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
inactive	9657668	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657669	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657670	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCCCC1Nc1nccc(Nc2ccccc2C(=O)O)n1		CHEMBL1985153	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657671	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9657672	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657673	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657674	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9657675	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9657676	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
inactive	9657677	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657678	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	FC(F)(F)c1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1966040	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9657679	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
inactive	9657680	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657681	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	<	Ki	nM	31622.78	CHEMBL4101	Homo sapiens	pKi		4.5
inactive	9657682	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657683	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
active	9657684	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9657685	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9657686	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657687	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657688	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
active	9657689	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCCCC1Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1994438	=	Ki	nM	3.162	CHEMBL4101	Homo sapiens	pKi		8.5
inactive	9657690	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657691	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	10000.0	CHEMBL4101	Homo sapiens	pKi		5.0
active	9657692	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9657693	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657694	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9657695	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657696	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
active	9657697	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9657698	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657699	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657700	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	3.981	CHEMBL4101	Homo sapiens	pKi		8.4
inactive	9657701	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657702	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
inactive	9657703	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657704	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657705	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657706	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9657707	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657708	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
active	9657709	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	31622.78	CHEMBL4101	Homo sapiens	pKi		4.5
inactive	9657710	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657711	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
active	9657712	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Ki	nM	15848.93	CHEMBL4101	Homo sapiens	pKi		4.8
active	9657713	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9657714	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	19.95	CHEMBL4101	Homo sapiens	pKi		7.7
active	9657715	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657716	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657717	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657718	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657719	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9657720	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657721	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657722	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657723	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657724	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657725	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccccc1)c1c[nH]n2c(=O)cc(-c3ccncc3)nc12		CHEMBL1974250	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9657726	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657727	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657728	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657729	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657730	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9657731	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ccc(-c2cccn3c(=O)[nH]nc23)cc1		CHEMBL1975503	=	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9657732	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657733	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657734	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL2003229	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9657735	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657736	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657737	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(CNc2cc(-c3c[nH]c4ncccc34)cc(Cl)n2)c1C		CHEMBL1988331	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9657738	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657739	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657740	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3cncc(OCCN(C)S(C)(=O)=O)c3)cc12		CHEMBL1998826	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
active	9657741	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
inactive	9657742	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657743	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657744	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
active	9657745	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	=	Ki	nM	25.12	CHEMBL4101	Homo sapiens	pKi		7.6
active	9657746	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cnc2[nH]cc(-c3ccnc(NCC4CCCCC4)n3)c2c1		CHEMBL213207	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9657747	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9657748	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9657749	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
inactive	9657750	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9657751	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C(N)=O)n2nc(C(C)(C)C)cc2n1		CHEMBL1986684	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9657752	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657753	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657754	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657755	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9657756	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9657757	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657758	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
active	9657759	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9657760	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCc2ccc(-c3ccc(Cl)cc3)cc21		CHEMBL2002202	=	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9657761	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9657762	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9657763	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(F)cc1		CHEMBL1966204	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9657764	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657765	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	12.59	CHEMBL4101	Homo sapiens	pKi		7.9
active	9657766	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	=	Ki	nM	100.0	CHEMBL4101	Homo sapiens	pKi		7.0
active	9657767	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2-c2ccccc2)cc1		CHEMBL1969473	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
active	9657768	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	FC(F)(F)c1ccccc1CNc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1999153	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
inactive	9657769	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9657770	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
active	9661781	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9661782	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661783	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661784	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9661785	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661786	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661787	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9661788	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661789	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661790	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661791	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	79.43	CHEMBL4101	Homo sapiens	pKi		7.1
active	9661792	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9661793	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661794	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661795	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661796	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9661797	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661798	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661799	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	19.95	CHEMBL4101	Homo sapiens	pKi		7.7
active	9661800	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(C)c3c2)nnn1Cc1ccccc1		CHEMBL1983315	=	Ki	nM	3.981	CHEMBL4101	Homo sapiens	pKi		8.4
inactive	9661801	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661802	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661803	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661804	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9661805	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661806	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9661807	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661808	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661809	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9661810	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1995712	=	Ki	nM	39.81	CHEMBL4101	Homo sapiens	pKi		7.4
inactive	9661811	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661812	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661813	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661814	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	=	Ki	nM	10000.0	CHEMBL4101	Homo sapiens	pKi		5.0
inactive	9661815	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661816	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661817	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661818	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9661819	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661820	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661821	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
active	9661822	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
active	9661823	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	12589.25	CHEMBL4101	Homo sapiens	pKi		4.9
inactive	9661824	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661825	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661826	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661827	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	=	Ki	nM	39.81	CHEMBL4101	Homo sapiens	pKi		7.4
inactive	9661828	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661829	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
active	9661830	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1980562	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
inactive	9661831	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661832	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661833	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	31622.78	CHEMBL4101	Homo sapiens	pKi		4.5
inactive	9661834	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ncnc(Nc2cccc(F)c2)n1		CHEMBL1979933	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661835	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661836	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
active	9661837	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	10000.0	CHEMBL4101	Homo sapiens	pKi		5.0
active	9661838	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9661839	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661840	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(O)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005387	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
active	9661841	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
active	9661842	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661843	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661844	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1972988	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661845	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661846	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661847	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661848	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661849	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9661850	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661851	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661852	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1987448	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
inactive	9661853	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661854	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661855	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661856	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661857	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9661858	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
inactive	9661859	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661860	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9661861	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005216	=	Ki	nM	63.1	CHEMBL4101	Homo sapiens	pKi		7.2
active	9661862	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9661863	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661864	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661865	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
active	9661866	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	15848.93	CHEMBL4101	Homo sapiens	pKi		4.8
inactive	9661867	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661868	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661869	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9661870	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661871	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661872	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661873	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	5.012	CHEMBL4101	Homo sapiens	pKi		8.3
active	9661874	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661875	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	7.943	CHEMBL4101	Homo sapiens	pKi		8.1
inactive	9661876	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661877	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661878	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661879	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661880	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661881	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661882	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9661883	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661884	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661885	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661886	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	=	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9661887	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661888	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	39.81	CHEMBL4101	Homo sapiens	pKi		7.4
inactive	9661889	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661890	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2ccc(-c3cc(Cc4ccccc4)no3)cc12		CHEMBL1682358	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
inactive	9661891	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661892	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661893	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661894	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661895	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661896	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661897	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	=	Ki	nM	25.12	CHEMBL4101	Homo sapiens	pKi		7.6
inactive	9661898	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661899	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	7.943	CHEMBL4101	Homo sapiens	pKi		8.1
inactive	9661900	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661901	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661902	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661903	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661904	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661905	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	19.95	CHEMBL4101	Homo sapiens	pKi		7.7
inactive	9661906	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661907	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661908	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	=	Ki	nM	31.62	CHEMBL4101	Homo sapiens	pKi		7.5
active	9661909	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
active	9661910	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	31622.78	CHEMBL4101	Homo sapiens	pKi		4.5
active	9661911	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	1584.89	CHEMBL4101	Homo sapiens	pKi		5.8
inactive	9661912	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661913	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661914	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661915	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
inactive	9661916	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL2001477	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661917	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661918	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661919	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661920	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661921	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661922	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9661923	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661924	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661925	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9661926	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	794.33	CHEMBL4101	Homo sapiens	pKi		6.1
inactive	9661927	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661928	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661929	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9661930	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661931	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661932	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661933	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661934	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661935	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661936	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
inactive	9661937	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661938	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661939	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
active	9661940	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9661941	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9661942	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661943	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661944	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	316.23	CHEMBL4101	Homo sapiens	pKi		6.5
active	9661945	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9661946	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661947	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661948	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661949	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9661950	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661951	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
active	9661952	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
inactive	9661953	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661954	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661955	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661956	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1989006	=	Ki	nM	158.49	CHEMBL4101	Homo sapiens	pKi		6.8
active	9661957	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	=	Ki	nM	50.12	CHEMBL4101	Homo sapiens	pKi		7.3
active	9661958	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
inactive	9661959	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661960	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
active	9661961	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	C=CCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1996339	=	Ki	nM	398.11	CHEMBL4101	Homo sapiens	pKi		6.4
inactive	9661962	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661963	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661964	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9661965	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661966	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661967	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661968	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1990162	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9661969	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661970	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1992220	=	Ki	nM	25.12	CHEMBL4101	Homo sapiens	pKi		7.6
inactive	9661971	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9661972	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661973	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661974	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9661975	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661976	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661977	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661978	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661979	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661980	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661981	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661982	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661983	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCc2ccc(-c3ccccc3)cc21		CHEMBL1973795	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9661984	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	19.95	CHEMBL4101	Homo sapiens	pKi		7.7
inactive	9661985	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661986	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661987	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	6309.57	CHEMBL4101	Homo sapiens	pKi		5.2
inactive	9661988	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661989	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661990	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661991	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	15848.93	CHEMBL4101	Homo sapiens	pKi		4.8
inactive	9661992	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661993	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9661994	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9661995	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	630.96	CHEMBL4101	Homo sapiens	pKi		6.2
inactive	9661996	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	2511.89	CHEMBL4101	Homo sapiens	pKi		5.6
active	9661997	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9661998	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9661999	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9662000	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9662001	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9662002	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
active	9662003	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CN)CNc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1968930	=	Ki	nM	3.981	CHEMBL4101	Homo sapiens	pKi		8.4
inactive	9662004	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9662005	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9662006	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	<	Ki	nM	50118.72	CHEMBL4101	Homo sapiens	pKi		4.3
inactive	9662007	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9662008	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(O)c1ccccc1Nc1ccnc(NCc2cccc(O)c2)n1		CHEMBL1970950	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9662009	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	5011.87	CHEMBL4101	Homo sapiens	pKi		5.3
active	9662010	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	125.89	CHEMBL4101	Homo sapiens	pKi		6.9
inactive	9662011	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9662012	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	1000.0	CHEMBL4101	Homo sapiens	pKi		6.0
active	9662013	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	=	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9662014	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9662015	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9662016	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9662017	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9662018	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9662019	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9665990	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9665991	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9665992	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9665993	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9665994	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	=	Ki	nM	501.19	CHEMBL4101	Homo sapiens	pKi		6.3
inactive	9665995	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9665996	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9665997	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9665998	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9665999	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	=	Ki	nM	1995.26	CHEMBL4101	Homo sapiens	pKi		5.7
inactive	9666000	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9666001	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9666002	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9666003	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9666004	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9666005	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	251.19	CHEMBL4101	Homo sapiens	pKi		6.6
inactive	9666006	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9666007	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9666008	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9666009	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
inactive	9666010	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	1258.93	CHEMBL4101	Homo sapiens	pKi		5.9
active	9666011	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	199.53	CHEMBL4101	Homo sapiens	pKi		6.7
inactive	9666012	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9666013	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9666014	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
active	9666015	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	c1ccc(C2CCc3[nH]ncc32)cc1		CHEMBL1965683	=	Ki	nM	39810.72	CHEMBL4101	Homo sapiens	pKi		4.4
inactive	9666016	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
inactive	9666017	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
active	9666018	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	3981.07	CHEMBL4101	Homo sapiens	pKi		5.4
inactive	9666019	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	3162.28	CHEMBL4101	Homo sapiens	pKi		5.5
inactive	9666020	CHEMBL1963835	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	7943.28	CHEMBL4101	Homo sapiens	pKi		5.1
	10839452	CHEMBL2015483	Inhibition of PKACa at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	28.0	CHEMBL4101	Homo sapiens	INH	%	28.0
	10849725	CHEMBL2019684	Inhibition of PRKACA	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL4101	Homo sapiens	IC50	uM	40.0
	10889031	CHEMBL2032484	Inhibition of PKAalpha	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	10889058	CHEMBL2032484	Inhibition of PKAalpha	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	10980280	CHEMBL2065129	Inhibition of PRKACA at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL4101	Homo sapiens	INH	%	25.0
	10980281	CHEMBL2065129	Inhibition of PRKACA at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL4101	Homo sapiens	INH	%	15.0
	10980315	CHEMBL2065159	Inhibition of PRKACA by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	12060936	CHEMBL2157415	Binding affinity to PKACalpha at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	88.0	CHEMBL4101	Homo sapiens	Activity	%	88.0
	12252176	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	84.0	CHEMBL4101	Homo sapiens	Residual Activity	%	84.0
	12252177	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	110.0	CHEMBL4101	Homo sapiens	Residual Activity	%	110.0
	12252178	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12252179	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL4101	Homo sapiens	Residual Activity	%	106.0
	12252180	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12252181	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	109.0	CHEMBL4101	Homo sapiens	Residual Activity	%	109.0
	12252182	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12252183	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	111.0	CHEMBL4101	Homo sapiens	Residual Activity	%	111.0
	12252184	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	104.0	CHEMBL4101	Homo sapiens	Residual Activity	%	104.0
	12252185	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	99.0	CHEMBL4101	Homo sapiens	Residual Activity	%	99.0
	12252186	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	99.0	CHEMBL4101	Homo sapiens	Residual Activity	%	99.0
	12252187	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12252188	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12252189	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	34.0	CHEMBL4101	Homo sapiens	Residual Activity	%	34.0
	12252190	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	114.0	CHEMBL4101	Homo sapiens	Residual Activity	%	114.0
	12252191	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12252192	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	110.0	CHEMBL4101	Homo sapiens	Residual Activity	%	110.0
	12252193	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	98.0	CHEMBL4101	Homo sapiens	Residual Activity	%	98.0
	12252194	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	97.0	CHEMBL4101	Homo sapiens	Residual Activity	%	97.0
	12252195	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252196	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12252197	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL4101	Homo sapiens	Residual Activity	%	100.0
	12252198	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	124.0	CHEMBL4101	Homo sapiens	Residual Activity	%	124.0
	12252199	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12252200	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252201	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	73.0	CHEMBL4101	Homo sapiens	Residual Activity	%	73.0
	12252202	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	74.0	CHEMBL4101	Homo sapiens	Residual Activity	%	74.0
	12252203	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12252204	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12252205	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	69.0	CHEMBL4101	Homo sapiens	Residual Activity	%	69.0
	12252206	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	111.0	CHEMBL4101	Homo sapiens	Residual Activity	%	111.0
	12252207	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	108.0	CHEMBL4101	Homo sapiens	Residual Activity	%	108.0
	12252208	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	97.0	CHEMBL4101	Homo sapiens	Residual Activity	%	97.0
	12252209	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12252210	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL4101	Homo sapiens	Residual Activity	%	108.0
	12252211	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12252212	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252213	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	112.0	CHEMBL4101	Homo sapiens	Residual Activity	%	112.0
	12252214	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	87.0	CHEMBL4101	Homo sapiens	Residual Activity	%	87.0
	12252215	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	108.0	CHEMBL4101	Homo sapiens	Residual Activity	%	108.0
	12252216	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12252217	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	87.0	CHEMBL4101	Homo sapiens	Residual Activity	%	87.0
	12252218	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	28.0	CHEMBL4101	Homo sapiens	Residual Activity	%	28.0
	12252219	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	61.0	CHEMBL4101	Homo sapiens	Residual Activity	%	61.0
	12252220	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	90.0	CHEMBL4101	Homo sapiens	Residual Activity	%	90.0
	12252221	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12252222	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12252223	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252224	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12252225	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12252226	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	37.0	CHEMBL4101	Homo sapiens	Residual Activity	%	37.0
	12252227	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12252228	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	25.0	CHEMBL4101	Homo sapiens	Residual Activity	%	25.0
	12252229	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	69.0	CHEMBL4101	Homo sapiens	Residual Activity	%	69.0
	12252230	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	76.0	CHEMBL4101	Homo sapiens	Residual Activity	%	76.0
	12252231	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	80.0	CHEMBL4101	Homo sapiens	Residual Activity	%	80.0
	12252232	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	71.0	CHEMBL4101	Homo sapiens	Residual Activity	%	71.0
	12252233	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	92.0	CHEMBL4101	Homo sapiens	Residual Activity	%	92.0
	12252234	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	70.0	CHEMBL4101	Homo sapiens	Residual Activity	%	70.0
	12252235	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12252236	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	68.0	CHEMBL4101	Homo sapiens	Residual Activity	%	68.0
	12252237	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	13.0	CHEMBL4101	Homo sapiens	Residual Activity	%	13.0
	12252238	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12252239	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	69.0	CHEMBL4101	Homo sapiens	Residual Activity	%	69.0
	12252240	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252241	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252242	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	79.0	CHEMBL4101	Homo sapiens	Residual Activity	%	79.0
	12252243	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	72.0	CHEMBL4101	Homo sapiens	Residual Activity	%	72.0
	12252244	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	71.0	CHEMBL4101	Homo sapiens	Residual Activity	%	71.0
	12252245	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	92.0	CHEMBL4101	Homo sapiens	Residual Activity	%	92.0
	12252246	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12252247	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	75.0	CHEMBL4101	Homo sapiens	Residual Activity	%	75.0
	12252248	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	60.0	CHEMBL4101	Homo sapiens	Residual Activity	%	60.0
	12252249	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12252250	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	78.0	CHEMBL4101	Homo sapiens	Residual Activity	%	78.0
	12252251	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12252252	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12252253	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	81.0	CHEMBL4101	Homo sapiens	Residual Activity	%	81.0
	12252254	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	99.0	CHEMBL4101	Homo sapiens	Residual Activity	%	99.0
	12252255	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4101	Homo sapiens	Residual Activity	%	1.0
	12252256	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12252257	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	107.0	CHEMBL4101	Homo sapiens	Residual Activity	%	107.0
	12252258	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	97.0	CHEMBL4101	Homo sapiens	Residual Activity	%	97.0
	12252259	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12252260	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12252261	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL4101	Homo sapiens	Residual Activity	%	107.0
	12252262	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12252263	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL4101	Homo sapiens	Residual Activity	%	105.0
	12252264	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12252265	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	90.0	CHEMBL4101	Homo sapiens	Residual Activity	%	90.0
	12252266	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	87.0	CHEMBL4101	Homo sapiens	Residual Activity	%	87.0
	12252267	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	97.0	CHEMBL4101	Homo sapiens	Residual Activity	%	97.0
	12252268	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12252269	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12252270	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	92.0	CHEMBL4101	Homo sapiens	Residual Activity	%	92.0
	12252271	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	53.0	CHEMBL4101	Homo sapiens	Residual Activity	%	53.0
	12252272	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	105.0	CHEMBL4101	Homo sapiens	Residual Activity	%	105.0
	12252273	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12252274	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12252275	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12252276	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12252277	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	7.0	CHEMBL4101	Homo sapiens	Residual Activity	%	7.0
	12252278	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12252279	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	70.0	CHEMBL4101	Homo sapiens	Residual Activity	%	70.0
	12252280	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	92.0	CHEMBL4101	Homo sapiens	Residual Activity	%	92.0
	12252281	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	98.0	CHEMBL4101	Homo sapiens	Residual Activity	%	98.0
	12252282	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	90.0	CHEMBL4101	Homo sapiens	Residual Activity	%	90.0
	12252283	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	94.0	CHEMBL4101	Homo sapiens	Residual Activity	%	94.0
	12252284	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	100.0	CHEMBL4101	Homo sapiens	Residual Activity	%	100.0
	12252285	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252286	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	97.0	CHEMBL4101	Homo sapiens	Residual Activity	%	97.0
	12252287	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	94.0	CHEMBL4101	Homo sapiens	Residual Activity	%	94.0
	12252288	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12252289	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	105.0	CHEMBL4101	Homo sapiens	Residual Activity	%	105.0
	12252290	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	106.0	CHEMBL4101	Homo sapiens	Residual Activity	%	106.0
	12252291	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	91.0	CHEMBL4101	Homo sapiens	Residual Activity	%	91.0
	12252292	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	92.0	CHEMBL4101	Homo sapiens	Residual Activity	%	92.0
	12252293	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	105.0	CHEMBL4101	Homo sapiens	Residual Activity	%	105.0
	12252294	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12252295	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	94.0	CHEMBL4101	Homo sapiens	Residual Activity	%	94.0
	12252296	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	111.0	CHEMBL4101	Homo sapiens	Residual Activity	%	111.0
	12252297	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	109.0	CHEMBL4101	Homo sapiens	Residual Activity	%	109.0
	12252298	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12252299	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	99.0	CHEMBL4101	Homo sapiens	Residual Activity	%	99.0
	12252300	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12252301	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL4101	Homo sapiens	Residual Activity	%	99.0
	12252302	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	106.0	CHEMBL4101	Homo sapiens	Residual Activity	%	106.0
	12252303	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL4101	Homo sapiens	Residual Activity	%	100.0
	12252304	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12252305	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	53.0	CHEMBL4101	Homo sapiens	Residual Activity	%	53.0
	12252306	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12252307	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	109.0	CHEMBL4101	Homo sapiens	Residual Activity	%	109.0
	12252308	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252309	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12252310	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	94.0	CHEMBL4101	Homo sapiens	Residual Activity	%	94.0
	12252311	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12252312	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	111.0	CHEMBL4101	Homo sapiens	Residual Activity	%	111.0
	12252313	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	80.0	CHEMBL4101	Homo sapiens	Residual Activity	%	80.0
	12252314	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12252315	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	87.0	CHEMBL4101	Homo sapiens	Residual Activity	%	87.0
	12252316	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	79.0	CHEMBL4101	Homo sapiens	Residual Activity	%	79.0
	12252317	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	2.0	CHEMBL4101	Homo sapiens	Residual Activity	%	2.0
	12252318	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	73.0	CHEMBL4101	Homo sapiens	Residual Activity	%	73.0
	12252319	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	71.0	CHEMBL4101	Homo sapiens	Residual Activity	%	71.0
	12252320	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	92.0	CHEMBL4101	Homo sapiens	Residual Activity	%	92.0
	12252321	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL4101	Homo sapiens	Residual Activity	%	90.0
	12252322	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12252323	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12252324	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12252325	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	91.0	CHEMBL4101	Homo sapiens	Residual Activity	%	91.0
	12252326	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	79.0	CHEMBL4101	Homo sapiens	Residual Activity	%	79.0
	12252327	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12252328	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12252329	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12252330	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	105.0	CHEMBL4101	Homo sapiens	Residual Activity	%	105.0
	12252331	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12252332	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	67.0	CHEMBL4101	Homo sapiens	Residual Activity	%	67.0
	12252333	CHEMBL2219390	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	5.0	CHEMBL4101	Homo sapiens	Residual Activity	%	5.0
	12253742	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	59.0	CHEMBL4101	Homo sapiens	Residual Activity	%	59.0
	12253743	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	55.0	CHEMBL4101	Homo sapiens	Residual Activity	%	55.0
	12253744	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	112.0	CHEMBL4101	Homo sapiens	Residual Activity	%	112.0
	12253745	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	120.0	CHEMBL4101	Homo sapiens	Residual Activity	%	120.0
	12253746	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	98.0	CHEMBL4101	Homo sapiens	Residual Activity	%	98.0
	12253747	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	77.0	CHEMBL4101	Homo sapiens	Residual Activity	%	77.0
	12253748	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	57.0	CHEMBL4101	Homo sapiens	Residual Activity	%	57.0
	12253749	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12253750	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	106.0	CHEMBL4101	Homo sapiens	Residual Activity	%	106.0
	12253751	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	75.0	CHEMBL4101	Homo sapiens	Residual Activity	%	75.0
	12253752	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	77.0	CHEMBL4101	Homo sapiens	Residual Activity	%	77.0
	12253753	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	80.0	CHEMBL4101	Homo sapiens	Residual Activity	%	80.0
	12253754	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12253755	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	8.0	CHEMBL4101	Homo sapiens	Residual Activity	%	8.0
	12253756	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	141.0	CHEMBL4101	Homo sapiens	Residual Activity	%	141.0
	12253757	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	98.0	CHEMBL4101	Homo sapiens	Residual Activity	%	98.0
	12253758	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	146.0	CHEMBL4101	Homo sapiens	Residual Activity	%	146.0
	12253759	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	73.0	CHEMBL4101	Homo sapiens	Residual Activity	%	73.0
	12253760	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12253761	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	77.0	CHEMBL4101	Homo sapiens	Residual Activity	%	77.0
	12253762	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12253763	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12253764	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12253765	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	83.0	CHEMBL4101	Homo sapiens	Residual Activity	%	83.0
	12253766	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12253767	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12253768	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12253769	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	90.0	CHEMBL4101	Homo sapiens	Residual Activity	%	90.0
	12253770	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	132.0	CHEMBL4101	Homo sapiens	Residual Activity	%	132.0
	12253771	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	43.0	CHEMBL4101	Homo sapiens	Residual Activity	%	43.0
	12253772	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12253773	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	98.0	CHEMBL4101	Homo sapiens	Residual Activity	%	98.0
	12253774	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	145.0	CHEMBL4101	Homo sapiens	Residual Activity	%	145.0
	12253775	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	104.0	CHEMBL4101	Homo sapiens	Residual Activity	%	104.0
	12253776	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	97.0	CHEMBL4101	Homo sapiens	Residual Activity	%	97.0
	12253777	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12253778	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	98.0	CHEMBL4101	Homo sapiens	Residual Activity	%	98.0
	12253779	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	141.0	CHEMBL4101	Homo sapiens	Residual Activity	%	141.0
	12253780	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	91.0	CHEMBL4101	Homo sapiens	Residual Activity	%	91.0
	12253781	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	80.0	CHEMBL4101	Homo sapiens	Residual Activity	%	80.0
	12253782	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	147.0	CHEMBL4101	Homo sapiens	Residual Activity	%	147.0
	12253783	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12253784	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	36.0	CHEMBL4101	Homo sapiens	Residual Activity	%	36.0
	12253785	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	26.0	CHEMBL4101	Homo sapiens	Residual Activity	%	26.0
	12253786	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	118.0	CHEMBL4101	Homo sapiens	Residual Activity	%	118.0
	12253787	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	50.0	CHEMBL4101	Homo sapiens	Residual Activity	%	50.0
	12253788	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	118.0	CHEMBL4101	Homo sapiens	Residual Activity	%	118.0
	12253789	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	87.0	CHEMBL4101	Homo sapiens	Residual Activity	%	87.0
	12253790	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12253791	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12253792	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	17.0	CHEMBL4101	Homo sapiens	Residual Activity	%	17.0
	12253793	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12253794	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	5.0	CHEMBL4101	Homo sapiens	Residual Activity	%	5.0
	12253795	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	59.0	CHEMBL4101	Homo sapiens	Residual Activity	%	59.0
	12253796	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	75.0	CHEMBL4101	Homo sapiens	Residual Activity	%	75.0
	12253797	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12253798	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12253799	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	114.0	CHEMBL4101	Homo sapiens	Residual Activity	%	114.0
	12253800	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	104.0	CHEMBL4101	Homo sapiens	Residual Activity	%	104.0
	12253801	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	68.0	CHEMBL4101	Homo sapiens	Residual Activity	%	68.0
	12253802	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	66.0	CHEMBL4101	Homo sapiens	Residual Activity	%	66.0
	12253803	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	10.0	CHEMBL4101	Homo sapiens	Residual Activity	%	10.0
	12253804	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	63.0	CHEMBL4101	Homo sapiens	Residual Activity	%	63.0
	12253805	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	81.0	CHEMBL4101	Homo sapiens	Residual Activity	%	81.0
	12253806	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	109.0	CHEMBL4101	Homo sapiens	Residual Activity	%	109.0
	12253807	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12253808	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	70.0	CHEMBL4101	Homo sapiens	Residual Activity	%	70.0
	12253809	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	83.0	CHEMBL4101	Homo sapiens	Residual Activity	%	83.0
	12253810	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	70.0	CHEMBL4101	Homo sapiens	Residual Activity	%	70.0
	12253811	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	134.0	CHEMBL4101	Homo sapiens	Residual Activity	%	134.0
	12253812	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	75.0	CHEMBL4101	Homo sapiens	Residual Activity	%	75.0
	12253813	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	106.0	CHEMBL4101	Homo sapiens	Residual Activity	%	106.0
	12253814	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	20.0	CHEMBL4101	Homo sapiens	Residual Activity	%	20.0
	12253815	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	141.0	CHEMBL4101	Homo sapiens	Residual Activity	%	141.0
	12253816	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	133.0	CHEMBL4101	Homo sapiens	Residual Activity	%	133.0
	12253817	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	123.0	CHEMBL4101	Homo sapiens	Residual Activity	%	123.0
	12253818	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	74.0	CHEMBL4101	Homo sapiens	Residual Activity	%	74.0
	12253819	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12253820	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	74.0	CHEMBL4101	Homo sapiens	Residual Activity	%	74.0
	12253821	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4101	Homo sapiens	Residual Activity	%	1.0
	12253822	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	90.0	CHEMBL4101	Homo sapiens	Residual Activity	%	90.0
	12253823	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	84.0	CHEMBL4101	Homo sapiens	Residual Activity	%	84.0
	12253824	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12253825	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	80.0	CHEMBL4101	Homo sapiens	Residual Activity	%	80.0
	12253826	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12253827	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	128.0	CHEMBL4101	Homo sapiens	Residual Activity	%	128.0
	12253828	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	133.0	CHEMBL4101	Homo sapiens	Residual Activity	%	133.0
	12253829	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	71.0	CHEMBL4101	Homo sapiens	Residual Activity	%	71.0
	12253830	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	104.0	CHEMBL4101	Homo sapiens	Residual Activity	%	104.0
	12253831	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	54.0	CHEMBL4101	Homo sapiens	Residual Activity	%	54.0
	12253832	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	94.0	CHEMBL4101	Homo sapiens	Residual Activity	%	94.0
	12253833	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	77.0	CHEMBL4101	Homo sapiens	Residual Activity	%	77.0
	12253834	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	70.0	CHEMBL4101	Homo sapiens	Residual Activity	%	70.0
	12253835	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12253836	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12253837	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	17.0	CHEMBL4101	Homo sapiens	Residual Activity	%	17.0
	12253838	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12253839	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12253840	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	106.0	CHEMBL4101	Homo sapiens	Residual Activity	%	106.0
	12253841	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12253842	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12253843	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL4101	Homo sapiens	Residual Activity	%	3.0
	12253844	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	95.0	CHEMBL4101	Homo sapiens	Residual Activity	%	95.0
	12253845	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	68.0	CHEMBL4101	Homo sapiens	Residual Activity	%	68.0
	12253846	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12253847	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	99.0	CHEMBL4101	Homo sapiens	Residual Activity	%	99.0
	12253848	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	91.0	CHEMBL4101	Homo sapiens	Residual Activity	%	91.0
	12253849	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	98.0	CHEMBL4101	Homo sapiens	Residual Activity	%	98.0
	12253850	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	91.0	CHEMBL4101	Homo sapiens	Residual Activity	%	91.0
	12253851	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	94.0	CHEMBL4101	Homo sapiens	Residual Activity	%	94.0
	12253852	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12253853	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12253854	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	54.0	CHEMBL4101	Homo sapiens	Residual Activity	%	54.0
	12253855	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	115.0	CHEMBL4101	Homo sapiens	Residual Activity	%	115.0
	12253856	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	129.0	CHEMBL4101	Homo sapiens	Residual Activity	%	129.0
	12253857	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12253858	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	82.0	CHEMBL4101	Homo sapiens	Residual Activity	%	82.0
	12253859	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	118.0	CHEMBL4101	Homo sapiens	Residual Activity	%	118.0
	12253860	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	64.0	CHEMBL4101	Homo sapiens	Residual Activity	%	64.0
	12253861	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	84.0	CHEMBL4101	Homo sapiens	Residual Activity	%	84.0
	12253862	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	100.0	CHEMBL4101	Homo sapiens	Residual Activity	%	100.0
	12253863	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	86.0	CHEMBL4101	Homo sapiens	Residual Activity	%	86.0
	12253864	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12253865	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	79.0	CHEMBL4101	Homo sapiens	Residual Activity	%	79.0
	12253866	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	38.0	CHEMBL4101	Homo sapiens	Residual Activity	%	38.0
	12253867	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	101.0	CHEMBL4101	Homo sapiens	Residual Activity	%	101.0
	12253868	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	103.0	CHEMBL4101	Homo sapiens	Residual Activity	%	103.0
	12253869	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	129.0	CHEMBL4101	Homo sapiens	Residual Activity	%	129.0
	12253870	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	94.0	CHEMBL4101	Homo sapiens	Residual Activity	%	94.0
	12253871	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	16.0	CHEMBL4101	Homo sapiens	Residual Activity	%	16.0
	12253872	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12253873	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12253874	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	73.0	CHEMBL4101	Homo sapiens	Residual Activity	%	73.0
	12253875	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	84.0	CHEMBL4101	Homo sapiens	Residual Activity	%	84.0
	12253876	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	85.0	CHEMBL4101	Homo sapiens	Residual Activity	%	85.0
	12253877	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	87.0	CHEMBL4101	Homo sapiens	Residual Activity	%	87.0
	12253878	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	83.0	CHEMBL4101	Homo sapiens	Residual Activity	%	83.0
	12253879	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	52.0	CHEMBL4101	Homo sapiens	Residual Activity	%	52.0
	12253880	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	97.0	CHEMBL4101	Homo sapiens	Residual Activity	%	97.0
	12253881	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	90.0	CHEMBL4101	Homo sapiens	Residual Activity	%	90.0
	12253882	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	80.0	CHEMBL4101	Homo sapiens	Residual Activity	%	80.0
	12253883	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	6.0	CHEMBL4101	Homo sapiens	Residual Activity	%	6.0
	12253884	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12253885	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	32.0	CHEMBL4101	Homo sapiens	Residual Activity	%	32.0
	12253886	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12253887	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	89.0	CHEMBL4101	Homo sapiens	Residual Activity	%	89.0
	12253888	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	93.0	CHEMBL4101	Homo sapiens	Residual Activity	%	93.0
	12253889	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	88.0	CHEMBL4101	Homo sapiens	Residual Activity	%	88.0
	12253890	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	77.0	CHEMBL4101	Homo sapiens	Residual Activity	%	77.0
	12253891	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	74.0	CHEMBL4101	Homo sapiens	Residual Activity	%	74.0
	12253892	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	68.0	CHEMBL4101	Homo sapiens	Residual Activity	%	68.0
	12253893	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	71.0	CHEMBL4101	Homo sapiens	Residual Activity	%	71.0
	12253894	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	96.0	CHEMBL4101	Homo sapiens	Residual Activity	%	96.0
	12253895	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL4101	Homo sapiens	Residual Activity	%	102.0
	12253896	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	91.0	CHEMBL4101	Homo sapiens	Residual Activity	%	91.0
	12253897	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	124.0	CHEMBL4101	Homo sapiens	Residual Activity	%	124.0
	12253898	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	19.0	CHEMBL4101	Homo sapiens	Residual Activity	%	19.0
	12253899	CHEMBL2219391	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	1.0	CHEMBL4101	Homo sapiens	Residual Activity	%	1.0
	12668268	CHEMBL2345063	Inhibition of PRKACA (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	-2.0	CHEMBL4101	Homo sapiens	INH	%	-2.0
	12668269	CHEMBL2345063	Inhibition of PRKACA (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	53.0	CHEMBL4101	Homo sapiens	INH	%	53.0
	12668270	CHEMBL2345063	Inhibition of PRKACA (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	43.0	CHEMBL4101	Homo sapiens	INH	%	43.0
	12668271	CHEMBL2345063	Inhibition of PRKACA (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	29.0	CHEMBL4101	Homo sapiens	INH	%	29.0
	12668272	CHEMBL2345063	Inhibition of PRKACA (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	0.0	CHEMBL4101	Homo sapiens	INH	%	0.0
	12668273	CHEMBL2345063	Inhibition of PRKACA (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	-1.0	CHEMBL4101	Homo sapiens	INH	%	-1.0
	12668274	CHEMBL2345063	Inhibition of PRKACA (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	12700122	CHEMBL2344134	Inhibition of recombinant PRKACA (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	11.0	CHEMBL4101	Homo sapiens	INH	%	11.0
	12723646	CHEMBL2350477	Inhibition of PRKACA (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	-3.0	CHEMBL4101	Homo sapiens	INH	%	-3.0
	12724734	CHEMBL2350784	Inhibition of PRKACA (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	9.0	CHEMBL4101	Homo sapiens	INH	%	9.0
	12724735	CHEMBL2350784	Inhibition of PRKACA (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	9.0	CHEMBL4101	Homo sapiens	INH	%	9.0
Not Active	13328753	CHEMBL2388476	Inhibition of PRKACA (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	13439938	CHEMBL2429481	Competitive binding affinity to PKAC-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	13445448	CHEMBL2429481	Competitive binding affinity to PKAC-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	13448503	CHEMBL2429481	Competitive binding affinity to PKAC-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	13448639	CHEMBL2429481	Competitive binding affinity to PKAC-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	13451434	CHEMBL2429481	Competitive binding affinity to PKAC-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	13454619	CHEMBL2429481	Competitive binding affinity to PKAC-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
Not Active	13863532	CHEMBL3101999	Inhibition of PRKACA (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Active	13863533	CHEMBL3101999	Inhibition of PRKACA (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Determined	13870253	CHEMBL3100279	Inhibition of PKAalpha (unknown origin) using serine/threonine 01 peptide as substrate after 1 hr by FRET based Z'-LYTE assay	B	O=C1C=CC(=O)c2ccccc21		CHEMBL55934		IC50			CHEMBL4101	Homo sapiens	IC50		
	13870254	CHEMBL3100279	Inhibition of PKAalpha (unknown origin) using serine/threonine 01 peptide as substrate after 1 hr by FRET based Z'-LYTE assay	B	C=CC(=O)c1ccccc1		CHEMBL3099615	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	13870255	CHEMBL3100279	Inhibition of PKAalpha (unknown origin) using serine/threonine 01 peptide as substrate after 1 hr by FRET based Z'-LYTE assay	B	COC(=O)CC/C=C/C(=O)c1ccccc1		CHEMBL3099614	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	13870256	CHEMBL3100279	Inhibition of PKAalpha (unknown origin) using serine/threonine 01 peptide as substrate after 1 hr by FRET based Z'-LYTE assay	B	COC/C=C/C(=O)c1ccccc1		CHEMBL3099613	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	13870257	CHEMBL3100279	Inhibition of PKAalpha (unknown origin) using serine/threonine 01 peptide as substrate after 1 hr by FRET based Z'-LYTE assay	B	O=C1C[C@@H](O)[C@@H](C2=CC(=O)c3ccccc3C2=O)O1		CHEMBL3099612	=	IC50	nM	430.0	CHEMBL4101	Homo sapiens	IC50	uM	0.43
	13870258	CHEMBL3100279	Inhibition of PKAalpha (unknown origin) using serine/threonine 01 peptide as substrate after 1 hr by FRET based Z'-LYTE assay	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1ccccc1C2=O		CHEMBL522996	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	13870259	CHEMBL3100279	Inhibition of PKAalpha (unknown origin) using serine/threonine 01 peptide as substrate after 1 hr by FRET based Z'-LYTE assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.5	CHEMBL4101	Homo sapiens	IC50	uM	0.0015
	13899589	CHEMBL3111854	Inhibition of human PKAalpha at 1 uM	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144	<	Inhibition	%	10.0	CHEMBL4101	Homo sapiens	INH	%	10.0
	14582582	CHEMBL3241646	Inhibition of human PKAC-alpha assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	110.0	CHEMBL4101	Homo sapiens	Activity	%	110.0
	14664287	CHEMBL3271255	Inhibition of PKACalpha (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	100.0	CHEMBL4101	Homo sapiens	INH	%	100.0
	14664288	CHEMBL3271255	Inhibition of PKACalpha (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	69.0	CHEMBL4101	Homo sapiens	INH	%	69.0
	14664289	CHEMBL3271255	Inhibition of PKACalpha (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	70.0	CHEMBL4101	Homo sapiens	INH	%	70.0
	14983172	CHEMBL3385027	Inhibition of PRKACA (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	14984414	CHEMBL3384377	Inhibition of PRKACA (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	4.0	CHEMBL4101	Homo sapiens	INH	%	4.0
	14992847	CHEMBL3372242	Inhibition of recombinant PRKACA (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
Not Active	14999389	CHEMBL3368685	Inhibition of human PKA at 10 uM relative to control	B	CC(C)(C)C1=NN(c2cccc(Cl)c2)C(c2ccc(F)c(O)c2)C1		CHEMBL3323358		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	15036918	CHEMBL3381099	Inhibition of PKAalpha (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	15036919	CHEMBL3381099	Inhibition of PKAalpha (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	15036920	CHEMBL3381099	Inhibition of PKAalpha (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	15036921	CHEMBL3381099	Inhibition of PKAalpha (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	15036922	CHEMBL3381099	Inhibition of PKAalpha (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
Not Active	15062581	CHEMBL3370294	Inhibition of human PKAC-alpha by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	15173722	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	Fc1cnc2[nH]cc(-c3ncc(F)c(N[C@H]4C5CCC(CC5)[C@@H]4c4nnn[nH]4)n3)c2c1		CHEMBL3401975	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173723	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	O=P(O)(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401976	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173724	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	O=P(O)(O)CC[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401977	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173725	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	O=c1[nH]c(=O)n(C[C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401978	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173726	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)no1		CHEMBL3401979	=	Ki	nM	590.0	CHEMBL4101	Homo sapiens	Ki	uM	0.59
	15173727	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	CC(=O)NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401980	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173728	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)on1		CHEMBL3401981	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173729	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	O=c1nc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]o1		CHEMBL3401982	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173730	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401983	=	Ki	nM	490.0	CHEMBL4101	Homo sapiens	Ki	uM	0.49
	15173731	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	OCC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401984	=	Ki	nM	230.0	CHEMBL4101	Homo sapiens	Ki	uM	0.23
	15173732	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]n1		CHEMBL3401985	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173733	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401986	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173734	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	CC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401987	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173735	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	Cc1noc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)n1		CHEMBL3401988	=	Ki	nM	1100.0	CHEMBL4101	Homo sapiens	Ki	uM	1.1
	15173736	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	Cc1nnc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401989	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	15173737	CHEMBL3405456	Inhibition of PKAa (unknown origin)	B	CS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401990	=	Ki	nM	1500.0	CHEMBL4101	Homo sapiens	Ki	uM	1.5
	15190915	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	5.0	CHEMBL4101	Homo sapiens	INH	%	5.0
	15190916	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	5.0	CHEMBL4101	Homo sapiens	INH	%	5.0
	15190917	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	15190918	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	33.0	CHEMBL4101	Homo sapiens	INH	%	33.0
	15190919	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	22.0	CHEMBL4101	Homo sapiens	INH	%	22.0
	15190920	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	32.0	CHEMBL4101	Homo sapiens	INH	%	32.0
	15190921	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	13.0	CHEMBL4101	Homo sapiens	INH	%	13.0
	15190922	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	5.0	CHEMBL4101	Homo sapiens	INH	%	5.0
	15190923	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	15190924	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	8.0	CHEMBL4101	Homo sapiens	INH	%	8.0
	15190925	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	15190926	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	15190927	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	33.0	CHEMBL4101	Homo sapiens	INH	%	33.0
	15190928	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	15190929	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	15190930	CHEMBL3412787	Inhibition of PKACalpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	0.0	CHEMBL4101	Homo sapiens	INH	%	0.0
	15258373	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	2.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.0
	15258433	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.0
	15258493	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	-0.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.5
	15258553	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	6.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	6.4
	15258613	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	-0.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.6
	15258673	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15258733	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.3
	15258793	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.9	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.9
	15258853	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	-0.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258913	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	5.9	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	5.9
	15258973	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.8
	15259033	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.6
	15259093	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	1.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.1
	15259153	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	4.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	4.0
	15259213	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	4.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	4.1
	15259273	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	0.9	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.9
	15259333	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	2.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.0
	15259393	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.5
	15259453	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	1.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.5
	15259513	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	-0.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.7
	15259573	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.7
	15259633	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	-0.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.8
	15259693	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15259753	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	9.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	9.2
	15259813	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15259873	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15259933	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259993	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	2.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.3
	15260053	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	3.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.1
	15260113	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.3
	15260173	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.9	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.9
	15260233	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15260293	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	1.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.1
	15260353	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	2.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.2
	15260413	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	-0.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.1
	15260473	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.4
	15260533	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	4.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	4.8
	15260593	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	1.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.3
	15260653	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15260713	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	6.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	6.5
	15260773	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	4.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	4.8
	15260833	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	14.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	14.1
	15260893	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	2.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.3
	15260953	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15261013	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.2
	15261073	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15261133	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	1.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.1
	15261156	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.0
	15261216	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.6
	15261276	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	0.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.6
	15261336	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15261396	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.8
	15261451	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	0.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.0
	15261511	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.2
	15261571	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	2.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.1
	15261631	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15261704	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15261764	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	-0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261824	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	1.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.7
	15261884	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	2.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.1
	15261940	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	-0.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262000	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.5
	15262060	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	1.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.1
	15262120	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15262193	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	2.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.1
	15262253	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	2.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.3
	15262313	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	1.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.3
	15262373	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	-0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262433	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15262493	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	1.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.2
	15262553	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15262613	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.3
	15262673	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.7
	15262733	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	3.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.1
	15262793	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.6
	15262853	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	2.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.3
	15262913	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	3.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.8
	15262973	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	0.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.3
	15263033	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15263093	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.6
	15263153	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.6
	15263213	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.6
	15263273	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15263333	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15263429	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	0.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.5
	15263484	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15263544	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	2.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.3
	15263604	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.7
	15263664	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.6
	15263724	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	5.9	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	5.9
	15263738	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15263798	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	3.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.5
	15263858	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	-1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-1.6
	15263918	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.2
	15264032	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	1.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.3
	15264092	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	0.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.6
	15264152	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	1.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.1
	15264212	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	4.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	4.0
	15264225	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	-0.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264285	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.6
	15264345	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15264405	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	3.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.4
	15264465	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	0.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.8
	15264521	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	3.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.8
	15264581	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	7.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	7.1
	15264641	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-4.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-4.1
	15264701	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	2.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.5
	15264773	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	0.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.5
	15264833	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.8
	15264893	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	2.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.6
	15264953	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.6
	15265009	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	1.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.7
	15265069	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	2.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.5
	15265129	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15265189	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	3.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.0
	15265262	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15265322	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265382	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.2
	15265442	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	0.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.5
	15265498	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	6.9	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	6.9
	15265558	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.9	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.9
	15265618	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.8
	15265678	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.7
	15265750	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.2
	15265810	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.2
	15265870	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15265930	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.3
	15265987	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	2.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.5
	15266047	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	2.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.7
	15266107	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.7
	15266167	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	-0.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.7
	15266239	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	2.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.1
	15266299	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-0.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.2
	15266359	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	0.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.3
	15266419	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	1.7	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.7
	15266474	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	1.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.2
	15266534	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	3.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.0
	15266594	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	3.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	3.6
	15266654	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	2.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.6
	15266727	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	4.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	4.2
	15266787	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15266847	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	1.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.0
	15266907	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.8
	15266962	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	1.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.4
	15267022	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	4.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	4.4
	15267082	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	1.5	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.5
	15267142	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	2.2	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.2
	15267215	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.6
	15267275	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	2.8	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.8
	15267335	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.1	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.1
	15267395	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	2.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	2.6
	15267450	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	11.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	11.3
	15267510	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.4	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.4
	15267570	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	1.6	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	1.6
	15267630	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.0	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	0.0
	15267690	CHEMBL3430832	Delta TM value showing the stabilisation of PRKACA produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.3	CHEMBL4101	Homo sapiens	Thermal melting change	degrees C	-0.3
	15620135	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2cc(-c3ccncn3)cs2)c1		CHEMBL3581138	=	Ki	nM	2900.0	CHEMBL4101	Homo sapiens	Ki	nM	2900.0
	15620136	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccncn3)cs2)c1		CHEMBL3581137	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620137	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nnc(-c3ccncc3)s2)c1		CHEMBL3581136	=	Ki	nM	1700.0	CHEMBL4101	Homo sapiens	Ki	nM	1700.0
	15620138	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccncc3)ns2)c1		CHEMBL3581135	=	Ki	nM	500.0	CHEMBL4101	Homo sapiens	Ki	nM	500.0
	15620139	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2ccc(-c3ccncc3)s2)c1		CHEMBL3581134	=	Ki	nM	1070.0	CHEMBL4101	Homo sapiens	Ki	nM	1070.0
	15620140	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2csc(-c3ccncc3)c2)c1		CHEMBL3581133	=	Ki	nM	2400.0	CHEMBL4101	Homo sapiens	Ki	nM	2400.0
	15620141	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2cc(-c3ccncc3)cs2)c1		CHEMBL3581132	=	Ki	nM	600.0	CHEMBL4101	Homo sapiens	Ki	nM	600.0
	15620142	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2cnc(-c3ccncc3)s2)c1		CHEMBL3581131	=	Ki	nM	520.0	CHEMBL4101	Homo sapiens	Ki	nM	520.0
	15620143	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2csc(-c3ccncc3)n2)c1		CHEMBL3581130	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620144	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(C2CCCN(c3nc(-c4ccncc4)cs3)C2=O)c1		CHEMBL3581129	=	Ki	nM	2300.0	CHEMBL4101	Homo sapiens	Ki	nM	2300.0
	15620145	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3ccncc3)cs2)c1		CHEMBL3581128	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620146	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Nc1cccc(CC(=O)Nc2nc(-c3ccncc3)cs2)c1		CHEMBL3581127	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620147	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1ccc2c(c1Cl)OCO2)Nc1nc(-c2ccncc2)cs1		CHEMBL3581126	=	Ki	nM	310.0	CHEMBL4101	Homo sapiens	Ki	nM	310.0
	15620148	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1ccc2c(c1)OCO2)Nc1nc(-c2ccncc2)cs1		CHEMBL3581125	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620149	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1ccc(O)cc1)Nc1nc(-c2ccncc2)cs1		CHEMBL3581124	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620150	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3581123	=	Ki	nM	1700.0	CHEMBL4101	Homo sapiens	Ki	nM	1700.0
	15620151	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1ccccc1O)Nc1nc(-c2ccncc2)cs1		CHEMBL3581122	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620152	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1ccc(CC(=O)Nc2nc(-c3ccncc3)cs2)cc1		CHEMBL1427910	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620153	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccncc3)cs2)c1		CHEMBL3581121	=	Ki	nM	2500.0	CHEMBL4101	Homo sapiens	Ki	nM	2500.0
	15620154	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1ccccc1CC(=O)Nc1nc(-c2ccncc2)cs1		CHEMBL3581120	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	nM	5000.0
	15620155	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1ccc(F)cc1)Nc1nc(-c2ccncc2)cs1		CHEMBL3581119	=	Ki	nM	1580.0	CHEMBL4101	Homo sapiens	Ki	nM	1580.0
	15620156	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(F)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3581118	=	Ki	nM	2000.0	CHEMBL4101	Homo sapiens	Ki	nM	2000.0
	15620157	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1ccccc1F)Nc1nc(-c2ccncc2)cs1		CHEMBL3581117	=	Ki	nM	2090.0	CHEMBL4101	Homo sapiens	Ki	nM	2090.0
	15620158	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1ccccc1)Nc1nc(-c2ccncc2)cs1		CHEMBL3581116	=	Ki	nM	3500.0	CHEMBL4101	Homo sapiens	Ki	nM	3500.0
	15620159	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1nc(-c2ccncc2)cs1)c1ccccc1F		CHEMBL3581115	>	Ki	nM	5000.0	CHEMBL4101	Homo sapiens	Ki	uM	5.0
	15620198	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccnc(C)c3)cs2)c1		CHEMBL3581139	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620199	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccnc(N)c3)cs2)c1		CHEMBL3581140	=	Ki	nM	1850.0	CHEMBL4101	Homo sapiens	Ki	nM	1850.0
	15620200	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CNc1cc(-c2csc(NC(=O)Cc3cccc(OC)c3)n2)ccn1		CHEMBL3581141	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620201	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccnc(N(C)C)c3)cs2)c1		CHEMBL3581142	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620783	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccnc(OC)c3)cs2)c1		CHEMBL3581143	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620784	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccnc(F)c3)cs2)c1		CHEMBL3581144	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620785	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccnc(Cl)c3)cs2)c1		CHEMBL3581145	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620786	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2cc(-c3ccnc(F)c3)cs2)c1		CHEMBL3581146	=	Ki	nM	780.0	CHEMBL4101	Homo sapiens	Ki	nM	780.0
	15620787	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2cc(-c3ccnc(F)c3)cs2)c1		CHEMBL3580669	=	Ki	nM	3000.0	CHEMBL4101	Homo sapiens	Ki	nM	3000.0
	15620788	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2cc(-c3ccnc(Cl)c3)cs2)c1		CHEMBL3581147	=	Ki	nM	2200.0	CHEMBL4101	Homo sapiens	Ki	nM	2200.0
	15620789	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2cc(-c3ccnc(Cl)c3)cs2)c1		CHEMBL3581148	>	Ki	nM	3300.0	CHEMBL4101	Homo sapiens	Ki	nM	3300.0
	15620790	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2cc(-c3ccnc(N)c3)cs2)c1		CHEMBL3581149	=	Ki	nM	140.0	CHEMBL4101	Homo sapiens	Ki	nM	140.0
	15620791	CHEMBL3585198	Inhibition of PKAalpha (1 to 351 amino acids) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2cc(-c3ccnc(N)c3)cs2)c1		CHEMBL3581150	=	Ki	nM	850.0	CHEMBL4101	Homo sapiens	Ki	nM	850.0
	15685913	CHEMBL3606456	Inhibition of human PKAalpha	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	15755921	CHEMBL3631572	Inhibition of PKAC-alpha (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	92.0	CHEMBL4101	Homo sapiens	Activity	%	92.0
267719	16262992	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(C)(C)O	Outside typical range	CHEMBL1922123	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267713	16273084	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CCC(O)[C@@H](CC)Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1	Outside typical range	CHEMBL1922120	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267714	16287015	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CCC(O)[C@H](CC)Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1	Outside typical range	CHEMBL1922209	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267715	16288484	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)C	Outside typical range	CHEMBL1922121	=	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267711	16301451	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@H](C)O	Outside typical range	CHEMBL1922218	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267712	16302763	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@@H](C)O	Outside typical range	CHEMBL1922219	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267717	16303271	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)(C)C	Outside typical range	CHEMBL1922122	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267720	16314702	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(C)(C)O	Outside typical range	CHEMBL1922212	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267716	16327095	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)C	Outside typical range	CHEMBL1922210	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
267718	16344982	CHEMBL3707736	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)(C)C	Outside typical range	CHEMBL1922211	>	IC50	nM	200000.0	CHEMBL4101	Homo sapiens	IC50	nM	200000.0
	16379687	CHEMBL3739160	Inhibition of PKACalpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	4.0	CHEMBL4101	Homo sapiens	INH	%	4.0
	16379688	CHEMBL3739160	Inhibition of PKACalpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	18.4	CHEMBL4101	Homo sapiens	INH	%	18.4
	16388318	CHEMBL3737493	Inhibition of PRKACA (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	3.0	CHEMBL4101	Homo sapiens	INH	%	3.0
	16458581	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	-8.0	CHEMBL4101	Homo sapiens	INH	%	-8.0
	16458582	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	-6.0	CHEMBL4101	Homo sapiens	INH	%	-6.0
	16458583	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	-5.0	CHEMBL4101	Homo sapiens	INH	%	-5.0
	16458584	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	-5.0	CHEMBL4101	Homo sapiens	INH	%	-5.0
	16458585	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	9.0	CHEMBL4101	Homo sapiens	INH	%	9.0
	16458586	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	16458587	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	1.0	CHEMBL4101	Homo sapiens	INH	%	1.0
	16458588	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	16458589	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-1.0	CHEMBL4101	Homo sapiens	INH	%	-1.0
	16458590	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	8.0	CHEMBL4101	Homo sapiens	INH	%	8.0
	16458591	CHEMBL3761597	Inhibition of PRKACA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-10.0	CHEMBL4101	Homo sapiens	INH	%	-10.0
	16486380	CHEMBL3771946	Inhibition of human recombinant PKACalpha assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	94.0	CHEMBL4101	Homo sapiens	Activity	%	94.0
Not Active	16506515	CHEMBL3776510	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Active	16506516	CHEMBL3776511	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Active	16515645	CHEMBL3782386	Inhibition of partial length human PKACalpha expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	16525656	CHEMBL3790303	Inhibition of PRKACA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	16525657	CHEMBL3790303	Inhibition of PRKACA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	16525658	CHEMBL3790303	Inhibition of PRKACA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	780.0	CHEMBL4101	Homo sapiens	IC50	uM	0.78
	16525659	CHEMBL3790303	Inhibition of PRKACA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	16525660	CHEMBL3790303	Inhibition of PRKACA (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	16525661	CHEMBL3790303	Inhibition of PRKACA (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	16559748	CHEMBL3794947	Inhibition of full length human N-terminal GST-tagged PKACalpha (1 to 351 residues) expressed in baculovirus expression system using fluorescence labelled kemptide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	3.1	CHEMBL4101	Homo sapiens	INH	%	3.1
	16559749	CHEMBL3794947	Inhibition of full length human N-terminal GST-tagged PKACalpha (1 to 351 residues) expressed in baculovirus expression system using fluorescence labelled kemptide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	2.7	CHEMBL4101	Homo sapiens	INH	%	2.7
	16559750	CHEMBL3794947	Inhibition of full length human N-terminal GST-tagged PKACalpha (1 to 351 residues) expressed in baculovirus expression system using fluorescence labelled kemptide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-1.4	CHEMBL4101	Homo sapiens	INH	%	-1.4
	16565773	CHEMBL3801113	Inhibition of human PKACA using GRTGRRNSI-NH2 as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356433	<	IC50	nM	1.0	CHEMBL4101	Homo sapiens	IC50	nM	1.0
	16565774	CHEMBL3801113	Inhibition of human PKACA using GRTGRRNSI-NH2 as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	Cc1[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c2c1C		CHEMBL3799326	>	IC50	nM	1000.0	CHEMBL4101	Homo sapiens	IC50	nM	1000.0
	16565775	CHEMBL3801113	Inhibition of human PKACA using GRTGRRNSI-NH2 as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3797874	>	IC50	nM	1000.0	CHEMBL4101	Homo sapiens	IC50	nM	1000.0
	16566674	CHEMBL3801316	Inhibition of human PRKACA at 300 nM using GRTGRRNSI-NH2 as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356433	>	Inhibition	%	90.0	CHEMBL4101	Homo sapiens	INH	%	90.0
	16587042	CHEMBL3807853	Inhibition of PKAalpha (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	uM	10.0
	16593516	CHEMBL3812368	Inhibition of His-tagged human recombinant PKA C-alpha (1 to 351 residues) expressed in Escherichia coli using Fluorescein-Crosstide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4101	Homo sapiens	INH	%	40.0
	16594849	CHEMBL3812888	Inhibition of human PKAC-alpha (10 to 351 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	84.0	CHEMBL4101	Homo sapiens	Activity	%	84.0
	16612658	CHEMBL3815504	Inhibition of human PKA alpha (2 to 351 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-66.0	CHEMBL4101	Homo sapiens	Activity	%	-66.0
	16612659	CHEMBL3815504	Inhibition of human PKA alpha (2 to 351 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-54.0	CHEMBL4101	Homo sapiens	Activity	%	-54.0
	16612660	CHEMBL3815504	Inhibition of human PKA alpha (2 to 351 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-38.0	CHEMBL4101	Homo sapiens	Activity	%	-38.0
	16612661	CHEMBL3815504	Inhibition of human PKA alpha (2 to 351 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-42.0	CHEMBL4101	Homo sapiens	Activity	%	-42.0
	16618107	CHEMBL3816389	Inhibition of recombinant human His-tagged PRKACA catalytic domain (1 to 351 residues) expressed in Escherichia coli at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	16618127	CHEMBL3816513	Inhibition of recombinant human His-tagged PRKAA1 catalytic domain (1 to 351 residues) expressed in Escherichia coli at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	16618128	CHEMBL3816514	Inhibition of recombinant human His-tagged PRKAA2 catalytic domain (1 to 351 residues) expressed in Escherichia coli at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	16619689	CHEMBL3820257	Inhibition of recombinant human full length His-tagged PRKACA expressed in Escherichia coli at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL4101	Homo sapiens	INH	%	75.0
	16621540	CHEMBL3820843	Inhibition of PKACalpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL4101	Homo sapiens	IC50	nM	30000.0
	16622247	CHEMBL3820843	Inhibition of PKACalpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.3	CHEMBL4101	Homo sapiens	IC50	nM	2.3
	16627558	CHEMBL3820355	Inhibition of full length recombinant human PKAC-alpha expressed in Escherichia coli BL21(DE3) pLysS cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-4.0	CHEMBL4101	Homo sapiens	INH	%	-4.0
	16627559	CHEMBL3820355	Inhibition of full length recombinant human PKAC-alpha expressed in Escherichia coli BL21(DE3) pLysS cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	-10.0	CHEMBL4101	Homo sapiens	INH	%	-10.0
	16667610	CHEMBL3854608	Binding affinity to PKAalpha (unknown origin) using Lys-Arg-Thr-Leu-Arg-Arg as substrate after 8 mins in presence of [gamma-32P]ATP by liquid scintillation spectrometry	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	Kd	nM	3.9	CHEMBL4101	Homo sapiens	Kd	nM	3.9
	16737960	CHEMBL3856677	Inhibition of human recombinant PRKACA expressed in Escherichia coli assessed as remaining activity at 10 uM preincubated for 15 mins followed by PKA substrate peptide addition measured after 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	112.0	CHEMBL4101	Homo sapiens	Activity	%	112.0
	16739442	CHEMBL3857072	Inhibition of His tagged recombinant human PRKACA catalytic domain (1 to 351 residues) expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	8.0	CHEMBL4101	Homo sapiens	INH	%	8.0
	16739520	CHEMBL3857072	Inhibition of His tagged recombinant human PRKACA catalytic domain (1 to 351 residues) expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	5.0	CHEMBL4101	Homo sapiens	INH	%	5.0
	16739521	CHEMBL3857072	Inhibition of His tagged recombinant human PRKACA catalytic domain (1 to 351 residues) expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-10.0	CHEMBL4101	Homo sapiens	INH	%	-10.0
	16837460	CHEMBL3876122	Inhibition of human recombinant His-tagged PRKACA catalytic domain (1 to 351 residues) expressed in Escherichia coli	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	nM	10000.0
	16888315	CHEMBL3881289	Inhibition of full length human recombinant PKA catalytic subunit type alpha using GRTGRRNSI peptide substrate and [gamma33P]-ATP incubated for 20 mins by scintillation counting method	B	NCC(O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3922916	<	IC50	nM	1000.0	CHEMBL4101	Homo sapiens	IC50	uM	1.0
	16888316	CHEMBL3881289	Inhibition of full length human recombinant PKA catalytic subunit type alpha using GRTGRRNSI peptide substrate and [gamma33P]-ATP incubated for 20 mins by scintillation counting method	B	NC[C@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3942454	=	IC50	nM	250.0	CHEMBL4101	Homo sapiens	IC50	uM	0.25
	16888320	CHEMBL3881291	Inhibition of full length human recombinant PKA catalytic subunit type alpha at 0.03 uM using GRTGRRNSI peptide substrate and [gamma33P]-ATP incubated for 20 mins by scintillation counting method	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	=	Inhibition	%	44.0	CHEMBL4101	Homo sapiens	INH	%	44.0
412044	17776759	CHEMBL3888687	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL4101	Homo sapiens	IC50	nM	10000.0
Inactive	17928339	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928340	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928341	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928342	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928343	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928344	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928345	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928346	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928347	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928348	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928349	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928350	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928351	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928352	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928353	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928354	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928355	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928356	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928357	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928358	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928359	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928360	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928361	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928362	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928363	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928364	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928365	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928366	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928367	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928368	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928369	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928370	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Active	17928371	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	935.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	935.0
Active	17928372	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	10.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	10.0
Inactive	17928373	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928374	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928375	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928376	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928377	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928378	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928379	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928380	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928381	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928382	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928383	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928384	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928385	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928386	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928387	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928388	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928389	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928390	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928391	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928392	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928393	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928394	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928395	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928396	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928397	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928398	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928399	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928400	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928401	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928402	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928403	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928404	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928405	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928406	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928407	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928408	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Active	17928409	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	3191.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	3191.0
Inactive	17928410	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928411	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928412	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928413	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928414	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928415	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928416	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928417	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928418	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928419	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928420	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928421	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928422	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928423	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928424	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928425	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928426	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Active	17928427	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	3597.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	3597.0
Inactive	17928428	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928429	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928430	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928431	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928432	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928433	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928434	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928435	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928436	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928437	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928438	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928439	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928440	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928441	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17928442	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	=	Kd	nM	13.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	13.0
Inactive	17928443	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928444	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928445	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928446	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928447	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928448	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928449	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928450	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928451	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928452	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928453	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928454	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928455	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928456	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928457	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928458	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928459	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928460	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928461	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928462	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928463	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928464	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928465	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928466	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928467	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928468	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928469	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928470	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928471	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928472	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928473	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928474	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928475	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928476	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928477	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928478	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928479	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928480	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928481	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928482	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928483	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928484	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928485	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928486	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928487	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Active	17928488	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	916.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	916.0
Active	17928489	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	387.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	387.0
Inactive	17928490	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928491	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928492	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928493	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928494	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928495	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928496	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928497	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928498	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928499	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928500	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928501	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928502	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928503	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928504	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928505	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928506	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928507	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928508	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928509	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928510	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928511	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928512	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928513	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Active	17928514	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	23245.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	23245.0
Inactive	17928515	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928516	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928517	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928518	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928519	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928520	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928521	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928522	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928523	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928524	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928525	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928526	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928527	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928528	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928529	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928530	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928531	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928532	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928533	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928534	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Active	17928535	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	=	Kd	nM	15.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	15.0
Inactive	17928536	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928537	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928538	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928539	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928540	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928541	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928542	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928543	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928544	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928545	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928546	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928547	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928548	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928549	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928550	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928551	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928552	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928553	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928554	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928555	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928556	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928557	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928558	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928559	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928560	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928561	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928562	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928563	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928564	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928565	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928566	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928567	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928568	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928569	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928570	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928571	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928572	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928573	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Active	17928574	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	=	Kd	nM	133.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	133.0
Inactive	17928575	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928576	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928577	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928578	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928579	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928580	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17928581	CHEMBL3991836	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4101	Homo sapiens	Kd apparent	nM	30000.0
	17964942	CHEMBL3995051	Inhibition of human PKACalpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	75.0	CHEMBL4101	Homo sapiens	Activity	%	75.0
	17979268	CHEMBL3998072	Inhibition of recombinant human His-tagged PKACalpha catalytic domain (1 to 351 residues) expressed in Escherichia coli at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21	Outside typical range	CHEMBL4061152	=	Inhibition	%	-14.0	CHEMBL4101	Homo sapiens	INH	%	-14.0
	18102167	CHEMBL4022204	Inhibition of recombinant human His-tagged PKA catalytic domain (1 to 351 residues) expressed in Escherichia coli using Ser/Thr 7 as substrate after 1 hr by by FRET-based Z'-Lyte assay	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	<	IC50	nM	10.0	CHEMBL4101	Homo sapiens	IC50	nM	10.0
	18114798	CHEMBL4025328	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	18203852	CHEMBL4044139	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	18231703	CHEMBL4050195	Inhibition of human PKACA using LCGRTGRRNSI as substrate in presence of [gamma-32P]ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.58	CHEMBL4101	Homo sapiens	IC50	10'-9M	1.58
Not Determined	18231733	CHEMBL4050195	Inhibition of human PKACA using LCGRTGRRNSI as substrate in presence of [gamma-32P]ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339		IC50			CHEMBL4101	Homo sapiens	IC50		
	18248613	CHEMBL4053896	Inhibition of PRKACA (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	18253921	CHEMBL4055245	Inhibition of wild-type human partial length PKACA (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	18253922	CHEMBL4055245	Inhibition of wild-type human partial length PKACA (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	18265744	CHEMBL4057194	Inhibition of PKC-alpha (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.7	CHEMBL4101	Homo sapiens	INH	%	13.7
	18265960	CHEMBL4057410	Inhibition of PKC-alpha (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	18282739	CHEMBL4120324	Inhibition of PKC-alpha (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.7	CHEMBL4101	Homo sapiens	INH	%	13.7
	18282916	CHEMBL4120501	Inhibition of PKC-alpha (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-1.7	CHEMBL4101	Homo sapiens	INH	%	-1.7
	18283136	CHEMBL4120721	Inhibition of PKC-alpha (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	1.3	CHEMBL4101	Homo sapiens	INH	%	1.3
	18286324	CHEMBL4121559	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-4.0	CHEMBL4101	Homo sapiens	INH	%	-4.0
	18420974	CHEMBL4153931	Inhibition of DNA-tagged PKACalpha (unknown origin) expressed in HEK293 cells at 10 uM after 1 hr by real-time fluorescent quantitative PCR analysis	B	Fc1ccc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cc1		CHEMBL4175978	=	Inhibition	%	0.0	CHEMBL4101	Homo sapiens	INH	%	0.0
	18431079	CHEMBL4155760	Inhibition of recombinant his-tagged human PKA catalytic domain expressed in Escherichia coli at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	91.0	CHEMBL4101	Homo sapiens	INH	%	91.0
	18440394	CHEMBL4157218	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	94.0	CHEMBL4101	Homo sapiens	Activity	%	94.0
	18449837	CHEMBL4178074	Inhibition of human PKAalpha (2 to 351 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	115.0	CHEMBL4101	Homo sapiens	Activity	%	115.0
	18450267	CHEMBL4178313	Inhibition of recombinant human full length N-terminal GST-tagged PKACalpha expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-2.0	CHEMBL4101	Homo sapiens	Activity	%	-2.0
	18450317	CHEMBL4178313	Inhibition of recombinant human full length N-terminal GST-tagged PKACalpha expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	0.0	CHEMBL4101	Homo sapiens	Activity	%	0.0
	18462188	CHEMBL4180875	Inhibition of recombinant human full length GST-tagged PKA expressed in Escherichia coli assessed as residual activity at 1 uM using LRRASLG peptide substrate after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	96.0	CHEMBL4101	Homo sapiens	Activity	%	96.0
	18463781	CHEMBL4181197	Inhibition of recombinant human full length PKA expressed in Escherichia coli BL21(DE3) pLysS cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-5.0	CHEMBL4101	Homo sapiens	INH	%	-5.0
	18484350	CHEMBL4185997	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	18484834	CHEMBL4185997	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	87.0	CHEMBL4101	Homo sapiens	Activity	%	87.0
	18489554	CHEMBL4187295	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	85.0	CHEMBL4101	Homo sapiens	Activity	%	85.0
	18507659	CHEMBL4191132	Inhibition of recombinant full-length human PRKACA at 1 uM using LRRASLG (Kemptide) as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	4.0	CHEMBL4101	Homo sapiens	INH	%	4.0
	18653409	CHEMBL4230201	Inhibition of PRKACA (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	2.0	CHEMBL4101	Homo sapiens	INH	%	2.0
	18653410	CHEMBL4230201	Inhibition of PRKACA (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	4.0	CHEMBL4101	Homo sapiens	INH	%	4.0
	18655338	CHEMBL4230897	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	18663950	CHEMBL4232934	Inhibition of human PKACalpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	88.0	CHEMBL4101	Homo sapiens	Activity	%	88.0
	18664047	CHEMBL4233031	Binding affinity to human PKACalpha (G10 to F351 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4101	Homo sapiens	Kd	uM	5.0
	18665459	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	CN1CCC(CCCOc2cccc(CC(=O)Nc3nc(-c4ccncc4)cs3)c2)CC1		CHEMBL4237479	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665498	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665501	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4ccncc4)cs3)c2)CC1		CHEMBL4241204	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665571	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665574	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(OCCCN2CCOCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4241299	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665577	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(OCCCN2CCCCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4249314	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665580	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	CN1CCN(CCOc2cccc(CC(=O)Nc3nc(-c4ccncc4)cs3)c2)CC1		CHEMBL4241689	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665583	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(OCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4240949	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665586	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(OCCN2CCOCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4248852	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	nM	4000.0
	18665589	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	O=C(Cc1cccc(OCCN2CCCCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4242549	=	Ki	nM	580.0	CHEMBL4101	Homo sapiens	Ki	nM	580.0
	18665592	CHEMBL4233279	Inhibition of PKAalpha (1 to 351 residues) (unknown origin) using Leu-Arg-Arg-Ala-Ser-Leu-Gly as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	B	COc1cccc(CC(=O)Nc2nc(-c3ccncc3)cs2)c1		CHEMBL3581121	=	Ki	nM	1400.0	CHEMBL4101	Homo sapiens	Ki	nM	1400.0
	18694020	CHEMBL4253473	Inhibition of recombinant human His-tagged PKA expressed in Escherichia coli at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	0.0	CHEMBL4101	Homo sapiens	INH	%	0.0
	18694102	CHEMBL4253555	Inhibition of recombinant human His-tagged PKA expressed in Escherichia coli at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	8.0	CHEMBL4101	Homo sapiens	INH	%	8.0
	18697677	CHEMBL4254350	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	79.0	CHEMBL4101	Homo sapiens	Activity	%	79.0
	18702478	CHEMBL4255129	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1	Outside typical range	CHEMBL4278211	=	Inhibition	%	-12.0	CHEMBL4101	Homo sapiens	INH	%	-12.0
	18702560	CHEMBL4255129	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	-1.0	CHEMBL4101	Homo sapiens	INH	%	-1.0
	18702605	CHEMBL4255129	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	-5.0	CHEMBL4101	Homo sapiens	INH	%	-5.0
	18702657	CHEMBL4255129	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	1.0	CHEMBL4101	Homo sapiens	INH	%	1.0
	18702700	CHEMBL4255129	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	-1.0	CHEMBL4101	Homo sapiens	INH	%	-1.0
	18702743	CHEMBL4255129	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	3.0	CHEMBL4101	Homo sapiens	INH	%	3.0
	18725406	CHEMBL4259103	Inhibition of PKC-alpha (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	18751215	CHEMBL4263924	Inhibition of PRKACA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-1.0	CHEMBL4101	Homo sapiens	INH	%	-1.0
	18752149	CHEMBL4264486	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	87.0	CHEMBL4101	Homo sapiens	Activity	%	87.0
	18786934	CHEMBL4271848	Inhibition of PKAalpha (unknown origin) at 30 uM relative to control	B	O=c1cc(-c2ccc(-c3ccccc3)cc2)c2ccc(N3CCC(NCCc4ccccc4)CC3)cc2o1		CHEMBL4276817	=	Inhibition	%	5.17	CHEMBL4101	Homo sapiens	INH	%	5.17
Not Active	18847277	CHEMBL4304943	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	18858149	CHEMBL4307995	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	84.0	CHEMBL4101	Homo sapiens	Activity	%	84.0
	18892946	CHEMBL4314912	Inhibition of recombinant full-length human PKA assessed as residual activity at 10 uM using Kemptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	91.0	CHEMBL4101	Homo sapiens	Activity	%	91.0
	18919561	CHEMBL4322917	Binding affinity to recombinant human full length N-terminal GST-tagged PRKACA expressed in baculovirus expression system using kemptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	116.0	CHEMBL4101	Homo sapiens	Kd	nM	116.0
	18919749	CHEMBL4322917	Binding affinity to recombinant human full length N-terminal GST-tagged PRKACA expressed in baculovirus expression system using kemptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	42.0	CHEMBL4101	Homo sapiens	Kd	nM	42.0
	18938207	CHEMBL4327830	Inhibition of human PKA assessed as residual activity at 1 uM using LCGRTGRRNSI as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	94.8	CHEMBL4101	Homo sapiens	Activity	%	94.8
	18938208	CHEMBL4327830	Inhibition of human PKA assessed as residual activity at 1 uM using LCGRTGRRNSI as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.57	CHEMBL4101	Homo sapiens	Activity	%	99.57
	18938675	CHEMBL4328194	Inhibition of human PKA assessed as residual activity at 100 uM using LCGRTGRRNSI as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4101	Homo sapiens	Activity	%	65.0
	18939059	CHEMBL4328558	Inhibition of human PKA using LCGRTGRRNSI as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.935	CHEMBL4101	Homo sapiens	IC50	10'-10M	9.35
	18958611	CHEMBL4333580	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	85.0	CHEMBL4101	Homo sapiens	Activity	%	85.0
	18964582	CHEMBL4335232	Inhibition of recombinant human PKA assessed as residual activity at 1 uM using Kemptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	107.0	CHEMBL4101	Homo sapiens	Activity	%	107.0
	18964583	CHEMBL4335232	Inhibition of recombinant human PKA assessed as residual activity at 1 uM using Kemptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	82.0	CHEMBL4101	Homo sapiens	Activity	%	82.0
	18972045	CHEMBL4337055	Inhibition of recombinant human PKA assessed as residual activity at 10 uM relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	82.0	CHEMBL4101	Homo sapiens	Activity	%	82.0
	19030025	CHEMBL4349164	Inhibition of recombinant human His-tagged PRKACA catalytic domain (1 to 351 residues) expressed in Escherichia coli assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	86.0	CHEMBL4101	Homo sapiens	Activity	%	86.0
Not Active	19040103	CHEMBL4352007	Inhibition of recombinant full-length human PKA at 10 uM using Kemptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	19059774	CHEMBL4358075	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	19090338	CHEMBL4365912	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	81.0	CHEMBL4101	Homo sapiens	Activity	%	81.0
	19092068	CHEMBL4366542	Inhibition of human PKA at 100 nM using LCGRTGRRNSI as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	15.14	CHEMBL4101	Homo sapiens	INH	%	15.14
	19092278	CHEMBL4366698	Inhibition of PKA (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	43.0	CHEMBL4101	Homo sapiens	INH	%	43.0
	19140834	CHEMBL4376598	Inhibition of recombinant full length human His-tagged PRKACA expressed in Escherichia coli at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	19144749	CHEMBL4377765	Inhibition of recombinant full-length human PKA at 1 uM using Kemptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	1.0	CHEMBL4101	Homo sapiens	INH	%	1.0
	19154465	CHEMBL4380700	Inhibition of PKAC-alpha (unknown origin) using CREBtide as substrate at 5 uM incubated for 40 mins in presence of 10 uM ATP by kiase-Glo luminescence assay relative to control	B	COc1ccc2c(c1)cc1n2CCN2C(=O)c3cc(F)ccc3N(C)C12		CHEMBL4537640	<	Inhibition	%	20.0	CHEMBL4101	Homo sapiens	INH	%	20.0
	19159602	CHEMBL4382706	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	19191405	CHEMBL4389425	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	98.0	CHEMBL4101	Homo sapiens	INH	%	98.0
	19192088	CHEMBL4389902	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	76.0	CHEMBL4101	Homo sapiens	INH	%	76.0
	19200344	CHEMBL4391528	Binding affinity to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	19225484	CHEMBL4395904	Inhibition of human recombinant PKA at 1 uM using Ulight-RRRSLLE as substrate measured after 10 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	-7.3	CHEMBL4101	Homo sapiens	INH	%	-7.3
	19230867	CHEMBL4397154	Inhibition of PKA (unknown origin) expressed in Escherichia coli at 100 nM using PKA substrate peptide preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 10 mins by topcount scintillation counting method relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	12.0	CHEMBL4101	Homo sapiens	INH	%	12.0
	19240667	CHEMBL4399587	Inhibition of protein kinase A (unknown origin) using Kemptide (LRRASLG) as substrate incubated for 15 mins in presence of ATP by spectrophotometric analysis	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ccc23)n1		CHEMBL4453941	=	Ki	nM	110.0	CHEMBL4101	Homo sapiens	Ki	nM	110.0
	19240668	CHEMBL4399587	Inhibition of protein kinase A (unknown origin) using Kemptide (LRRASLG) as substrate incubated for 15 mins in presence of ATP by spectrophotometric analysis	B	NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CCOCC1		CHEMBL4457150	=	Ki	nM	30.0	CHEMBL4101	Homo sapiens	Ki	nM	30.0
	19242743	CHEMBL4400078	Inhibition of recombinant full length human PRKACA assessed as residual activity at 10 uM using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	77.0	CHEMBL4101	Homo sapiens	Activity	%	77.0
	19266567	CHEMBL4405517	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4101	Homo sapiens	INH	%	50.0
	19298487	CHEMBL4413162	Binding affinity to wild-type partial length human PKACalpha (G10 to F351 residues) expressed in bacterial expression system by Kinomescan assay	B	CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@@H]42)C=C3[C@@H](O)[C@@H]1O		CHEMBL4080906	=	Kd	nM	3500.0	CHEMBL4101	Homo sapiens	Kd	nM	3500.0
	19371149	CHEMBL4424901	Inhibition of full length human untagged PKAalpha expressed in Escherichia coli BL21 (DE3) pLysS cells using Kemptide as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL4101	Homo sapiens	IC50	nM	1000.0
	19476620	CHEMBL4479768	Inhibition of recombinant human His-tagged PRKACA catalytic domain expressed in Escherichia coli by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	15000.0	CHEMBL4101	Homo sapiens	IC50	nM	15000.0
	19476720	CHEMBL4479768	Inhibition of recombinant human His-tagged PRKACA catalytic domain expressed in Escherichia coli by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	nM	100000.0
	19476820	CHEMBL4479768	Inhibition of recombinant human His-tagged PRKACA catalytic domain expressed in Escherichia coli by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	27.0	CHEMBL4101	Homo sapiens	IC50	nM	27.0
	19476920	CHEMBL4479768	Inhibition of recombinant human His-tagged PRKACA catalytic domain expressed in Escherichia coli by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	3000.0	CHEMBL4101	Homo sapiens	IC50	nM	3000.0
	20600636	CHEMBL4603588	Inhibition of recombinant human His-tagged PRKACA catalytic domain expressed in Escherichia coli using fluorophore-labeled serine/threonine-1 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4101	Homo sapiens	IC50	uM	100.0
	20601681	CHEMBL4603813	Inhibition of recombinant human His-tagged PRKACA (1 to 351 residues) expressed in Escherichia coli expression system using Ser/Thr01 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	0.0	CHEMBL4101	Homo sapiens	INH	%	0.0
	20669038	CHEMBL4620285	Inhibition of biotinylated ligand binding to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cccc6cnccc56)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4637601	>	Inhibition	%	80.0	CHEMBL4101	Homo sapiens	INH	%	80.0
	20669039	CHEMBL4620285	Inhibition of biotinylated ligand binding to wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4637411	>	Inhibition	%	80.0	CHEMBL4101	Homo sapiens	INH	%	80.0
	22391722	CHEMBL4666980	Inhibition of recombinant human His-tagged PKA (1 to 351 residues) expressed in Escherichia coli expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	5.0	CHEMBL4101	Homo sapiens	INH	%	5.0
	22391723	CHEMBL4666980	Inhibition of recombinant human His-tagged PKA (1 to 351 residues) expressed in Escherichia coli expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	-4.0	CHEMBL4101	Homo sapiens	INH	%	-4.0
	22391724	CHEMBL4666980	Inhibition of recombinant human His-tagged PKA (1 to 351 residues) expressed in Escherichia coli expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	5.0	CHEMBL4101	Homo sapiens	INH	%	5.0
	22446998	CHEMBL4679716	Inhibition of PKA (unknown origin)	B	Cc1nc(NC(=O)NCCc2cn(CC(F)F)cn2)sc1C#Cc1cccnc1		CHEMBL4795990	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	22446999	CHEMBL4679716	Inhibition of PKA (unknown origin)	B	COc1cc(C#Cc2sc(NC(=O)NCCOCC3CC3)nc2C)cnc1OC		CHEMBL4759283	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	22447000	CHEMBL4679716	Inhibition of PKA (unknown origin)	B	Cc1nc(NC(=O)NCCOCC2CC2)sc1C#Cc1ccc2cncn2c1		CHEMBL4764646	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	22447001	CHEMBL4679716	Inhibition of PKA (unknown origin)	B	Cc1cncc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)c1		CHEMBL4784202	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	22447002	CHEMBL4679716	Inhibition of PKA (unknown origin)	B	Cc1cc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)cnc1C		CHEMBL4756664	>	Ki	nM	4000.0	CHEMBL4101	Homo sapiens	Ki	uM	4.0
	22470405	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C(=O)N(C)C)C4)CC1)c1ccc(Cl)cc1		CHEMBL4744557	=	Activity	%	80.0	CHEMBL4101	Homo sapiens	Activity	%	80.0
	22470406	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1)c1ccccc1Cl		CHEMBL4744717	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	22470407	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	COc1ccc(C(CNC(C)C)C(=O)N2CCN(c3ncnc4sc5c(c34)CCC5)CC2)cc1		CHEMBL4776972	=	Activity	%	66.0	CHEMBL4101	Homo sapiens	Activity	%	66.0
	22470408	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1)c1ccc(Br)cc1		CHEMBL4787195	=	Activity	%	23.0	CHEMBL4101	Homo sapiens	Activity	%	23.0
	22470409	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1)c1ccc(F)cc1		CHEMBL4753482	=	Activity	%	77.0	CHEMBL4101	Homo sapiens	Activity	%	77.0
	22470410	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	O=C(C(CNC1CCCCC1)c1ccc(Cl)cc1)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1		CHEMBL4745768	=	Activity	%	29.0	CHEMBL4101	Homo sapiens	Activity	%	29.0
	22470411	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	O=C(C(CNC1CCCC1)c1ccc(Cl)cc1)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1		CHEMBL4757904	=	Activity	%	35.0	CHEMBL4101	Homo sapiens	Activity	%	35.0
	22470412	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CCCCNCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1)c1ccc(Cl)cc1		CHEMBL4781445	=	Activity	%	37.0	CHEMBL4101	Homo sapiens	Activity	%	37.0
	22470413	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CCNCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1)c1ccc(Cl)cc1		CHEMBL4793499	=	Activity	%	31.0	CHEMBL4101	Homo sapiens	Activity	%	31.0
	22470414	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCOC4)CC1)c1ccc(Cl)cc1		CHEMBL4749173	=	Activity	%	78.0	CHEMBL4101	Homo sapiens	Activity	%	78.0
	22470415	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1)c1ccc(Cl)cc1		CHEMBL4785199	=	Activity	%	45.0	CHEMBL4101	Homo sapiens	Activity	%	45.0
	22470416	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1)c1ccc(Cl)cc1		CHEMBL4750379	=	Activity	%	78.0	CHEMBL4101	Homo sapiens	Activity	%	78.0
	22470417	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C)C4)CC1)c1ccccc1Cl		CHEMBL4800620	=	Activity	%	86.0	CHEMBL4101	Homo sapiens	Activity	%	86.0
	22470418	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	COc1ccc(C(CNC(C)C)C(=O)N2CCN(c3ncnc4sc5c(c34)CCN(C)C5)CC2)cc1		CHEMBL4781839	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	22470419	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	Cc1ccc(C(CNC(C)C)C(=O)N2CCN(c3ncnc4sc5c(c34)CCN(C)C5)CC2)cc1		CHEMBL4776552	=	Activity	%	90.0	CHEMBL4101	Homo sapiens	Activity	%	90.0
	22470420	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C)C4)CC1)c1ccc(Br)cc1		CHEMBL4747290	=	Activity	%	88.0	CHEMBL4101	Homo sapiens	Activity	%	88.0
	22470421	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C)C4)CC1)c1ccc(F)cc1		CHEMBL4797537	=	Activity	%	97.0	CHEMBL4101	Homo sapiens	Activity	%	97.0
	22470422	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CN1CCc2c(sc3ncnc(N4CCN(C(=O)C(CNC5CCCCC5)c5ccc(Cl)cc5)CC4)c23)C1		CHEMBL4754428	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	22470423	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CN1CCc2c(sc3ncnc(N4CCN(C(=O)C(CNC5CCCC5)c5ccc(Cl)cc5)CC4)c23)C1		CHEMBL4756067	=	Activity	%	82.0	CHEMBL4101	Homo sapiens	Activity	%	82.0
	22470424	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CCCCNCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C)C4)CC1)c1ccc(Cl)cc1		CHEMBL4762720	=	Activity	%	81.0	CHEMBL4101	Homo sapiens	Activity	%	81.0
	22470425	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CCNCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C)C4)CC1)c1ccc(Cl)cc1		CHEMBL4787253	=	Activity	%	91.0	CHEMBL4101	Homo sapiens	Activity	%	91.0
	22470426	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C(C)C)C4)CC1)c1ccc(Cl)cc1		CHEMBL4762457	=	Activity	%	84.0	CHEMBL4101	Homo sapiens	Activity	%	84.0
	22470427	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C2CC2)C4)CC1)c1ccc(Cl)cc1		CHEMBL4783415	=	Activity	%	92.0	CHEMBL4101	Homo sapiens	Activity	%	92.0
	22470428	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(Cc2ccccc2)C4)CC1)c1ccc(Cl)cc1		CHEMBL4788316	=	Activity	%	80.0	CHEMBL4101	Homo sapiens	Activity	%	80.0
	22470429	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CCCN1CCc2c(sc3ncnc(N4CCN(C(=O)C(CNC(C)C)c5ccc(Cl)cc5)CC4)c23)C1		CHEMBL4742710	=	Activity	%	88.0	CHEMBL4101	Homo sapiens	Activity	%	88.0
	22470430	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CCN1CCc2c(sc3ncnc(N4CCN(C(=O)C(CNC(C)C)c5ccc(Cl)cc5)CC4)c23)C1		CHEMBL4755498	=	Activity	%	87.0	CHEMBL4101	Homo sapiens	Activity	%	87.0
	22470431	CHEMBL4685023	Inhibition of full length human PKAcalpha assessed as remaining activity at 1 uM using LRRASLG as substrate incubated for 40 mins by scintillation counting method relative to control	B	CC(C)NCC(C(=O)N1CCN(c2ncnc3sc4c(c23)CCN(C)C4)CC1)c1ccc(Cl)cc1		CHEMBL4758396	=	Activity	%	72.0	CHEMBL4101	Homo sapiens	Activity	%	72.0
	22836366	CHEMBL4718883	Inhibition of recombinant human His-tagged PRKACA (1 to 351 residues) expressed in Escherichia coli expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-10.0	CHEMBL4101	Homo sapiens	INH	%	-10.0
	22836367	CHEMBL4718883	Inhibition of recombinant human His-tagged PRKACA (1 to 351 residues) expressed in Escherichia coli expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	7.0	CHEMBL4101	Homo sapiens	INH	%	7.0
	22836368	CHEMBL4718883	Inhibition of recombinant human His-tagged PRKACA (1 to 351 residues) expressed in Escherichia coli expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	4.0	CHEMBL4101	Homo sapiens	INH	%	4.0
	22836369	CHEMBL4718883	Inhibition of recombinant human His-tagged PRKACA (1 to 351 residues) expressed in Escherichia coli expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	6.0	CHEMBL4101	Homo sapiens	INH	%	6.0
	22836370	CHEMBL4718883	Inhibition of recombinant human His-tagged PRKACA (1 to 351 residues) expressed in Escherichia coli expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	-1.0	CHEMBL4101	Homo sapiens	INH	%	-1.0
	22836371	CHEMBL4718883	Inhibition of recombinant human His-tagged PRKACA (1 to 351 residues) expressed in Escherichia coli expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	1.0	CHEMBL4101	Homo sapiens	INH	%	1.0
	22845469	CHEMBL4721750	Binding affinity to Nluc-tagged PRKACA (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	3.06	CHEMBL4101	Homo sapiens	deltaTm	degrees C	3.06
	22845492	CHEMBL4721773	Binding affinity to PRKACA (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	613.0	CHEMBL4101	Homo sapiens	IC50	nM	613.0
Not Active	22889551	CHEMBL4729070	Inhibition of wild-type human partial length PKAC-alpha (G10 to F351 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Active	22909967	CHEMBL4734083	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli expression system using serine/threonine-01 peptide as substrate at 10 uM by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Active	22909968	CHEMBL4734083	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli expression system using serine/threonine-01 peptide as substrate at 10 uM by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Active	22909969	CHEMBL4734083	Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli expression system using serine/threonine-01 peptide as substrate at 10 uM by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
Not Active	22936056	CHEMBL4739753	Inhibition of human PKACalpha at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL4101	Homo sapiens	INH		
	23122759	CHEMBL4805110	Inhibition of human PKAC-alpha assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	93.0	CHEMBL4101	Homo sapiens	Activity	%	93.0
	23123454	CHEMBL4805698	Inhibition of human PKAC-alpha assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	85.0	CHEMBL4101	Homo sapiens	Activity	%	85.0
	23123909	CHEMBL4806153	Inhibition of DNA-tagged human PKAC-alpha assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	93.0	CHEMBL4101	Homo sapiens	Activity	%	93.0
	23124998	CHEMBL4806715	Inhibition of human PKAC-alpha assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	95.0	CHEMBL4101	Homo sapiens	Activity	%	95.0
	23124999	CHEMBL4806715	Inhibition of human PKAC-alpha assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4101	Homo sapiens	Activity	%	100.0
	23290610	CHEMBL4839419	Inhibition of human PKAC-alpha at 1 uM by Kinomescan method relative to control	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	Inhibition	%	74.0	CHEMBL4101	Homo sapiens	INH	%	74.0
Not Active	23317595	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	78.0	CHEMBL4101	Homo sapiens	% Control	%	78.0
Not Active	23318063	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23318729	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	81.0	CHEMBL4101	Homo sapiens	% Control	%	81.0
Not Active	23319213	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	94.0	CHEMBL4101	Homo sapiens	% Control	%	94.0
Not Active	23319850	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23320325	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	81.9	CHEMBL4101	Homo sapiens	% Control	%	81.9
Not Active	23321003	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	91.0	CHEMBL4101	Homo sapiens	% Control	%	91.0
Not Active	23321471	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	92.0	CHEMBL4101	Homo sapiens	% Control	%	92.0
Not Active	23322101	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23322569	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23323258	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23323726	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23324095	CHEMBL4880714	PKA (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-27.0	CHEMBL4101	Homo sapiens	% inhibition	%	-27.0
Not Active	23324580	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	96.7	CHEMBL4101	Homo sapiens	% Control	%	96.7
Not Active	23325215	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	97.0	CHEMBL4101	Homo sapiens	% Control	%	97.0
Not Active	23325683	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	90.0	CHEMBL4101	Homo sapiens	% Control	%	90.0
Not Active	23326330	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	94.0	CHEMBL4101	Homo sapiens	% Control	%	94.0
Not Active	23326798	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	94.0	CHEMBL4101	Homo sapiens	% Control	%	94.0
Not Active	23327498	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	86.0	CHEMBL4101	Homo sapiens	% Control	%	86.0
Not Active	23327966	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	98.0	CHEMBL4101	Homo sapiens	% Control	%	98.0
Not Active	23328553	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	78.0	CHEMBL4101	Homo sapiens	% Control	%	78.0
Not Active	23329021	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	87.0	CHEMBL4101	Homo sapiens	% Control	%	87.0
Not Active	23329475	CHEMBL4881182	PKA(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	99.0	CHEMBL4101	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23329967	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23330435	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23331191	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23331659	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23332246	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	95.6	CHEMBL4101	Homo sapiens	% Control	%	95.6
Not Active	23332712	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23333430	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	92.3	CHEMBL4101	Homo sapiens	% Control	%	92.3
Not Active	23334069	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23334537	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23334931	CHEMBL4881554	PKA (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	95.0	CHEMBL4101	Homo sapiens	% inhibition	%	95.0
	23334932	CHEMBL4881554	PKA (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		IC50	nM	734.0	CHEMBL4101	Homo sapiens	IC50	nM	734.0
Slightly Active	23335516	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	28.0	CHEMBL4101	Homo sapiens	% Control	%	28.0
Not Active	23335984	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	90.0	CHEMBL4101	Homo sapiens	% Control	%	90.0
Not Active	23336611	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23337079	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	88.0	CHEMBL4101	Homo sapiens	% Control	%	88.0
Not Active	23337733	CHEMBL4882104	PRKACA Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	103.5	CHEMBL4101	Homo sapiens	% Ctrl	%	103.5
Not Active	23338160	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	87.0	CHEMBL4101	Homo sapiens	% Control	%	87.0
Not Active	23338628	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	91.0	CHEMBL4101	Homo sapiens	% Control	%	91.0
Not Active	23339240	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23339708	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23340345	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23340813	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23341470	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23341938	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23342554	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23343022	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Active	23343281	CHEMBL4882466	PRKACA Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	10.0	CHEMBL4101	Homo sapiens	% Ctrl	%	10.0
Not Active	23343652	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	85.0	CHEMBL4101	Homo sapiens	% Control	%	85.0
Not Active	23344120	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23344758	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	92.0	CHEMBL4101	Homo sapiens	% Control	%	92.0
Not Active	23345331	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	97.0	CHEMBL4101	Homo sapiens	% Control	%	97.0
Not Active	23345799	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	92.0	CHEMBL4101	Homo sapiens	% Control	%	92.0
Not Active	23346376	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23346844	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23347446	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	91.8	CHEMBL4101	Homo sapiens	% Control	%	91.8
Not Active	23347936	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	87.7	CHEMBL4101	Homo sapiens	% Control	%	87.7
Not Active	23348515	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23348983	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23349570	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23350188	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23350656	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23351261	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23351729	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23352186	CHEMBL4882875	PRKACA (PKA) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-2.258	CHEMBL4101	Homo sapiens	% Inhibition	%	-2.2576
Not Active	23352753	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	85.0	CHEMBL4101	Homo sapiens	% Control	%	85.0
Not Active	23353221	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	95.0	CHEMBL4101	Homo sapiens	% Control	%	95.0
Not Active	23354103	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23354571	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23355303	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	82.0	CHEMBL4101	Homo sapiens	% Control	%	82.0
Not Active	23355771	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	89.0	CHEMBL4101	Homo sapiens	% Control	%	89.0
Not Active	23356407	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23356875	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23357484	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23358131	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23358599	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	93.0	CHEMBL4101	Homo sapiens	% Control	%	93.0
Not Active	23359185	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23359783	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23360251	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23360836	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23361304	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23361877	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	83.0	CHEMBL4101	Homo sapiens	% Control	%	83.0
Not Active	23362413	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23362881	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	75.0	CHEMBL4101	Homo sapiens	% Control	%	75.0
Not Active	23363300	CHEMBL4883266	PRKACA (PKA) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	3.619	CHEMBL4101	Homo sapiens	% inhibition	%	3.6187
Not Active	23363301	CHEMBL4883266	PRKACA (PKA) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-1.573	CHEMBL4101	Homo sapiens	% inhibition	%	-1.5729
Not Active	23364523	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	78.0	CHEMBL4101	Homo sapiens	% Control	%	78.0
Not Active	23364991	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	76.0	CHEMBL4101	Homo sapiens	% Control	%	76.0
Not Active	23365730	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	89.0	CHEMBL4101	Homo sapiens	% Control	%	89.0
Not Active	23366273	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	84.0	CHEMBL4101	Homo sapiens	% Control	%	84.0
Not Active	23366863	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23367331	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23367701	CHEMBL4884054	PKA ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	94.0	CHEMBL4101	Homo sapiens	% Residual activity with Skepinone-L	%	94.0
Not Active	23368209	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	82.0	CHEMBL4101	Homo sapiens	% Control	%	82.0
Not Active	23368677	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL4101	Homo sapiens	% Control	%	95.0
Not Active	23369276	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23369744	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23370191	CHEMBL4884433	PKA(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	103.0	CHEMBL4101	Homo sapiens	% residual kinase activity	%	103.0
Not Active	23370712	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	89.0	CHEMBL4101	Homo sapiens	% Control	%	89.0
Not Active	23371180	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	77.0	CHEMBL4101	Homo sapiens	% Control	%	77.0
Not Active	23371989	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23372457	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
	23372856	CHEMBL4884821	PKAalpha(PRCALGH1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4101	Homo sapiens	pIC50		6.0
	23373265	CHEMBL4885112	PKAalpha(PRCALGH1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4101	Homo sapiens	pIC50		6.0
	23373621	CHEMBL4885398	PKAalpha(PRCALGH1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4101	Homo sapiens	pIC50		6.0
Not Active	23375357	CHEMBL4886339	protein kinase, cAMP-dependent, catalytic, alpha  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-37.0	CHEMBL4101	Homo sapiens	% inhibition	%	-37.0
Not Active	23375884	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	96.0	CHEMBL4101	Homo sapiens	% Control	%	96.0
Not Active	23376352	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	96.0	CHEMBL4101	Homo sapiens	% Control	%	96.0
Not Active	23376929	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	91.0	CHEMBL4101	Homo sapiens	% Control	%	91.0
Not Active	23377397	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	81.0	CHEMBL4101	Homo sapiens	% Control	%	81.0
Not Active	23378257	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23378725	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	99.0	CHEMBL4101	Homo sapiens	% Control	%	99.0
Not Active	23379892	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	88.0	CHEMBL4101	Homo sapiens	% Control	%	88.0
Not Active	23380360	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	88.0	CHEMBL4101	Homo sapiens	% Control	%	88.0
Not Active	23381054	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23381702	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23382170	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23382426	CHEMBL4887141	PKACa Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	29.0	CHEMBL4101	Homo sapiens	% inhibition	%	29.0
Not Active	23382794	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4101	Homo sapiens	% Control	%	100.0
Not Active	23383262	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	81.0	CHEMBL4101	Homo sapiens	% Control	%	81.0
Not Active	23383944	CHEMBL4887553	PRKACA Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	98.0	CHEMBL4101	Homo sapiens	% Ctrl	%	98.0
Not Active	23383945	CHEMBL4887553	PRKACA Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	71.0	CHEMBL4101	Homo sapiens	% Ctrl	%	71.0
Not Active	23384412	CHEMBL4888007	PKA(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	11.0	CHEMBL4101	Homo sapiens	% inhibition	%	11.0
Not Active	23384687	CHEMBL4888213	PRKACA (PKA) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	-3.0	CHEMBL4101	Homo sapiens	% Inhibition	%	-3.0
Not Active	23385177	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	90.0	CHEMBL4101	Homo sapiens	% Control	%	90.0
Not Active	23385644	CHEMBL4879901	KinomeScan assay: inhibition of PKAC-alpha	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	87.0	CHEMBL4101	Homo sapiens	% Control	%	87.0
Not Active	23385902	CHEMBL4888375	PKA Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	1.0	CHEMBL4101	Homo sapiens	% inhibition	%	1.0
